id	sid	tid	token	lemma	pos
ajcp-1397	1	1	pa	pa	PROPN
ajcp-1397	1	2	ge	ge	PROPN
ajcp-1397	1	3	1	1	NUM
ajcp-1397	1	4	pa	pa	PROPN
ajcp-1397	1	5	ge	ge	PROPN
ajcp-1397	1	6	32	32	NUM
ajcp-1397	1	7	american	american	PROPN
ajcp-1397	1	8	journal	journal	PROPN
ajcp-1397	1	9	of	of	ADP
ajcp-1397	1	10	chemistry	chemistry	NOUN
ajcp-1397	1	11	and	and	CCONJ
ajcp-1397	1	12	pharmacy	pharmacy	NOUN
ajcp-1397	1	13	(	(	PUNCT
ajcp-1397	1	14	ajcp	ajcp	NOUN
ajcp-1397	1	15	)	)	PUNCT
ajcp-1397	1	16	covid	covid	PROPN
ajcp-1397	1	17	infection	infection	NOUN
ajcp-1397	1	18	and	and	CCONJ
ajcp-1397	1	19	variables	variable	NOUN
ajcp-1397	1	20	affecting	affect	VERB
ajcp-1397	1	21	its	its	PRON
ajcp-1397	1	22	severity	severity	NOUN
ajcp-1397	1	23	among	among	ADP
ajcp-1397	1	24	pregnant	pregnant	ADJ
ajcp-1397	1	25	women	woman	NOUN
ajcp-1397	1	26	in	in	ADP
ajcp-1397	1	27	dubai	dubai	NOUN
ajcp-1397	1	28	kefah	kefah	PROPN
ajcp-1397	1	29	el	el	PROPN
ajcp-1397	1	30	debek1	debek1	PROPN
ajcp-1397	1	31	*	*	PROPN
ajcp-1397	1	32	volume	volume	NOUN
ajcp-1397	1	33	2	2	NUM
ajcp-1397	1	34	issue	issue	NOUN
ajcp-1397	1	35	1	1	NUM
ajcp-1397	1	36	,	,	PUNCT
ajcp-1397	1	37	year	year	NOUN
ajcp-1397	1	38	2023	2023	NUM
ajcp-1397	1	39	issn	issn	X
ajcp-1397	1	40	:	:	PUNCT
ajcp-1397	1	41	2834	2834	NUM
ajcp-1397	1	42	-	-	SYM
ajcp-1397	1	43	0116	0116	NUM
ajcp-1397	1	44	(	(	PUNCT
ajcp-1397	1	45	online	online	ADJ
ajcp-1397	1	46	)	)	PUNCT
ajcp-1397	1	47	doi	doi	NOUN
ajcp-1397	1	48	:	:	PUNCT
ajcp-1397	1	49	https://doi.org/10.54536/ajcp.v2i1.1397	https://doi.org/10.54536/ajcp.v2i1.1397	PROPN
ajcp-1397	1	50	https://journals.e-palli.com/home/index.php/ajcp	https://journals.e-palli.com/home/index.php/ajcp	PROPN
ajcp-1397	1	51	article	article	NOUN
ajcp-1397	1	52	information	information	NOUN
ajcp-1397	1	53	abstract	abstract	ADV
ajcp-1397	1	54	received	receive	VERB
ajcp-1397	1	55	:	:	PUNCT
ajcp-1397	1	56	march	march	PROPN
ajcp-1397	1	57	16	16	NUM
ajcp-1397	1	58	,	,	PUNCT
ajcp-1397	1	59	2022	2022	NUM
ajcp-1397	1	60	accepted	accept	VERB
ajcp-1397	1	61	:	:	PUNCT
ajcp-1397	1	62	april	april	PROPN
ajcp-1397	1	63	27	27	NUM
ajcp-1397	1	64	,	,	PUNCT
ajcp-1397	1	65	2023	2023	NUM
ajcp-1397	1	66	published	publish	VERB
ajcp-1397	1	67	:	:	PUNCT
ajcp-1397	1	68	april	april	PROPN
ajcp-1397	1	69	30	30	NUM
ajcp-1397	1	70	,	,	PUNCT
ajcp-1397	1	71	2023	2023	NUM
ajcp-1397	1	72	the	the	DET
ajcp-1397	1	73	acute	acute	ADJ
ajcp-1397	1	74	respiratory	respiratory	ADJ
ajcp-1397	1	75	syndrome	syndrome	NOUN
ajcp-1397	1	76	has	have	AUX
ajcp-1397	1	77	produced	produce	VERB
ajcp-1397	1	78	an	an	DET
ajcp-1397	1	79	unprecedented	unprecedented	ADJ
ajcp-1397	1	80	global	global	ADJ
ajcp-1397	1	81	disaster	disaster	NOUN
ajcp-1397	1	82	since	since	SCONJ
ajcp-1397	1	83	december	december	PROPN
ajcp-1397	1	84	2019	2019	NUM
ajcp-1397	1	85	known	know	VERB
ajcp-1397	1	86	as	as	ADP
ajcp-1397	1	87	coronavirus	coronavirus	NOUN
ajcp-1397	1	88	2	2	NUM
ajcp-1397	1	89	(	(	PUNCT
ajcp-1397	1	90	sars	sar	NOUN
ajcp-1397	1	91	-	-	PUNCT
ajcp-1397	1	92	cov-2	cov-2	NOUN
ajcp-1397	1	93	)	)	PUNCT
ajcp-1397	1	94	.	.	PUNCT
ajcp-1397	2	1	pregnant	pregnant	ADJ
ajcp-1397	2	2	women	woman	NOUN
ajcp-1397	2	3	are	be	AUX
ajcp-1397	2	4	a	a	DET
ajcp-1397	2	5	particular	particular	ADJ
ajcp-1397	2	6	group	group	NOUN
ajcp-1397	2	7	that	that	PRON
ajcp-1397	2	8	needs	need	VERB
ajcp-1397	2	9	special	special	ADJ
ajcp-1397	2	10	care	care	NOUN
ajcp-1397	2	11	during	during	ADP
ajcp-1397	2	12	crises	crisis	NOUN
ajcp-1397	2	13	and	and	CCONJ
ajcp-1397	2	14	infectious	infectious	ADJ
ajcp-1397	2	15	illnesses	illness	NOUN
ajcp-1397	2	16	.	.	PUNCT
ajcp-1397	3	1	compared	compare	VERB
ajcp-1397	3	2	to	to	ADP
ajcp-1397	3	3	uninfected	uninfected	ADJ
ajcp-1397	3	4	women	woman	NOUN
ajcp-1397	3	5	,	,	PUNCT
ajcp-1397	3	6	this	this	DET
ajcp-1397	3	7	cross	cross	ADJ
ajcp-1397	3	8	-	-	ADJ
ajcp-1397	3	9	sectional	sectional	ADJ
ajcp-1397	3	10	study	study	NOUN
ajcp-1397	3	11	was	be	AUX
ajcp-1397	3	12	based	base	VERB
ajcp-1397	3	13	on	on	ADP
ajcp-1397	3	14	pregnant	pregnant	ADJ
ajcp-1397	3	15	women	woman	NOUN
ajcp-1397	3	16	infected	infect	VERB
ajcp-1397	3	17	with	with	ADP
ajcp-1397	3	18	covid-19	covid-19	PROPN
ajcp-1397	3	19	.	.	PUNCT
ajcp-1397	4	1	the	the	DET
ajcp-1397	4	2	data	datum	NOUN
ajcp-1397	4	3	was	be	AUX
ajcp-1397	4	4	collected	collect	VERB
ajcp-1397	4	5	from	from	ADP
ajcp-1397	4	6	dha	dha	PROPN
ajcp-1397	4	7	latifa	latifa	PROPN
ajcp-1397	4	8	hospital	hospital	PROPN
ajcp-1397	4	9	,	,	PUNCT
ajcp-1397	4	10	medical	medical	ADJ
ajcp-1397	4	11	records	record	NOUN
ajcp-1397	4	12	.	.	PUNCT
ajcp-1397	5	1	the	the	DET
ajcp-1397	5	2	research	research	PROPN
ajcp-1397	5	3	committee	committee	NOUN
ajcp-1397	5	4	approved	approve	VERB
ajcp-1397	5	5	the	the	DET
ajcp-1397	5	6	study	study	NOUN
ajcp-1397	5	7	in	in	ADP
ajcp-1397	5	8	dha	dha	PROPN
ajcp-1397	5	9	.	.	PUNCT
ajcp-1397	6	1	the	the	DET
ajcp-1397	6	2	study	study	NOUN
ajcp-1397	6	3	was	be	AUX
ajcp-1397	6	4	based	base	VERB
ajcp-1397	6	5	on	on	ADP
ajcp-1397	6	6	326	326	NUM
ajcp-1397	6	7	patients	patient	NOUN
ajcp-1397	6	8	aged	age	VERB
ajcp-1397	6	9	20	20	NUM
ajcp-1397	6	10	-	-	SYM
ajcp-1397	6	11	42	42	NUM
ajcp-1397	6	12	years	year	NOUN
ajcp-1397	6	13	,	,	PUNCT
ajcp-1397	6	14	of	of	ADP
ajcp-1397	6	15	which	which	PRON
ajcp-1397	6	16	covid	covid	NOUN
ajcp-1397	6	17	-	-	PUNCT
ajcp-1397	6	18	infected	infect	VERB
ajcp-1397	6	19	pregnant	pregnant	ADJ
ajcp-1397	6	20	women	woman	NOUN
ajcp-1397	6	21	were	be	AUX
ajcp-1397	6	22	199	199	NUM
ajcp-1397	6	23	and	and	CCONJ
ajcp-1397	6	24	118	118	NUM
ajcp-1397	6	25	were	be	AUX
ajcp-1397	6	26	uninfected	uninfected	ADJ
ajcp-1397	6	27	.	.	PUNCT
ajcp-1397	7	1	most	most	ADJ
ajcp-1397	7	2	patients	patient	NOUN
ajcp-1397	7	3	were	be	AUX
ajcp-1397	7	4	from	from	ADP
ajcp-1397	7	5	the	the	DET
ajcp-1397	7	6	uae	uae	PROPN
ajcp-1397	7	7	,	,	PUNCT
ajcp-1397	7	8	with	with	ADP
ajcp-1397	7	9	a	a	DET
ajcp-1397	7	10	mean	mean	ADJ
ajcp-1397	7	11	age	age	NOUN
ajcp-1397	7	12	of	of	ADP
ajcp-1397	7	13	31.63	31.63	NUM
ajcp-1397	7	14	+	+	CCONJ
ajcp-1397	7	15	6.36	6.36	NUM
ajcp-1397	7	16	and	and	CCONJ
ajcp-1397	7	17	an	an	DET
ajcp-1397	7	18	average	average	ADJ
ajcp-1397	7	19	bmi	bmi	NOUN
ajcp-1397	7	20	of	of	ADP
ajcp-1397	7	21	28.96±1.16	28.96±1.16	NUM
ajcp-1397	7	22	kg	kg	PROPN
ajcp-1397	7	23	/	/	SYM
ajcp-1397	7	24	m2	m2	PROPN
ajcp-1397	7	25	of	of	ADP
ajcp-1397	7	26	covid	covid	PROPN
ajcp-1397	7	27	-	-	PUNCT
ajcp-1397	7	28	infected	infect	VERB
ajcp-1397	7	29	pregnant	pregnant	ADJ
ajcp-1397	7	30	women	woman	NOUN
ajcp-1397	7	31	.	.	PUNCT
ajcp-1397	8	1	while	while	SCONJ
ajcp-1397	8	2	the	the	DET
ajcp-1397	8	3	mean	mean	ADJ
ajcp-1397	8	4	age	age	NOUN
ajcp-1397	8	5	of	of	ADP
ajcp-1397	8	6	31.33	31.33	NUM
ajcp-1397	8	7	+	+	SYM
ajcp-1397	8	8	6.23	6.23	NUM
ajcp-1397	8	9	and	and	CCONJ
ajcp-1397	8	10	an	an	DET
ajcp-1397	8	11	average	average	ADJ
ajcp-1397	8	12	bmi	bmi	NOUN
ajcp-1397	8	13	of	of	ADP
ajcp-1397	8	14	27.06±11.05	27.06±11.05	NUM
ajcp-1397	8	15	kg	kg	PROPN
ajcp-1397	8	16	/	/	SYM
ajcp-1397	8	17	m2	m2	PROPN
ajcp-1397	8	18	of	of	ADP
ajcp-1397	8	19	uninfected	uninfected	ADJ
ajcp-1397	8	20	pregnant	pregnant	ADJ
ajcp-1397	8	21	women	woman	NOUN
ajcp-1397	8	22	.	.	PUNCT
ajcp-1397	9	1	hemoglobin	hemoglobin	NOUN
ajcp-1397	9	2	(	(	PUNCT
ajcp-1397	9	3	hb	hb	PROPN
ajcp-1397	9	4	)	)	PUNCT
ajcp-1397	9	5	,	,	PUNCT
ajcp-1397	9	6	white	white	ADJ
ajcp-1397	9	7	blood	blood	NOUN
ajcp-1397	9	8	cells	cell	NOUN
ajcp-1397	9	9	(	(	PUNCT
ajcp-1397	9	10	wbcs	wbcs	PROPN
ajcp-1397	9	11	)	)	PUNCT
ajcp-1397	9	12	,	,	PUNCT
ajcp-1397	9	13	and	and	CCONJ
ajcp-1397	9	14	c	c	X
ajcp-1397	9	15	-	-	PUNCT
ajcp-1397	9	16	reactive	reactive	ADJ
ajcp-1397	9	17	protein(crp	protein(crp	NOUN
ajcp-1397	9	18	)	)	PUNCT
ajcp-1397	9	19	showed	show	VERB
ajcp-1397	9	20	significantly	significantly	ADV
ajcp-1397	9	21	different	different	ADJ
ajcp-1397	9	22	when	when	SCONJ
ajcp-1397	9	23	compared	compare	VERB
ajcp-1397	9	24	to	to	ADP
ajcp-1397	9	25	covid	covid	VERB
ajcp-1397	9	26	-	-	PUNCT
ajcp-1397	9	27	infected	infected	ADJ
ajcp-1397	9	28	and	and	CCONJ
ajcp-1397	9	29	uninfected	uninfected	ADJ
ajcp-1397	9	30	pregnant	pregnant	ADJ
ajcp-1397	9	31	women	woman	NOUN
ajcp-1397	9	32	.	.	PUNCT
ajcp-1397	10	1	significant	significant	ADJ
ajcp-1397	10	2	results	result	NOUN
ajcp-1397	10	3	showed	show	VERB
ajcp-1397	10	4	in	in	ADP
ajcp-1397	10	5	comorbid	comorbid	NOUN
ajcp-1397	10	6	diseases	disease	NOUN
ajcp-1397	10	7	compared	compare	VERB
ajcp-1397	10	8	with	with	ADP
ajcp-1397	10	9	covid	covid	NOUN
ajcp-1397	10	10	-	-	PUNCT
ajcp-1397	10	11	infected	infected	ADJ
ajcp-1397	10	12	and	and	CCONJ
ajcp-1397	10	13	uninfected	uninfected	ADJ
ajcp-1397	10	14	pregnant	pregnant	ADJ
ajcp-1397	10	15	women	woman	NOUN
ajcp-1397	10	16	,	,	PUNCT
ajcp-1397	10	17	but	but	CCONJ
ajcp-1397	10	18	a	a	DET
ajcp-1397	10	19	high	high	ADJ
ajcp-1397	10	20	frequency	frequency	NOUN
ajcp-1397	10	21	was	be	AUX
ajcp-1397	10	22	observed	observe	VERB
ajcp-1397	10	23	in	in	ADP
ajcp-1397	10	24	uninfected	uninfected	ADJ
ajcp-1397	10	25	women	woman	NOUN
ajcp-1397	10	26	.	.	PUNCT
ajcp-1397	11	1	the	the	DET
ajcp-1397	11	2	results	result	NOUN
ajcp-1397	11	3	showed	show	VERB
ajcp-1397	11	4	insignificance	insignificance	NOUN
ajcp-1397	11	5	with	with	ADP
ajcp-1397	11	6	comorbid	comorbid	NOUN
ajcp-1397	11	7	diseases	disease	NOUN
ajcp-1397	11	8	when	when	SCONJ
ajcp-1397	11	9	compared	compare	VERB
ajcp-1397	11	10	with	with	ADP
ajcp-1397	11	11	covidinfected	covidinfecte	VERB
ajcp-1397	11	12	pregnant	pregnant	ADJ
ajcp-1397	11	13	women	woman	NOUN
ajcp-1397	11	14	and	and	CCONJ
ajcp-1397	11	15	uninfected	uninfected	ADJ
ajcp-1397	11	16	pregnant	pregnant	ADJ
ajcp-1397	11	17	women	woman	NOUN
ajcp-1397	11	18	.	.	PUNCT
ajcp-1397	12	1	a	a	DET
ajcp-1397	12	2	decrease	decrease	NOUN
ajcp-1397	12	3	in	in	ADP
ajcp-1397	12	4	wbc	wbc	PROPN
ajcp-1397	12	5	and	and	CCONJ
ajcp-1397	12	6	crp	crp	PROPN
ajcp-1397	12	7	was	be	AUX
ajcp-1397	12	8	observed	observe	VERB
ajcp-1397	12	9	in	in	ADP
ajcp-1397	12	10	covidinfected	covidinfecte	VERB
ajcp-1397	12	11	pregnant	pregnant	ADJ
ajcp-1397	12	12	women	woman	NOUN
ajcp-1397	12	13	keywords	keyword	NOUN
ajcp-1397	12	14	covid	covid	PROPN
ajcp-1397	12	15	,	,	PUNCT
ajcp-1397	12	16	comorbid	comorbid	NOUN
ajcp-1397	12	17	diseases	disease	NOUN
ajcp-1397	12	18	,	,	PUNCT
ajcp-1397	12	19	hemoglobin	hemoglobin	NOUN
ajcp-1397	12	20	,	,	PUNCT
ajcp-1397	12	21	infection	infection	NOUN
ajcp-1397	12	22	,	,	PUNCT
ajcp-1397	12	23	pregnant	pregnant	ADJ
ajcp-1397	12	24	women	woman	NOUN
ajcp-1397	12	25	1	1	NUM
ajcp-1397	12	26	dubai	dubai	PROPN
ajcp-1397	12	27	health	health	NOUN
ajcp-1397	12	28	authority	authority	NOUN
ajcp-1397	12	29	,	,	PUNCT
ajcp-1397	12	30	united	united	PROPN
ajcp-1397	12	31	arab	arab	PROPN
ajcp-1397	12	32	emirates	emirates	PROPN
ajcp-1397	13	1	*	*	PUNCT
ajcp-1397	13	2	corresponding	correspond	VERB
ajcp-1397	13	3	author	author	NOUN
ajcp-1397	13	4	’s	’s	PART
ajcp-1397	13	5	e	e	NOUN
ajcp-1397	13	6	-	-	NOUN
ajcp-1397	13	7	mail	mail	NOUN
ajcp-1397	13	8	:	:	PUNCT
ajcp-1397	13	9	khaldbk@dha.gov.uae	khaldbk@dha.gov.uae	PROPN
ajcp-1397	13	10	introduction	introduction	NOUN
ajcp-1397	13	11	the	the	DET
ajcp-1397	13	12	severe	severe	ADJ
ajcp-1397	13	13	acute	acute	ADJ
ajcp-1397	13	14	respiratory	respiratory	ADJ
ajcp-1397	13	15	syndrome	syndrome	NOUN
ajcp-1397	13	16	has	have	AUX
ajcp-1397	13	17	produced	produce	VERB
ajcp-1397	13	18	an	an	DET
ajcp-1397	13	19	unprecedented	unprecedented	ADJ
ajcp-1397	13	20	global	global	ADJ
ajcp-1397	13	21	disaster	disaster	NOUN
ajcp-1397	13	22	since	since	SCONJ
ajcp-1397	13	23	december	december	PROPN
ajcp-1397	13	24	2019	2019	NUM
ajcp-1397	13	25	known	know	VERB
ajcp-1397	13	26	as	as	ADP
ajcp-1397	13	27	coronavirus	coronavirus	NOUN
ajcp-1397	13	28	2	2	NUM
ajcp-1397	13	29	(	(	PUNCT
ajcp-1397	13	30	sars	sar	NOUN
ajcp-1397	13	31	-	-	PUNCT
ajcp-1397	13	32	cov-2	cov-2	NOUN
ajcp-1397	13	33	)	)	PUNCT
ajcp-1397	13	34	(	(	PUNCT
ajcp-1397	13	35	kamel	kamel	PROPN
ajcp-1397	13	36	boulos	boulos	PROPN
ajcp-1397	13	37	&	&	CCONJ
ajcp-1397	13	38	geraghty	geraghty	PROPN
ajcp-1397	13	39	,	,	PUNCT
ajcp-1397	13	40	2020	2020	NUM
ajcp-1397	13	41	;	;	PUNCT
ajcp-1397	13	42	sohrabi	sohrabi	NOUN
ajcp-1397	13	43	et	et	PROPN
ajcp-1397	13	44	al	al	PROPN
ajcp-1397	13	45	.	.	PROPN
ajcp-1397	13	46	,	,	PUNCT
ajcp-1397	13	47	2020	2020	NUM
ajcp-1397	13	48	)	)	PUNCT
ajcp-1397	13	49	.	.	PUNCT
ajcp-1397	14	1	pregnant	pregnant	ADJ
ajcp-1397	14	2	women	woman	NOUN
ajcp-1397	14	3	are	be	AUX
ajcp-1397	14	4	a	a	DET
ajcp-1397	14	5	particular	particular	ADJ
ajcp-1397	14	6	group	group	NOUN
ajcp-1397	14	7	that	that	PRON
ajcp-1397	14	8	needs	need	VERB
ajcp-1397	14	9	special	special	ADJ
ajcp-1397	14	10	care	care	NOUN
ajcp-1397	14	11	during	during	ADP
ajcp-1397	14	12	crises	crisis	NOUN
ajcp-1397	14	13	and	and	CCONJ
ajcp-1397	14	14	infectious	infectious	ADJ
ajcp-1397	14	15	illnesses	illness	NOUN
ajcp-1397	14	16	.	.	PUNCT
ajcp-1397	15	1	according	accord	VERB
ajcp-1397	15	2	to	to	ADP
ajcp-1397	15	3	the	the	DET
ajcp-1397	15	4	literature	literature	NOUN
ajcp-1397	15	5	,	,	PUNCT
ajcp-1397	15	6	pregnant	pregnant	ADJ
ajcp-1397	15	7	women	woman	NOUN
ajcp-1397	15	8	infected	infect	VERB
ajcp-1397	15	9	with	with	ADP
ajcp-1397	15	10	covid-19	covid-19	PROPN
ajcp-1397	15	11	suffer	suffer	VERB
ajcp-1397	15	12	a	a	DET
ajcp-1397	15	13	more	more	ADV
ajcp-1397	15	14	severe	severe	ADJ
ajcp-1397	15	15	form	form	NOUN
ajcp-1397	15	16	of	of	ADP
ajcp-1397	15	17	the	the	DET
ajcp-1397	15	18	disease	disease	NOUN
ajcp-1397	15	19	,	,	PUNCT
ajcp-1397	15	20	which	which	PRON
ajcp-1397	15	21	increases	increase	VERB
ajcp-1397	15	22	their	their	PRON
ajcp-1397	15	23	chance	chance	NOUN
ajcp-1397	15	24	of	of	ADP
ajcp-1397	15	25	dying	die	VERB
ajcp-1397	15	26	by	by	ADP
ajcp-1397	15	27	up	up	ADP
ajcp-1397	15	28	to	to	PART
ajcp-1397	15	29	35.0	35.0	NUM
ajcp-1397	15	30	percent	percent	NOUN
ajcp-1397	15	31	and	and	CCONJ
ajcp-1397	15	32	causes	cause	VERB
ajcp-1397	15	33	nearly	nearly	ADV
ajcp-1397	15	34	a	a	PRON
ajcp-1397	15	35	quarter	quarter	NOUN
ajcp-1397	15	36	of	of	ADP
ajcp-1397	15	37	them	they	PRON
ajcp-1397	15	38	to	to	PART
ajcp-1397	15	39	develop	develop	VERB
ajcp-1397	15	40	pneumonia	pneumonia	NOUN
ajcp-1397	15	41	.	.	PUNCT
ajcp-1397	16	1	furthermore	furthermore	ADV
ajcp-1397	16	2	,	,	PUNCT
ajcp-1397	16	3	pregnant	pregnant	ADJ
ajcp-1397	16	4	women	woman	NOUN
ajcp-1397	16	5	affected	affect	VERB
ajcp-1397	16	6	by	by	ADP
ajcp-1397	16	7	covid-19	covid-19	PROPN
ajcp-1397	16	8	infection	infection	NOUN
ajcp-1397	16	9	had	have	VERB
ajcp-1397	16	10	a	a	DET
ajcp-1397	16	11	higher	high	ADJ
ajcp-1397	16	12	likelihood	likelihood	NOUN
ajcp-1397	16	13	of	of	ADP
ajcp-1397	16	14	being	be	AUX
ajcp-1397	16	15	hospitalized	hospitalize	VERB
ajcp-1397	16	16	than	than	ADP
ajcp-1397	16	17	non	non	ADJ
ajcp-1397	16	18	-	-	ADJ
ajcp-1397	16	19	pregnant	pregnant	ADJ
ajcp-1397	16	20	people	people	NOUN
ajcp-1397	16	21	of	of	ADP
ajcp-1397	16	22	the	the	DET
ajcp-1397	16	23	same	same	ADJ
ajcp-1397	16	24	age	age	NOUN
ajcp-1397	16	25	(	(	PUNCT
ajcp-1397	16	26	31.5	31.5	NUM
ajcp-1397	16	27	percent	percent	NOUN
ajcp-1397	16	28	versus	versus	ADP
ajcp-1397	16	29	5.8	5.8	NUM
ajcp-1397	16	30	percent	percent	NOUN
ajcp-1397	16	31	)	)	PUNCT
ajcp-1397	16	32	,	,	PUNCT
ajcp-1397	16	33	as	as	SCONJ
ajcp-1397	16	34	reported	report	VERB
ajcp-1397	16	35	by	by	ADP
ajcp-1397	16	36	the	the	DET
ajcp-1397	16	37	cdc	cdc	PROPN
ajcp-1397	16	38	(	(	PUNCT
ajcp-1397	16	39	centers	center	NOUN
ajcp-1397	16	40	for	for	ADP
ajcp-1397	16	41	disease	disease	NOUN
ajcp-1397	16	42	control	control	NOUN
ajcp-1397	16	43	and	and	CCONJ
ajcp-1397	16	44	prevention	prevention	NOUN
ajcp-1397	16	45	)	)	PUNCT
ajcp-1397	16	46	.	.	PUNCT
ajcp-1397	17	1	ukoss	ukoss	NOUN
ajcp-1397	17	2	research	research	NOUN
ajcp-1397	17	3	showed	show	VERB
ajcp-1397	17	4	that	that	SCONJ
ajcp-1397	17	5	many	many	ADJ
ajcp-1397	17	6	pregnant	pregnant	ADJ
ajcp-1397	17	7	/	/	SYM
ajcp-1397	17	8	expected	expect	VERB
ajcp-1397	17	9	women	woman	NOUN
ajcp-1397	17	10	were	be	AUX
ajcp-1397	17	11	admitted	admit	VERB
ajcp-1397	17	12	to	to	ADP
ajcp-1397	17	13	the	the	DET
ajcp-1397	17	14	hospital	hospital	NOUN
ajcp-1397	17	15	in	in	ADP
ajcp-1397	17	16	the	the	DET
ajcp-1397	17	17	third	third	ADJ
ajcp-1397	17	18	trimester	trimester	NOUN
ajcp-1397	17	19	or	or	CCONJ
ajcp-1397	17	20	postpartum	postpartum	NOUN
ajcp-1397	17	21	,	,	PUNCT
ajcp-1397	17	22	and	and	CCONJ
ajcp-1397	17	23	severe	severe	ADJ
ajcp-1397	17	24	illness	illness	NOUN
ajcp-1397	17	25	happened	happen	VERB
ajcp-1397	17	26	in	in	ADP
ajcp-1397	17	27	later	later	ADJ
ajcp-1397	17	28	pregnancy	pregnancy	NOUN
ajcp-1397	17	29	(	(	PUNCT
ajcp-1397	17	30	vousden	vousden	VERB
ajcp-1397	17	31	et	et	PROPN
ajcp-1397	17	32	al	al	PROPN
ajcp-1397	17	33	.	.	PROPN
ajcp-1397	17	34	,	,	PUNCT
ajcp-1397	17	35	2021	2021	NUM
ajcp-1397	17	36	)	)	PUNCT
ajcp-1397	17	37	.	.	PUNCT
ajcp-1397	18	1	according	accord	VERB
ajcp-1397	18	2	to	to	ADP
ajcp-1397	18	3	the	the	DET
ajcp-1397	18	4	literature	literature	NOUN
ajcp-1397	18	5	,	,	PUNCT
ajcp-1397	18	6	immunologic	immunologic	ADJ
ajcp-1397	18	7	and	and	CCONJ
ajcp-1397	18	8	physiological	physiological	ADJ
ajcp-1397	18	9	changes	change	NOUN
ajcp-1397	18	10	during	during	ADP
ajcp-1397	18	11	pregnancy	pregnancy	NOUN
ajcp-1397	18	12	can	can	AUX
ajcp-1397	18	13	be	be	AUX
ajcp-1397	18	14	blamed	blame	VERB
ajcp-1397	18	15	for	for	ADP
ajcp-1397	18	16	the	the	DET
ajcp-1397	18	17	complexity	complexity	NOUN
ajcp-1397	18	18	of	of	ADP
ajcp-1397	18	19	the	the	DET
ajcp-1397	18	20	maternal	maternal	ADJ
ajcp-1397	18	21	disease	disease	NOUN
ajcp-1397	18	22	and	and	CCONJ
ajcp-1397	18	23	obstetric	obstetric	ADJ
ajcp-1397	18	24	effects	effect	NOUN
ajcp-1397	18	25	.	.	PUNCT
ajcp-1397	19	1	these	these	DET
ajcp-1397	19	2	changes	change	NOUN
ajcp-1397	19	3	include	include	VERB
ajcp-1397	19	4	reduced	reduce	VERB
ajcp-1397	19	5	lung	lung	NOUN
ajcp-1397	19	6	volume	volume	NOUN
ajcp-1397	19	7	,	,	PUNCT
ajcp-1397	19	8	cardiovascular	cardiovascular	ADJ
ajcp-1397	19	9	and	and	CCONJ
ajcp-1397	19	10	hemodynamic	hemodynamic	ADJ
ajcp-1397	19	11	deviations	deviation	NOUN
ajcp-1397	19	12	,	,	PUNCT
ajcp-1397	19	13	high	high	ADJ
ajcp-1397	19	14	oxygen	oxygen	NOUN
ajcp-1397	19	15	demand	demand	NOUN
ajcp-1397	19	16	,	,	PUNCT
ajcp-1397	19	17	hypoxia	hypoxia	NOUN
ajcp-1397	19	18	causing	cause	VERB
ajcp-1397	19	19	respiration	respiration	NOUN
ajcp-1397	19	20	problems	problem	NOUN
ajcp-1397	19	21	such	such	ADJ
ajcp-1397	19	22	as	as	ADP
ajcp-1397	19	23	low	low	ADJ
ajcp-1397	19	24	maternal	maternal	ADJ
ajcp-1397	19	25	tolerance	tolerance	NOUN
ajcp-1397	19	26	,	,	PUNCT
ajcp-1397	19	27	structural	structural	ADJ
ajcp-1397	19	28	changes	change	NOUN
ajcp-1397	19	29	with	with	ADP
ajcp-1397	19	30	an	an	DET
ajcp-1397	19	31	enlarged	enlarge	VERB
ajcp-1397	19	32	transthoracic	transthoracic	PROPN
ajcp-1397	19	33	diameter	diameter	NOUN
ajcp-1397	19	34	,	,	PUNCT
ajcp-1397	19	35	and	and	CCONJ
ajcp-1397	19	36	restricted	restrict	VERB
ajcp-1397	19	37	diaphragm	diaphragm	NOUN
ajcp-1397	19	38	expansion	expansion	NOUN
ajcp-1397	19	39	as	as	ADP
ajcp-1397	19	40	previous	previous	ADJ
ajcp-1397	19	41	health	health	NOUN
ajcp-1397	19	42	issues	issue	NOUN
ajcp-1397	19	43	like	like	ADP
ajcp-1397	19	44	preeclampsia	preeclampsia	NOUN
ajcp-1397	19	45	or	or	CCONJ
ajcp-1397	19	46	diastole	diastole	NOUN
ajcp-1397	19	47	(	(	PUNCT
ajcp-1397	19	48	chen	chen	PROPN
ajcp-1397	19	49	et	et	PROPN
ajcp-1397	19	50	al	al	PROPN
ajcp-1397	19	51	.	.	PROPN
ajcp-1397	19	52	,	,	PUNCT
ajcp-1397	19	53	2020	2020	NUM
ajcp-1397	19	54	;	;	PUNCT
ajcp-1397	19	55	yan	yan	PROPN
ajcp-1397	19	56	et	et	PROPN
ajcp-1397	19	57	al	al	PROPN
ajcp-1397	19	58	.	.	PROPN
ajcp-1397	19	59	,	,	PUNCT
ajcp-1397	19	60	2020	2020	NUM
ajcp-1397	19	61	)	)	PUNCT
ajcp-1397	19	62	.	.	PUNCT
ajcp-1397	20	1	the	the	DET
ajcp-1397	20	2	epidemiology	epidemiology	NOUN
ajcp-1397	20	3	of	of	ADP
ajcp-1397	20	4	severe	severe	ADJ
ajcp-1397	20	5	covid-19	covid-19	PROPN
ajcp-1397	20	6	-	-	PUNCT
ajcp-1397	20	7	mediated	mediate	VERB
ajcp-1397	20	8	pregnancy	pregnancy	NOUN
ajcp-1397	20	9	-	-	PUNCT
ajcp-1397	20	10	related	relate	VERB
ajcp-1397	20	11	changes	change	NOUN
ajcp-1397	20	12	in	in	ADP
ajcp-1397	20	13	the	the	DET
ajcp-1397	20	14	inflammatory	inflammatory	ADJ
ajcp-1397	20	15	response	response	NOUN
ajcp-1397	20	16	to	to	ADP
ajcp-1397	20	17	viruses	virus	NOUN
ajcp-1397	20	18	has	have	AUX
ajcp-1397	20	19	been	be	AUX
ajcp-1397	20	20	linked	link	VERB
ajcp-1397	20	21	to	to	ADP
ajcp-1397	20	22	an	an	DET
ajcp-1397	20	23	overt	overt	ADJ
ajcp-1397	20	24	th1	th1	NOUN
ajcp-1397	20	25	and	and	CCONJ
ajcp-1397	20	26	th2	th2	PROPN
ajcp-1397	20	27	response	response	NOUN
ajcp-1397	20	28	to	to	ADP
ajcp-1397	20	29	sars	sar	NOUN
ajcp-1397	20	30	-	-	PUNCT
ajcp-1397	20	31	cov-2	cov-2	NOUN
ajcp-1397	20	32	.	.	PUNCT
ajcp-1397	20	33	natural	natural	ADJ
ajcp-1397	20	34	killer	killer	NOUN
ajcp-1397	20	35	(	(	PUNCT
ajcp-1397	20	36	nk	nk	PROPN
ajcp-1397	20	37	)	)	PUNCT
ajcp-1397	20	38	,	,	PUNCT
ajcp-1397	20	39	plasmacytoid	plasmacytoid	VERB
ajcp-1397	20	40	dendritic	dendritic	ADJ
ajcp-1397	20	41	cells	cell	NOUN
ajcp-1397	20	42	decline	decline	VERB
ajcp-1397	20	43	while	while	SCONJ
ajcp-1397	20	44	increased	increase	VERB
ajcp-1397	20	45	progesterone	progesterone	NOUN
ajcp-1397	20	46	levels	level	NOUN
ajcp-1397	20	47	in	in	ADP
ajcp-1397	20	48	circulating	circulate	VERB
ajcp-1397	20	49	cells	cell	NOUN
ajcp-1397	20	50	during	during	ADP
ajcp-1397	20	51	pregnancy	pregnancy	NOUN
ajcp-1397	20	52	(	(	PUNCT
ajcp-1397	20	53	wastnedge	wastnedge	VERB
ajcp-1397	20	54	et	et	PROPN
ajcp-1397	20	55	al	al	PROPN
ajcp-1397	20	56	.	.	PROPN
ajcp-1397	20	57	,	,	PUNCT
ajcp-1397	20	58	2021	2021	NUM
ajcp-1397	20	59	)	)	PUNCT
ajcp-1397	20	60	.	.	PUNCT
ajcp-1397	21	1	these	these	DET
ajcp-1397	21	2	changes	change	NOUN
ajcp-1397	21	3	in	in	ADP
ajcp-1397	21	4	the	the	DET
ajcp-1397	21	5	mother	mother	NOUN
ajcp-1397	21	6	’s	’s	PART
ajcp-1397	21	7	immune	immune	ADJ
ajcp-1397	21	8	system	system	NOUN
ajcp-1397	21	9	affect	affect	VERB
ajcp-1397	21	10	the	the	DET
ajcp-1397	21	11	clinical	clinical	ADJ
ajcp-1397	21	12	course	course	NOUN
ajcp-1397	21	13	of	of	ADP
ajcp-1397	21	14	covid-19	covid-19	PROPN
ajcp-1397	21	15	and	and	CCONJ
ajcp-1397	21	16	the	the	DET
ajcp-1397	21	17	therapy	therapy	NOUN
ajcp-1397	21	18	and	and	CCONJ
ajcp-1397	21	19	prevention	prevention	NOUN
ajcp-1397	21	20	of	of	ADP
ajcp-1397	21	21	covid-19	covid-19	PROPN
ajcp-1397	21	22	in	in	ADP
ajcp-1397	21	23	pregnancy	pregnancy	NOUN
ajcp-1397	21	24	.	.	PUNCT
ajcp-1397	22	1	pregnant	pregnant	ADJ
ajcp-1397	22	2	women	woman	NOUN
ajcp-1397	22	3	may	may	AUX
ajcp-1397	22	4	be	be	AUX
ajcp-1397	22	5	more	more	ADV
ajcp-1397	22	6	prone	prone	ADJ
ajcp-1397	22	7	to	to	ADP
ajcp-1397	22	8	serious	serious	ADJ
ajcp-1397	22	9	respiratory	respiratory	ADJ
ajcp-1397	22	10	infections	infection	NOUN
ajcp-1397	22	11	because	because	SCONJ
ajcp-1397	22	12	of	of	ADP
ajcp-1397	22	13	decreased	decrease	VERB
ajcp-1397	22	14	lung	lung	NOUN
ajcp-1397	22	15	capacity	capacity	NOUN
ajcp-1397	22	16	and	and	CCONJ
ajcp-1397	22	17	difficulty	difficulty	NOUN
ajcp-1397	22	18	removing	remove	VERB
ajcp-1397	22	19	secretions	secretion	NOUN
ajcp-1397	22	20	(	(	PUNCT
ajcp-1397	22	21	thompson	thompson	PROPN
ajcp-1397	22	22	et	et	PROPN
ajcp-1397	22	23	al	al	PROPN
ajcp-1397	22	24	.	.	PROPN
ajcp-1397	22	25	,	,	PUNCT
ajcp-1397	22	26	2020	2020	NUM
ajcp-1397	22	27	)	)	PUNCT
ajcp-1397	22	28	.	.	PUNCT
ajcp-1397	23	1	regarding	regard	VERB
ajcp-1397	23	2	the	the	DET
ajcp-1397	23	3	potential	potential	ADJ
ajcp-1397	23	4	effects	effect	NOUN
ajcp-1397	23	5	of	of	ADP
ajcp-1397	23	6	covid	covid	PROPN
ajcp-1397	23	7	in	in	ADP
ajcp-1397	23	8	early	early	ADJ
ajcp-1397	23	9	pregnancy	pregnancy	NOUN
ajcp-1397	23	10	,	,	PUNCT
ajcp-1397	23	11	there	there	PRON
ajcp-1397	23	12	is	be	VERB
ajcp-1397	23	13	less	less	ADJ
ajcp-1397	23	14	research	research	NOUN
ajcp-1397	23	15	(	(	PUNCT
ajcp-1397	23	16	up	up	ADP
ajcp-1397	23	17	to	to	PART
ajcp-1397	23	18	12	12	NUM
ajcp-1397	23	19	weeks	week	NOUN
ajcp-1397	23	20	gestation	gestation	NOUN
ajcp-1397	23	21	)	)	PUNCT
ajcp-1397	23	22	.	.	PUNCT
ajcp-1397	24	1	seasonal	seasonal	ADJ
ajcp-1397	24	2	influenza	influenza	NOUN
ajcp-1397	24	3	has	have	AUX
ajcp-1397	24	4	been	be	AUX
ajcp-1397	24	5	linked	link	VERB
ajcp-1397	24	6	to	to	ADP
ajcp-1397	24	7	a	a	DET
ajcp-1397	24	8	greater	great	ADJ
ajcp-1397	24	9	incidence	incidence	NOUN
ajcp-1397	24	10	of	of	ADP
ajcp-1397	24	11	miscarriage	miscarriage	NOUN
ajcp-1397	24	12	(	(	PUNCT
ajcp-1397	24	13	dorélien	dorélien	NOUN
ajcp-1397	24	14	,	,	PUNCT
ajcp-1397	24	15	2019	2019	NUM
ajcp-1397	24	16	)	)	PUNCT
ajcp-1397	24	17	.	.	PUNCT
ajcp-1397	25	1	extrapolating	extrapolate	VERB
ajcp-1397	25	2	from	from	ADP
ajcp-1397	25	3	the	the	DET
ajcp-1397	25	4	impact	impact	NOUN
ajcp-1397	25	5	of	of	ADP
ajcp-1397	25	6	other	other	ADJ
ajcp-1397	25	7	viruses	virus	NOUN
ajcp-1397	25	8	in	in	ADP
ajcp-1397	25	9	late	late	ADJ
ajcp-1397	25	10	pregnancy	pregnancy	NOUN
ajcp-1397	25	11	(	(	PUNCT
ajcp-1397	25	12	more	more	ADJ
ajcp-1397	25	13	than	than	ADP
ajcp-1397	25	14	24	24	NUM
ajcp-1397	25	15	weeks	week	NOUN
ajcp-1397	25	16	gestation	gestation	NOUN
ajcp-1397	25	17	)	)	PUNCT
ajcp-1397	25	18	(	(	PUNCT
ajcp-1397	25	19	dorélien	dorélien	NOUN
ajcp-1397	25	20	,	,	PUNCT
ajcp-1397	25	21	2019	2019	NUM
ajcp-1397	25	22	)	)	PUNCT
ajcp-1397	25	23	(	(	PUNCT
ajcp-1397	25	24	mosby	mosby	NOUN
ajcp-1397	25	25	et	et	PROPN
ajcp-1397	25	26	al	al	PROPN
ajcp-1397	25	27	.	.	PROPN
ajcp-1397	25	28	,	,	PUNCT
ajcp-1397	25	29	2011	2011	NUM
ajcp-1397	25	30	)	)	PUNCT
ajcp-1397	25	31	,	,	PUNCT
ajcp-1397	25	32	covid-19	covid-19	PROPN
ajcp-1397	25	33	infection	infection	NOUN
ajcp-1397	25	34	might	might	AUX
ajcp-1397	25	35	result	result	VERB
ajcp-1397	25	36	in	in	ADP
ajcp-1397	25	37	higher	high	ADJ
ajcp-1397	25	38	rates	rate	NOUN
ajcp-1397	25	39	of	of	ADP
ajcp-1397	25	40	unfavourable	unfavourable	ADJ
ajcp-1397	25	41	pregnancy	pregnancy	NOUN
ajcp-1397	25	42	results	result	NOUN
ajcp-1397	25	43	in	in	ADP
ajcp-1397	25	44	fetal	fetal	ADJ
ajcp-1397	25	45	growth	growth	NOUN
ajcp-1397	25	46	limitation	limitation	NOUN
ajcp-1397	25	47	,	,	PUNCT
ajcp-1397	25	48	premature	premature	ADJ
ajcp-1397	25	49	delivery	delivery	NOUN
ajcp-1397	25	50	,	,	PUNCT
ajcp-1397	25	51	and	and	CCONJ
ajcp-1397	25	52	perinatal	perinatal	ADJ
ajcp-1397	25	53	death	death	NOUN
ajcp-1397	25	54	.	.	PUNCT
ajcp-1397	26	1	once	once	ADV
ajcp-1397	26	2	available	available	ADJ
ajcp-1397	26	3	,	,	PUNCT
ajcp-1397	26	4	population	population	NOUN
ajcp-1397	26	5	-	-	PUNCT
ajcp-1397	26	6	level	level	NOUN
ajcp-1397	26	7	data	datum	NOUN
ajcp-1397	26	8	on	on	ADP
ajcp-1397	26	9	these	these	DET
ajcp-1397	26	10	results	result	NOUN
ajcp-1397	26	11	must	must	AUX
ajcp-1397	26	12	be	be	AUX
ajcp-1397	26	13	evaluated	evaluate	VERB
ajcp-1397	26	14	to	to	PART
ajcp-1397	26	15	spot	spot	VERB
ajcp-1397	26	16	tendencies	tendency	NOUN
ajcp-1397	26	17	relevant	relevant	ADJ
ajcp-1397	26	18	to	to	ADP
ajcp-1397	26	19	the	the	DET
ajcp-1397	26	20	covid-19	covid-19	PROPN
ajcp-1397	26	21	pandemic	pandemic	NOUN
ajcp-1397	26	22	.	.	PUNCT
ajcp-1397	27	1	this	this	DET
ajcp-1397	27	2	research	research	NOUN
ajcp-1397	27	3	examines	examine	VERB
ajcp-1397	27	4	the	the	DET
ajcp-1397	27	5	relationship	relationship	NOUN
ajcp-1397	27	6	between	between	ADP
ajcp-1397	27	7	maternal	maternal	ADJ
ajcp-1397	27	8	severity	severity	NOUN
ajcp-1397	27	9	due	due	ADP
ajcp-1397	27	10	to	to	ADP
ajcp-1397	27	11	covid-19	covid-19	PROPN
ajcp-1397	27	12	and	and	CCONJ
ajcp-1397	27	13	the	the	DET
ajcp-1397	27	14	effect	effect	NOUN
ajcp-1397	27	15	of	of	ADP
ajcp-1397	27	16	comorbid	comorbid	NOUN
ajcp-1397	27	17	disease	disease	NOUN
ajcp-1397	27	18	.	.	PUNCT
ajcp-1397	28	1	examining	examine	VERB
ajcp-1397	28	2	how	how	SCONJ
ajcp-1397	28	3	demographic	demographic	ADJ
ajcp-1397	28	4	variables	variable	NOUN
ajcp-1397	28	5	affected	affect	VERB
ajcp-1397	28	6	by	by	ADP
ajcp-1397	28	7	covid	covid	PROPN
ajcp-1397	28	8	on	on	ADP
ajcp-1397	28	9	pregnant	pregnant	ADJ
ajcp-1397	28	10	women	woman	NOUN
ajcp-1397	28	11	.	.	PUNCT
ajcp-1397	29	1	we	we	PRON
ajcp-1397	29	2	also	also	ADV
ajcp-1397	29	3	studied	study	VERB
ajcp-1397	29	4	the	the	DET
ajcp-1397	29	5	correlation	correlation	NOUN
ajcp-1397	29	6	between	between	ADP
ajcp-1397	29	7	the	the	DET
ajcp-1397	29	8	severity	severity	NOUN
ajcp-1397	29	9	of	of	ADP
ajcp-1397	29	10	illness	illness	NOUN
ajcp-1397	29	11	and	and	CCONJ
ajcp-1397	29	12	the	the	DET
ajcp-1397	29	13	number	number	NOUN
ajcp-1397	29	14	of	of	ADP
ajcp-1397	29	15	dosages	dosage	NOUN
ajcp-1397	29	16	,	,	PUNCT
ajcp-1397	29	17	comorbid	comorbid	NOUN
ajcp-1397	29	18	diseases	disease	NOUN
ajcp-1397	29	19	,	,	PUNCT
ajcp-1397	29	20	and	and	CCONJ
ajcp-1397	29	21	the	the	DET
ajcp-1397	29	22	duration	duration	NOUN
ajcp-1397	29	23	of	of	ADP
ajcp-1397	29	24	the	the	DET
ajcp-1397	29	25	vaccine	vaccine	NOUN
ajcp-1397	29	26	(	(	PUNCT
ajcp-1397	29	27	the	the	DET
ajcp-1397	29	28	time	time	NOUN
ajcp-1397	29	29	since	since	SCONJ
ajcp-1397	29	30	it	it	PRON
ajcp-1397	29	31	was	be	AUX
ajcp-1397	29	32	given	give	VERB
ajcp-1397	29	33	wither	wither	NOUN
ajcp-1397	29	34	within	within	ADP
ajcp-1397	29	35	6	6	NUM
ajcp-1397	29	36	months	month	NOUN
ajcp-1397	29	37	or	or	CCONJ
ajcp-1397	29	38	in	in	ADP
ajcp-1397	29	39	more	more	ADJ
ajcp-1397	29	40	than	than	ADP
ajcp-1397	29	41	6	6	NUM
ajcp-1397	29	42	months	month	NOUN
ajcp-1397	29	43	)	)	PUNCT
ajcp-1397	29	44	.	.	PUNCT
ajcp-1397	30	1	materials	material	NOUN
ajcp-1397	30	2	and	and	CCONJ
ajcp-1397	30	3	methods	method	NOUN
ajcp-1397	30	4	this	this	DET
ajcp-1397	30	5	cross	cross	ADJ
ajcp-1397	30	6	-	-	ADJ
ajcp-1397	30	7	sectional	sectional	ADJ
ajcp-1397	30	8	study	study	NOUN
ajcp-1397	30	9	was	be	AUX
ajcp-1397	30	10	based	base	VERB
ajcp-1397	30	11	on	on	ADP
ajcp-1397	30	12	326	326	NUM
ajcp-1397	30	13	patients	patient	NOUN
ajcp-1397	30	14	https://doi.org/10.54536/ajcp.v2i1.1397	https://doi.org/10.54536/ajcp.v2i1.1397	NOUN
ajcp-1397	31	1	https://journals.e-palli.com/home/index.php/ajcp	https://journals.e-palli.com/home/index.php/ajcp	PROPN
ajcp-1397	31	2	pa	pa	PROPN
ajcp-1397	31	3	ge	ge	PROPN
ajcp-1397	31	4	33	33	NUM
ajcp-1397	31	5	https://journals.e-palli.com/home/index.php/ajcp	https://journals.e-palli.com/home/index.php/ajcp	PROPN
ajcp-1397	31	6	am	be	AUX
ajcp-1397	31	7	.	.	PUNCT
ajcp-1397	32	1	j.	j.	PROPN
ajcp-1397	32	2	chem	chem	PROPN
ajcp-1397	32	3	.	.	PUNCT
ajcp-1397	33	1	pharm	pharm	NOUN
ajcp-1397	33	2	.	.	PUNCT
ajcp-1397	34	1	2(1	2(1	NUM
ajcp-1397	34	2	)	)	PUNCT
ajcp-1397	34	3	32	32	NUM
ajcp-1397	34	4	-	-	SYM
ajcp-1397	34	5	37	37	NUM
ajcp-1397	34	6	,	,	PUNCT
ajcp-1397	34	7	2023	2023	NUM
ajcp-1397	34	8	aged	age	VERB
ajcp-1397	34	9	20	20	NUM
ajcp-1397	34	10	-	-	SYM
ajcp-1397	34	11	42	42	NUM
ajcp-1397	34	12	years	year	NOUN
ajcp-1397	34	13	,	,	PUNCT
ajcp-1397	34	14	of	of	ADP
ajcp-1397	34	15	which	which	PRON
ajcp-1397	34	16	covid	covid	NOUN
ajcp-1397	34	17	-	-	PUNCT
ajcp-1397	34	18	infected	infect	VERB
ajcp-1397	34	19	pregnant	pregnant	ADJ
ajcp-1397	34	20	women	woman	NOUN
ajcp-1397	34	21	were	be	AUX
ajcp-1397	34	22	199	199	NUM
ajcp-1397	34	23	while	while	SCONJ
ajcp-1397	34	24	118	118	NUM
ajcp-1397	34	25	were	be	AUX
ajcp-1397	34	26	uninfected	uninfected	ADJ
ajcp-1397	34	27	.	.	PUNCT
ajcp-1397	35	1	the	the	DET
ajcp-1397	35	2	data	datum	NOUN
ajcp-1397	35	3	was	be	AUX
ajcp-1397	35	4	collected	collect	VERB
ajcp-1397	35	5	from	from	ADP
ajcp-1397	35	6	dha	dha	PROPN
ajcp-1397	35	7	latifa	latifa	PROPN
ajcp-1397	35	8	hospital	hospital	PROPN
ajcp-1397	35	9	,	,	PUNCT
ajcp-1397	35	10	medical	medical	ADJ
ajcp-1397	35	11	records	record	NOUN
ajcp-1397	35	12	.	.	PUNCT
ajcp-1397	36	1	this	this	DET
ajcp-1397	36	2	research	research	NOUN
ajcp-1397	36	3	was	be	AUX
ajcp-1397	36	4	conducted	conduct	VERB
ajcp-1397	36	5	after	after	ADP
ajcp-1397	36	6	the	the	DET
ajcp-1397	36	7	ethical	ethical	ADJ
ajcp-1397	36	8	approval	approval	NOUN
ajcp-1397	36	9	from	from	ADP
ajcp-1397	36	10	the	the	DET
ajcp-1397	36	11	research	research	NOUN
ajcp-1397	36	12	committee	committee	PROPN
ajcp-1397	36	13	in	in	ADP
ajcp-1397	36	14	dha	dha	PROPN
ajcp-1397	36	15	.	.	PUNCT
ajcp-1397	37	1	informed	informed	ADJ
ajcp-1397	37	2	consent	consent	NOUN
ajcp-1397	37	3	was	be	AUX
ajcp-1397	37	4	also	also	ADV
ajcp-1397	37	5	obtained	obtain	VERB
ajcp-1397	37	6	.	.	PUNCT
ajcp-1397	38	1	the	the	DET
ajcp-1397	38	2	questionnaire	questionnaire	NOUN
ajcp-1397	38	3	contains	contain	VERB
ajcp-1397	38	4	data	datum	NOUN
ajcp-1397	38	5	on	on	ADP
ajcp-1397	38	6	demographic	demographic	ADJ
ajcp-1397	38	7	characteristics	characteristic	NOUN
ajcp-1397	38	8	,	,	PUNCT
ajcp-1397	38	9	symptoms	symptom	NOUN
ajcp-1397	38	10	,	,	PUNCT
ajcp-1397	38	11	blood	blood	NOUN
ajcp-1397	38	12	profile	profile	NOUN
ajcp-1397	38	13	,	,	PUNCT
ajcp-1397	38	14	and	and	CCONJ
ajcp-1397	38	15	vaccination	vaccination	NOUN
ajcp-1397	38	16	details	detail	NOUN
ajcp-1397	38	17	.	.	PUNCT
ajcp-1397	39	1	statistical	statistical	ADJ
ajcp-1397	39	2	package	package	NOUN
ajcp-1397	39	3	of	of	ADP
ajcp-1397	39	4	social	social	ADJ
ajcp-1397	39	5	sciences	science	NOUN
ajcp-1397	39	6	(	(	PUNCT
ajcp-1397	39	7	spss	spss	PROPN
ajcp-1397	39	8	,	,	PUNCT
ajcp-1397	39	9	v20.0	v20.0	PROPN
ajcp-1397	39	10	)	)	PUNCT
ajcp-1397	39	11	was	be	AUX
ajcp-1397	39	12	used	use	VERB
ajcp-1397	39	13	for	for	ADP
ajcp-1397	39	14	data	datum	NOUN
ajcp-1397	39	15	analysis	analysis	NOUN
ajcp-1397	39	16	.	.	PUNCT
ajcp-1397	40	1	the	the	DET
ajcp-1397	40	2	data	datum	NOUN
ajcp-1397	40	3	was	be	AUX
ajcp-1397	40	4	represented	represent	VERB
ajcp-1397	40	5	as	as	ADP
ajcp-1397	40	6	mean	mean	NOUN
ajcp-1397	40	7	±	±	NUM
ajcp-1397	40	8	sd	sd	NOUN
ajcp-1397	40	9	,	,	PUNCT
ajcp-1397	40	10	while	while	SCONJ
ajcp-1397	40	11	variable	variable	ADJ
ajcp-1397	40	12	differences	difference	NOUN
ajcp-1397	40	13	were	be	AUX
ajcp-1397	40	14	analyzed	analyze	VERB
ajcp-1397	40	15	as	as	ADP
ajcp-1397	40	16	frequency	frequency	NOUN
ajcp-1397	40	17	(	(	PUNCT
ajcp-1397	40	18	percentage	percentage	NOUN
ajcp-1397	40	19	)	)	PUNCT
ajcp-1397	40	20	.	.	PUNCT
ajcp-1397	41	1	fisher	fisher	PROPN
ajcp-1397	41	2	and	and	CCONJ
ajcp-1397	41	3	student	student	PROPN
ajcp-1397	41	4	t	t	PROPN
ajcp-1397	41	5	-	-	PUNCT
ajcp-1397	41	6	tests	test	NOUN
ajcp-1397	41	7	were	be	AUX
ajcp-1397	41	8	used	use	VERB
ajcp-1397	41	9	to	to	ADP
ajcp-1397	41	10	comparing	compare	VERB
ajcp-1397	41	11	covid	covid	NOUN
ajcp-1397	41	12	-	-	PUNCT
ajcp-1397	41	13	infected	infected	ADJ
ajcp-1397	41	14	and	and	CCONJ
ajcp-1397	41	15	uninfected	uninfected	ADJ
ajcp-1397	41	16	pregnant	pregnant	ADJ
ajcp-1397	41	17	women	woman	NOUN
ajcp-1397	41	18	.	.	PUNCT
ajcp-1397	42	1	a	a	DET
ajcp-1397	42	2	relative	relative	ADJ
ajcp-1397	42	3	regression	regression	NOUN
ajcp-1397	42	4	test	test	NOUN
ajcp-1397	42	5	was	be	AUX
ajcp-1397	42	6	performed	perform	VERB
ajcp-1397	42	7	to	to	PART
ajcp-1397	42	8	determine	determine	VERB
ajcp-1397	42	9	the	the	DET
ajcp-1397	42	10	relations	relation	NOUN
ajcp-1397	42	11	of	of	ADP
ajcp-1397	42	12	participants	participant	NOUN
ajcp-1397	42	13	’	'	PUNCT
ajcp-1397	42	14	characteristics	characteristic	NOUN
ajcp-1397	42	15	such	such	ADJ
ajcp-1397	42	16	as	as	ADP
ajcp-1397	42	17	age	age	NOUN
ajcp-1397	42	18	,	,	PUNCT
ajcp-1397	42	19	bmi	bmi	NOUN
ajcp-1397	42	20	,	,	PUNCT
ajcp-1397	42	21	and	and	CCONJ
ajcp-1397	42	22	severity	severity	NOUN
ajcp-1397	42	23	of	of	ADP
ajcp-1397	42	24	covid-19	covid-19	PROPN
ajcp-1397	42	25	symptoms	symptom	NOUN
ajcp-1397	42	26	and	and	CCONJ
ajcp-1397	42	27	blood	blood	NOUN
ajcp-1397	42	28	profile	profile	NOUN
ajcp-1397	42	29	.	.	PUNCT
ajcp-1397	43	1	the	the	DET
ajcp-1397	43	2	statistically	statistically	ADV
ajcp-1397	43	3	significant	significant	ADJ
ajcp-1397	43	4	value	value	NOUN
ajcp-1397	43	5	p=	p=	NOUN
ajcp-1397	43	6	<	<	NOUN
ajcp-1397	43	7	0.05	0.05	NUM
ajcp-1397	43	8	was	be	AUX
ajcp-1397	43	9	considered	consider	VERB
ajcp-1397	43	10	.	.	PUNCT
ajcp-1397	44	1	results	result	NOUN
ajcp-1397	44	2	and	and	CCONJ
ajcp-1397	44	3	discussion	discussion	NOUN
ajcp-1397	44	4	results	result	VERB
ajcp-1397	44	5	table	table	VERB
ajcp-1397	44	6	1	1	NUM
ajcp-1397	44	7	:	:	PUNCT
ajcp-1397	44	8	demographic	demographic	ADJ
ajcp-1397	44	9	characteristics	characteristic	NOUN
ajcp-1397	44	10	of	of	ADP
ajcp-1397	44	11	the	the	DET
ajcp-1397	44	12	study	study	NOUN
ajcp-1397	44	13	variables	variable	VERB
ajcp-1397	44	14	all	all	DET
ajcp-1397	44	15	patients	patient	NOUN
ajcp-1397	44	16	(	(	PUNCT
ajcp-1397	44	17	n=326	n=326	NOUN
ajcp-1397	44	18	)	)	PUNCT
ajcp-1397	44	19	p	p	ADJ
ajcp-1397	44	20	-	-	PUNCT
ajcp-1397	44	21	value	value	NOUN
ajcp-1397	44	22	age	age	NOUN
ajcp-1397	44	23	31.63	31.63	NUM
ajcp-1397	44	24	+	+	CCONJ
ajcp-1397	44	25	6.36	6.36	NUM
ajcp-1397	44	26	<	<	NOUN
ajcp-1397	44	27	0.001	0.001	NUM
ajcp-1397	44	28	*	*	NOUN
ajcp-1397	44	29	ethnicity	ethnicity	NOUN
ajcp-1397	44	30	,	,	PUNCT
ajcp-1397	44	31	n	n	CCONJ
ajcp-1397	44	32	(	(	PUNCT
ajcp-1397	44	33	%	%	INTJ
ajcp-1397	44	34	)	)	PUNCT
ajcp-1397	44	35	uae	uae	PROPN
ajcp-1397	44	36	182(0	182(0	NUM
ajcp-1397	44	37	)	)	PUNCT
ajcp-1397	44	38	0.005	0.005	NUM
ajcp-1397	44	39	*	*	PUNCT
ajcp-1397	44	40	yemen	yemen	PROPN
ajcp-1397	44	41	13(3.9	13(3.9	NUM
ajcp-1397	44	42	)	)	PUNCT
ajcp-1397	44	43	0.05	0.05	NUM
ajcp-1397	44	44	*	*	PUNCT
ajcp-1397	44	45	pakistan	pakistan	PROPN
ajcp-1397	44	46	12(3.68	12(3.68	NUM
ajcp-1397	44	47	)	)	PUNCT
ajcp-1397	44	48	0.05	0.05	NUM
ajcp-1397	44	49	*	*	PUNCT
ajcp-1397	44	50	oman	oman	NOUN
ajcp-1397	44	51	8(2.4	8(2.4	NUM
ajcp-1397	44	52	)	)	PUNCT
ajcp-1397	44	53	0.55	0.55	NUM
ajcp-1397	44	54	comery	comery	NOUN
ajcp-1397	44	55	1(0.3	1(0.3	NUM
ajcp-1397	44	56	)	)	PUNCT
ajcp-1397	44	57	0.55	0.55	NUM
ajcp-1397	44	58	kyrgyzstan	kyrgyzstan	PROPN
ajcp-1397	44	59	1(0.3	1(0.3	NUM
ajcp-1397	44	60	)	)	PUNCT
ajcp-1397	44	61	0.55	0.55	NUM
ajcp-1397	44	62	comoros	comoros	PROPN
ajcp-1397	44	63	4(1	4(1	NUM
ajcp-1397	44	64	..	..	PUNCT
ajcp-1397	44	65	22	22	NUM
ajcp-1397	44	66	)	)	PUNCT
ajcp-1397	44	67	0.55	0.55	NUM
ajcp-1397	44	68	kuwait	kuwait	PROPN
ajcp-1397	44	69	1(0.3	1(0.3	NUM
ajcp-1397	44	70	)	)	PUNCT
ajcp-1397	44	71	0.55	0.55	NUM
ajcp-1397	44	72	france	france	PROPN
ajcp-1397	44	73	1(0.3	1(0.3	NUM
ajcp-1397	44	74	)	)	PUNCT
ajcp-1397	44	75	0.55	0.55	NUM
ajcp-1397	44	76	pakistan	pakistan	NOUN
ajcp-1397	44	77	3(0.9	3(0.9	NUM
ajcp-1397	44	78	)	)	PUNCT
ajcp-1397	44	79	0.55	0.55	NUM
ajcp-1397	44	80	sri	sri	PROPN
ajcp-1397	44	81	lanka	lanka	NOUN
ajcp-1397	44	82	2(0.6	2(0.6	NUM
ajcp-1397	44	83	)	)	PUNCT
ajcp-1397	44	84	0.55	0.55	NUM
ajcp-1397	44	85	jordan	jordan	PROPN
ajcp-1397	44	86	7(2.1	7(2.1	NUM
ajcp-1397	44	87	)	)	PUNCT
ajcp-1397	44	88	0.55	0.55	NUM
ajcp-1397	44	89	tunisia	tunisia	NOUN
ajcp-1397	44	90	1(0.3	1(0.3	NUM
ajcp-1397	44	91	)	)	PUNCT
ajcp-1397	44	92	0.55	0.55	NUM
ajcp-1397	44	93	vietnam	vietnam	PROPN
ajcp-1397	44	94	1(0.3	1(0.3	NUM
ajcp-1397	44	95	)	)	PUNCT
ajcp-1397	44	96	0.55	0.55	NUM
ajcp-1397	44	97	tajikistan	tajikistan	PROPN
ajcp-1397	44	98	1(0.3	1(0.3	NUM
ajcp-1397	44	99	)	)	PUNCT
ajcp-1397	44	100	0.55	0.55	NUM
ajcp-1397	44	101	azerbaijan	azerbaijan	PROPN
ajcp-1397	44	102	1(0.3	1(0.3	NUM
ajcp-1397	44	103	)	)	PUNCT
ajcp-1397	44	104	0.55	0.55	NUM
ajcp-1397	44	105	filipi0	filipi0	NOUN
ajcp-1397	44	106	14(4.29	14(4.29	NUM
ajcp-1397	44	107	)	)	PUNCT
ajcp-1397	44	108	0.05	0.05	NUM
ajcp-1397	44	109	*	*	PUNCT
ajcp-1397	44	110	sudan	sudan	PROPN
ajcp-1397	44	111	1(0.3	1(0.3	NUM
ajcp-1397	44	112	)	)	PUNCT
ajcp-1397	44	113	0.55	0.55	NUM
ajcp-1397	44	114	bangladesh	bangladesh	NOUN
ajcp-1397	44	115	1(0.3	1(0.3	NUM
ajcp-1397	44	116	)	)	PUNCT
ajcp-1397	44	117	0.55	0.55	NUM
ajcp-1397	44	118	saudi	saudi	PROPN
ajcp-1397	44	119	arabia	arabia	PROPN
ajcp-1397	44	120	2(0.6	2(0.6	NUM
ajcp-1397	44	121	)	)	PUNCT
ajcp-1397	44	122	0.55	0.55	NUM
ajcp-1397	44	123	india	india	PROPN
ajcp-1397	44	124	15(4.6	15(4.6	NUM
ajcp-1397	44	125	)	)	PUNCT
ajcp-1397	44	126	0.05	0.05	NUM
ajcp-1397	44	127	*	*	PUNCT
ajcp-1397	44	128	leba0n	leba0n	PROPN
ajcp-1397	44	129	1(0.3	1(0.3	NUM
ajcp-1397	44	130	)	)	PUNCT
ajcp-1397	44	131	0.55	0.55	NUM
ajcp-1397	44	132	syrian	syrian	ADJ
ajcp-1397	44	133	8(2.4	8(2.4	NUM
ajcp-1397	44	134	)	)	PUNCT
ajcp-1397	44	135	0.35	0.35	NUM
ajcp-1397	44	136	iran	iran	PROPN
ajcp-1397	44	137	12(3.6	12(3.6	NUM
ajcp-1397	44	138	)	)	PUNCT
ajcp-1397	44	139	0.05	0.05	NUM
ajcp-1397	44	140	*	*	PUNCT
ajcp-1397	44	141	iraq	iraq	PROPN
ajcp-1397	44	142	1(0.3	1(0.3	NUM
ajcp-1397	44	143	)	)	PUNCT
ajcp-1397	44	144	0.55	0.55	NUM
ajcp-1397	44	145	egypt	egypt	PROPN
ajcp-1397	44	146	11(3.3	11(3.3	NUM
ajcp-1397	44	147	)	)	PUNCT
ajcp-1397	44	148	0.05	0.05	NUM
ajcp-1397	44	149	*	*	PUNCT
ajcp-1397	44	150	turkey	turkey	PROPN
ajcp-1397	44	151	1(0.3	1(0.3	NUM
ajcp-1397	44	152	)	)	PUNCT
ajcp-1397	44	153	0.55	0.55	NUM
ajcp-1397	44	154	china	china	NOUN
ajcp-1397	44	155	3(0.9	3(0.9	NUM
ajcp-1397	44	156	)	)	PUNCT
ajcp-1397	44	157	0.55	0.55	NUM
ajcp-1397	44	158	bahrain	bahrain	NOUN
ajcp-1397	44	159	2(0.6	2(0.6	NUM
ajcp-1397	44	160	)	)	PUNCT
ajcp-1397	44	161	0.55	0.55	NUM
ajcp-1397	44	162	morocco	morocco	NOUN
ajcp-1397	44	163	6(1.8	6(1.8	NUM
ajcp-1397	44	164	)	)	PUNCT
ajcp-1397	44	165	0.55	0.55	NUM
ajcp-1397	44	166	united	united	ADJ
ajcp-1397	44	167	kingdom	kingdom	PROPN
ajcp-1397	44	168	1(0.3	1(0.3	NUM
ajcp-1397	44	169	)	)	PUNCT
ajcp-1397	44	170	0.55	0.55	NUM
ajcp-1397	44	171	turkey	turkey	NOUN
ajcp-1397	44	172	1(0.3	1(0.3	NUM
ajcp-1397	44	173	)	)	PUNCT
ajcp-1397	44	174	0.55	0.55	NUM
ajcp-1397	44	175	leba0n	leba0n	PROPN
ajcp-1397	44	176	1(0.3	1(0.3	NUM
ajcp-1397	44	177	)	)	PUNCT
ajcp-1397	44	178	0.55	0.55	NUM
ajcp-1397	44	179	south	south	PROPN
ajcp-1397	44	180	africa	africa	PROPN
ajcp-1397	44	181	1(0.3	1(0.3	NUM
ajcp-1397	44	182	)	)	PUNCT
ajcp-1397	44	183	0.55	0.55	NUM
ajcp-1397	44	184	kazakhstan	kazakhstan	PROPN
ajcp-1397	44	185	2(0.6	2(0.6	NUM
ajcp-1397	44	186	)	)	PUNCT
ajcp-1397	44	187	0.55	0.55	NUM
ajcp-1397	44	188	kenya	kenya	NOUN
ajcp-1397	44	189	2(0.6	2(0.6	NUM
ajcp-1397	44	190	)	)	PUNCT
ajcp-1397	44	191	0.55	0.55	NUM
ajcp-1397	44	192	somalia	somalia	PROPN
ajcp-1397	44	193	1(0.3	1(0.3	NUM
ajcp-1397	44	194	)	)	PUNCT
ajcp-1397	44	195	0.65	0.65	NUM
ajcp-1397	44	196	*	*	NOUN
ajcp-1397	44	197	significance	significance	NOUN
ajcp-1397	44	198	at	at	ADP
ajcp-1397	44	199	p	p	NOUN
ajcp-1397	44	200	-	-	PUNCT
ajcp-1397	44	201	value<0.05	value<0.05	NOUN
ajcp-1397	44	202	.	.	PUNCT
ajcp-1397	44	203	table	table	NOUN
ajcp-1397	44	204	2	2	NUM
ajcp-1397	44	205	:	:	PUNCT
ajcp-1397	44	206	variation	variation	NOUN
ajcp-1397	44	207	in	in	ADP
ajcp-1397	44	208	the	the	DET
ajcp-1397	44	209	covidinfected	covidinfecte	VERB
ajcp-1397	44	210	and	and	CCONJ
ajcp-1397	44	211	uninfected	uninfected	ADJ
ajcp-1397	44	212	pregnant	pregnant	ADJ
ajcp-1397	44	213	women	woman	NOUN
ajcp-1397	44	214	related	relate	VERB
ajcp-1397	44	215	to	to	ADP
ajcp-1397	44	216	symptoms	symptom	NOUN
ajcp-1397	44	217	,	,	PUNCT
ajcp-1397	44	218	vaccination	vaccination	NOUN
ajcp-1397	44	219	and	and	CCONJ
ajcp-1397	44	220	blood	blood	NOUN
ajcp-1397	44	221	variables	variable	NOUN
ajcp-1397	44	222	.	.	PUNCT
ajcp-1397	45	1	variables	variable	NOUN
ajcp-1397	45	2	covidinfected	covidinfecte	VERB
ajcp-1397	45	3	pregnant	pregnant	ADJ
ajcp-1397	45	4	women	woman	NOUN
ajcp-1397	45	5	uninfected	uninfecte	VERB
ajcp-1397	45	6	pregnant	pregnant	ADJ
ajcp-1397	45	7	women	woman	NOUN
ajcp-1397	45	8	n	n	CCONJ
ajcp-1397	45	9	199	199	NUM
ajcp-1397	45	10	118	118	NUM
ajcp-1397	45	11	age	age	NOUN
ajcp-1397	45	12	31.63	31.63	NUM
ajcp-1397	45	13	+	+	CCONJ
ajcp-1397	45	14	6.36	6.36	NUM
ajcp-1397	45	15	31.33	31.33	NUM
ajcp-1397	45	16	+	+	NUM
ajcp-1397	45	17	6.23	6.23	NUM
ajcp-1397	45	18	bmi	bmi	X
ajcp-1397	45	19	(	(	PUNCT
ajcp-1397	45	20	kg	kg	NOUN
ajcp-1397	45	21	/	/	SYM
ajcp-1397	45	22	m2	m2	PROPN
ajcp-1397	45	23	)	)	PUNCT
ajcp-1397	45	24	28.96±1.16	28.96±1.16	PROPN
ajcp-1397	45	25	27.06±11.05	27.06±11.05	NOUN
ajcp-1397	46	1	https://journals.e-palli.com/home/index.php/ajcp	https://journals.e-palli.com/home/index.php/ajcp	PROPN
ajcp-1397	46	2	pa	pa	PROPN
ajcp-1397	46	3	ge	ge	PROPN
ajcp-1397	46	4	34	34	NUM
ajcp-1397	46	5	https://journals.e-palli.com/home/index.php/ajcp	https://journals.e-palli.com/home/index.php/ajcp	PROPN
ajcp-1397	46	6	am	be	AUX
ajcp-1397	46	7	.	.	PUNCT
ajcp-1397	47	1	j.	j.	PROPN
ajcp-1397	47	2	chem	chem	PROPN
ajcp-1397	47	3	.	.	PUNCT
ajcp-1397	48	1	pharm	pharm	NOUN
ajcp-1397	48	2	.	.	PUNCT
ajcp-1397	49	1	2(1	2(1	NUM
ajcp-1397	49	2	)	)	PUNCT
ajcp-1397	49	3	32	32	NUM
ajcp-1397	49	4	-	-	SYM
ajcp-1397	49	5	37	37	NUM
ajcp-1397	49	6	,	,	PUNCT
ajcp-1397	49	7	2023	2023	NUM
ajcp-1397	49	8	gestational	gestational	ADJ
ajcp-1397	49	9	age	age	NOUN
ajcp-1397	49	10	(	(	PUNCT
ajcp-1397	49	11	weeks	week	NOUN
ajcp-1397	49	12	)	)	PUNCT
ajcp-1397	49	13	25.06±3.5	25.06±3.5	PROPN
ajcp-1397	49	14	27.06±11.05	27.06±11.05	NUM
ajcp-1397	49	15	vaccinated	vaccinate	VERB
ajcp-1397	49	16	1±0.4	1±0.4	NUM
ajcp-1397	49	17	0.737	0.737	NUM
ajcp-1397	49	18	+	+	SYM
ajcp-1397	49	19	0.4	0.4	NUM
ajcp-1397	49	20	hb	hb	NOUN
ajcp-1397	49	21	11±0.141	11±0.141	NUM
ajcp-1397	49	22	11.20±	11.20±	NUM
ajcp-1397	49	23	1.34	1.34	NUM
ajcp-1397	49	24	wbc	wbc	NOUN
ajcp-1397	49	25	7	7	NUM
ajcp-1397	49	26	±	±	NUM
ajcp-1397	49	27	3.25	3.25	NUM
ajcp-1397	49	28	8.37	8.37	NUM
ajcp-1397	49	29	+	+	CCONJ
ajcp-1397	49	30	2.862	2.862	NUM
ajcp-1397	49	31	crp	crp	NOUN
ajcp-1397	49	32	18	18	NUM
ajcp-1397	49	33	±	±	NUM
ajcp-1397	49	34	10.1	10.1	NUM
ajcp-1397	49	35	17.79	17.79	NUM
ajcp-1397	49	36	+	+	SYM
ajcp-1397	49	37	3.722	3.722	NUM
ajcp-1397	49	38	procalcitonin	procalcitonin	ADJ
ajcp-1397	49	39	0±0.049	0±0.049	NOUN
ajcp-1397	49	40	0.489	0.489	NUM
ajcp-1397	49	41	+	+	SYM
ajcp-1397	49	42	3.27	3.27	NUM
ajcp-1397	49	43	fever	fever	NOUN
ajcp-1397	49	44	1±0.7	1±0.7	NUM
ajcp-1397	50	1	0±0.3	0±0.3	NOUN
ajcp-1397	50	2	sore	sore	ADJ
ajcp-1397	50	3	throat	throat	NOUN
ajcp-1397	50	4	0±0.0	0±0.0	NOUN
ajcp-1397	50	5	0±0.15	0±0.15	NUM
ajcp-1397	50	6	shortness	shortness	NOUN
ajcp-1397	50	7	of	of	ADP
ajcp-1397	50	8	breath	breath	NOUN
ajcp-1397	50	9	0±0.7	0±0.7	ADV
ajcp-1397	50	10	0±0.0	0±0.0	ADJ
ajcp-1397	50	11	cough	cough	NOUN
ajcp-1397	50	12	1±0	1±0	NUM
ajcp-1397	50	13	0±0.2	0±0.2	ADJ
ajcp-1397	50	14	dehydration	dehydration	NOUN
ajcp-1397	50	15	(	(	PUNCT
ajcp-1397	50	16	acetone	acetone	NOUN
ajcp-1397	50	17	in	in	ADP
ajcp-1397	50	18	urine	urine	NOUN
ajcp-1397	50	19	)	)	PUNCT
ajcp-1397	51	1	1±0.7	1±0.7	NOUN
ajcp-1397	51	2	1±0.41	1±0.41	NUM
ajcp-1397	51	3	lethargy	lethargy	NOUN
ajcp-1397	51	4	0±0	0±0	X
ajcp-1397	51	5	.	.	PUNCT
ajcp-1397	52	1	0±0	0±0	PROPN
ajcp-1397	52	2	.	.	PUNCT
ajcp-1397	53	1	figure	figure	NOUN
ajcp-1397	53	2	1	1	NUM
ajcp-1397	53	3	:	:	PUNCT
ajcp-1397	53	4	differences	difference	NOUN
ajcp-1397	53	5	between	between	ADP
ajcp-1397	53	6	demographic	demographic	ADJ
ajcp-1397	53	7	characteristics	characteristic	NOUN
ajcp-1397	53	8	of	of	ADP
ajcp-1397	53	9	covid	covid	NOUN
ajcp-1397	53	10	-	-	PUNCT
ajcp-1397	53	11	infected	infected	ADJ
ajcp-1397	53	12	and	and	CCONJ
ajcp-1397	53	13	uninfected	uninfected	ADJ
ajcp-1397	53	14	pregnant	pregnant	ADJ
ajcp-1397	53	15	women	woman	NOUN
ajcp-1397	53	16	figure	figure	VERB
ajcp-1397	53	17	2	2	NUM
ajcp-1397	53	18	:	:	PUNCT
ajcp-1397	53	19	differences	difference	NOUN
ajcp-1397	53	20	between	between	ADP
ajcp-1397	53	21	blood	blood	NOUN
ajcp-1397	53	22	variables	variable	NOUN
ajcp-1397	53	23	of	of	ADP
ajcp-1397	53	24	covid	covid	NOUN
ajcp-1397	53	25	-	-	PUNCT
ajcp-1397	53	26	infected	infected	ADJ
ajcp-1397	53	27	and	and	CCONJ
ajcp-1397	53	28	uninfected	uninfected	ADJ
ajcp-1397	53	29	pregnant	pregnant	ADJ
ajcp-1397	53	30	women	woman	NOUN
ajcp-1397	53	31	.	.	PUNCT
ajcp-1397	54	1	https://journals.e-palli.com/home/index.php/ajcp	https://journals.e-palli.com/home/index.php/ajcp	PROPN
ajcp-1397	54	2	pa	pa	PROPN
ajcp-1397	54	3	ge	ge	PROPN
ajcp-1397	54	4	35	35	NUM
ajcp-1397	54	5	https://journals.e-palli.com/home/index.php/ajcp	https://journals.e-palli.com/home/index.php/ajcp	PROPN
ajcp-1397	54	6	am	be	AUX
ajcp-1397	54	7	.	.	PUNCT
ajcp-1397	55	1	j.	j.	PROPN
ajcp-1397	55	2	chem	chem	PROPN
ajcp-1397	55	3	.	.	PUNCT
ajcp-1397	56	1	pharm	pharm	NOUN
ajcp-1397	56	2	.	.	PUNCT
ajcp-1397	57	1	2(1	2(1	NUM
ajcp-1397	57	2	)	)	PUNCT
ajcp-1397	57	3	32	32	NUM
ajcp-1397	57	4	-	-	SYM
ajcp-1397	57	5	37	37	NUM
ajcp-1397	57	6	,	,	PUNCT
ajcp-1397	57	7	2023	2023	NUM
ajcp-1397	57	8	figure	figure	NOUN
ajcp-1397	57	9	3	3	NUM
ajcp-1397	57	10	:	:	PUNCT
ajcp-1397	57	11	difference	difference	NOUN
ajcp-1397	57	12	between	between	ADP
ajcp-1397	57	13	comorbid	comorbid	NOUN
ajcp-1397	57	14	disease	disease	NOUN
ajcp-1397	57	15	in	in	ADP
ajcp-1397	57	16	covid	covid	PROPN
ajcp-1397	57	17	-	-	PUNCT
ajcp-1397	57	18	infected	infected	ADJ
ajcp-1397	57	19	and	and	CCONJ
ajcp-1397	57	20	uninfected	uninfected	ADJ
ajcp-1397	57	21	pregnant	pregnant	ADJ
ajcp-1397	57	22	women	woman	NOUN
ajcp-1397	57	23	demographic	demographic	ADJ
ajcp-1397	57	24	characteristics	characteristic	NOUN
ajcp-1397	57	25	showed	show	VERB
ajcp-1397	57	26	in	in	ADP
ajcp-1397	57	27	table	table	NOUN
ajcp-1397	57	28	1	1	NUM
ajcp-1397	57	29	.	.	PUNCT
ajcp-1397	58	1	most	most	ADJ
ajcp-1397	58	2	patients	patient	NOUN
ajcp-1397	58	3	were	be	AUX
ajcp-1397	58	4	from	from	ADP
ajcp-1397	58	5	the	the	DET
ajcp-1397	58	6	uae	uae	PROPN
ajcp-1397	58	7	,	,	PUNCT
ajcp-1397	58	8	with	with	ADP
ajcp-1397	58	9	a	a	DET
ajcp-1397	58	10	mean	mean	ADJ
ajcp-1397	58	11	age	age	NOUN
ajcp-1397	58	12	of	of	ADP
ajcp-1397	58	13	31.63	31.63	NUM
ajcp-1397	58	14	+	+	CCONJ
ajcp-1397	58	15	6.36	6.36	NUM
ajcp-1397	58	16	and	and	CCONJ
ajcp-1397	58	17	an	an	DET
ajcp-1397	58	18	average	average	ADJ
ajcp-1397	58	19	bmi	bmi	NOUN
ajcp-1397	58	20	of	of	ADP
ajcp-1397	58	21	28.96±1.16	28.96±1.16	NUM
ajcp-1397	58	22	kg	kg	PROPN
ajcp-1397	58	23	/	/	SYM
ajcp-1397	58	24	m2	m2	PROPN
ajcp-1397	58	25	of	of	ADP
ajcp-1397	58	26	covid	covid	PROPN
ajcp-1397	58	27	-	-	PUNCT
ajcp-1397	58	28	infected	infect	VERB
ajcp-1397	58	29	pregnant	pregnant	ADJ
ajcp-1397	58	30	women	woman	NOUN
ajcp-1397	58	31	.	.	PUNCT
ajcp-1397	59	1	while	while	SCONJ
ajcp-1397	59	2	the	the	DET
ajcp-1397	59	3	mean	mean	ADJ
ajcp-1397	59	4	age	age	NOUN
ajcp-1397	59	5	of	of	ADP
ajcp-1397	59	6	31.33	31.33	NUM
ajcp-1397	59	7	+	+	SYM
ajcp-1397	59	8	6.23	6.23	NUM
ajcp-1397	59	9	and	and	CCONJ
ajcp-1397	59	10	an	an	DET
ajcp-1397	59	11	average	average	ADJ
ajcp-1397	59	12	bmi	bmi	NOUN
ajcp-1397	59	13	of	of	ADP
ajcp-1397	59	14	27.06±11.05	27.06±11.05	NUM
ajcp-1397	59	15	kg	kg	PROPN
ajcp-1397	59	16	/	/	SYM
ajcp-1397	59	17	m2	m2	PROPN
ajcp-1397	59	18	of	of	ADP
ajcp-1397	59	19	uninfected	uninfected	ADJ
ajcp-1397	59	20	pregnant	pregnant	ADJ
ajcp-1397	59	21	women	woman	NOUN
ajcp-1397	59	22	.	.	PUNCT
ajcp-1397	60	1	variation	variation	NOUN
ajcp-1397	60	2	in	in	ADP
ajcp-1397	60	3	the	the	DET
ajcp-1397	60	4	covid	covid	NOUN
ajcp-1397	60	5	-	-	PUNCT
ajcp-1397	60	6	infected	infected	ADJ
ajcp-1397	60	7	and	and	CCONJ
ajcp-1397	60	8	uninfected	uninfected	ADJ
ajcp-1397	60	9	pregnant	pregnant	ADJ
ajcp-1397	60	10	women	woman	NOUN
ajcp-1397	60	11	related	relate	VERB
ajcp-1397	60	12	to	to	ADP
ajcp-1397	60	13	symptoms	symptom	NOUN
ajcp-1397	60	14	,	,	PUNCT
ajcp-1397	60	15	vaccination	vaccination	NOUN
ajcp-1397	60	16	and	and	CCONJ
ajcp-1397	60	17	blood	blood	NOUN
ajcp-1397	60	18	variables	variable	NOUN
ajcp-1397	60	19	(	(	PUNCT
ajcp-1397	60	20	table	table	NOUN
ajcp-1397	60	21	2	2	NUM
ajcp-1397	60	22	)	)	PUNCT
ajcp-1397	60	23	.	.	PUNCT
ajcp-1397	61	1	this	this	DET
ajcp-1397	61	2	study	study	NOUN
ajcp-1397	61	3	showed	show	VERB
ajcp-1397	61	4	that	that	SCONJ
ajcp-1397	61	5	the	the	DET
ajcp-1397	61	6	age	age	NOUN
ajcp-1397	61	7	,	,	PUNCT
ajcp-1397	61	8	bmi	bmi	NOUN
ajcp-1397	61	9	,	,	PUNCT
ajcp-1397	61	10	and	and	CCONJ
ajcp-1397	61	11	gestational	gestational	ADJ
ajcp-1397	61	12	age	age	NOUN
ajcp-1397	61	13	were	be	AUX
ajcp-1397	61	14	insignificant	insignificant	ADJ
ajcp-1397	61	15	compared	compare	VERB
ajcp-1397	61	16	to	to	ADP
ajcp-1397	61	17	the	the	DET
ajcp-1397	61	18	covid	covid	PROPN
ajcp-1397	61	19	-	-	PUNCT
ajcp-1397	61	20	infected	infected	ADJ
ajcp-1397	61	21	and	and	CCONJ
ajcp-1397	61	22	uninfected	uninfected	ADJ
ajcp-1397	61	23	pregnant	pregnant	ADJ
ajcp-1397	61	24	women	woman	NOUN
ajcp-1397	61	25	(	(	PUNCT
ajcp-1397	61	26	fig	fig	NOUN
ajcp-1397	61	27	1	1	NUM
ajcp-1397	61	28	)	)	PUNCT
ajcp-1397	61	29	.	.	PUNCT
ajcp-1397	62	1	hemoglobin	hemoglobin	NOUN
ajcp-1397	62	2	(	(	PUNCT
ajcp-1397	62	3	hb	hb	PROPN
ajcp-1397	62	4	)	)	PUNCT
ajcp-1397	62	5	,	,	PUNCT
ajcp-1397	62	6	white	white	ADJ
ajcp-1397	62	7	blood	blood	NOUN
ajcp-1397	62	8	cells	cell	NOUN
ajcp-1397	62	9	(	(	PUNCT
ajcp-1397	62	10	wbcs	wbcs	PROPN
ajcp-1397	62	11	)	)	PUNCT
ajcp-1397	62	12	,	,	PUNCT
ajcp-1397	62	13	and	and	CCONJ
ajcp-1397	62	14	c	c	X
ajcp-1397	62	15	-	-	PUNCT
ajcp-1397	62	16	reactive	reactive	ADJ
ajcp-1397	62	17	protein	protein	NOUN
ajcp-1397	62	18	(	(	PUNCT
ajcp-1397	62	19	crp	crp	PROPN
ajcp-1397	62	20	)	)	PUNCT
ajcp-1397	62	21	showed	show	VERB
ajcp-1397	62	22	significantly	significantly	ADV
ajcp-1397	62	23	different	different	ADJ
ajcp-1397	62	24	when	when	SCONJ
ajcp-1397	62	25	compared	compare	VERB
ajcp-1397	62	26	to	to	ADP
ajcp-1397	62	27	covid	covid	VERB
ajcp-1397	62	28	-	-	PUNCT
ajcp-1397	62	29	infected	infected	ADJ
ajcp-1397	62	30	and	and	CCONJ
ajcp-1397	62	31	uninfected	uninfected	ADJ
ajcp-1397	62	32	pregnant	pregnant	ADJ
ajcp-1397	62	33	women	woman	NOUN
ajcp-1397	62	34	(	(	PUNCT
ajcp-1397	62	35	fig	fig	NOUN
ajcp-1397	62	36	2	2	NUM
ajcp-1397	62	37	)	)	PUNCT
ajcp-1397	62	38	.	.	PUNCT
ajcp-1397	63	1	significant	significant	ADJ
ajcp-1397	63	2	results	result	NOUN
ajcp-1397	63	3	showed	show	VERB
ajcp-1397	63	4	in	in	ADP
ajcp-1397	63	5	comorbid	comorbid	NOUN
ajcp-1397	63	6	diseases	disease	NOUN
ajcp-1397	63	7	compared	compare	VERB
ajcp-1397	63	8	with	with	ADP
ajcp-1397	63	9	covid	covid	NOUN
ajcp-1397	63	10	-	-	PUNCT
ajcp-1397	63	11	infected	infected	ADJ
ajcp-1397	63	12	and	and	CCONJ
ajcp-1397	63	13	uninfected	uninfected	ADJ
ajcp-1397	63	14	pregnant	pregnant	ADJ
ajcp-1397	63	15	women	woman	NOUN
ajcp-1397	63	16	,	,	PUNCT
ajcp-1397	63	17	but	but	CCONJ
ajcp-1397	63	18	a	a	DET
ajcp-1397	63	19	high	high	ADJ
ajcp-1397	63	20	frequency	frequency	NOUN
ajcp-1397	63	21	was	be	AUX
ajcp-1397	63	22	observed	observe	VERB
ajcp-1397	63	23	in	in	ADP
ajcp-1397	63	24	uninfected	uninfected	ADJ
ajcp-1397	63	25	women	woman	NOUN
ajcp-1397	63	26	(	(	PUNCT
ajcp-1397	63	27	fig	fig	NOUN
ajcp-1397	63	28	3	3	NUM
ajcp-1397	63	29	)	)	PUNCT
ajcp-1397	63	30	.	.	PUNCT
ajcp-1397	64	1	table	table	NOUN
ajcp-1397	64	2	3	3	NUM
ajcp-1397	64	3	:	:	PUNCT
ajcp-1397	64	4	the	the	DET
ajcp-1397	64	5	severity	severity	NOUN
ajcp-1397	64	6	of	of	ADP
ajcp-1397	64	7	illness	illness	NOUN
ajcp-1397	64	8	and	and	CCONJ
ajcp-1397	64	9	its	its	PRON
ajcp-1397	64	10	correlates	correlate	NOUN
ajcp-1397	64	11	severity	severity	NOUN
ajcp-1397	64	12	of	of	ADP
ajcp-1397	64	13	illness	illness	NOUN
ajcp-1397	64	14	type	type	NOUN
ajcp-1397	64	15	of	of	ADP
ajcp-1397	64	16	vaccine	vaccine	NOUN
ajcp-1397	64	17	number	number	NOUN
ajcp-1397	64	18	of	of	ADP
ajcp-1397	64	19	doses	dose	NOUN
ajcp-1397	64	20	received	receive	VERB
ajcp-1397	64	21	less	less	ADJ
ajcp-1397	64	22	than	than	ADP
ajcp-1397	64	23	6	6	NUM
ajcp-1397	64	24	month	month	NOUN
ajcp-1397	64	25	more	more	ADJ
ajcp-1397	64	26	than	than	ADP
ajcp-1397	64	27	6	6	NUM
ajcp-1397	64	28	months	month	NOUN
ajcp-1397	64	29	severity	severity	NOUN
ajcp-1397	64	30	of	of	ADP
ajcp-1397	64	31	illness	illness	NOUN
ajcp-1397	64	32	pearson	pearson	NOUN
ajcp-1397	64	33	correlation	correlation	NOUN
ajcp-1397	64	34	1	1	NUM
ajcp-1397	64	35	-0.679	-0.679	NUM
ajcp-1397	64	36	-0.75	-0.75	NUM
ajcp-1397	64	37	-0.108	-0.108	X
ajcp-1397	64	38	-0.29	-0.29	ADJ
ajcp-1397	64	39	type	type	NOUN
ajcp-1397	64	40	of	of	ADP
ajcp-1397	64	41	vaccine	vaccine	NOUN
ajcp-1397	64	42	pearson	pearson	NOUN
ajcp-1397	64	43	correlation	correlation	NOUN
ajcp-1397	64	44	-0.679	-0.679	PUNCT
ajcp-1397	64	45	1	1	NUM
ajcp-1397	64	46	.828	.828	NUM
ajcp-1397	64	47	*	*	PUNCT
ajcp-1397	64	48	*	*	NOUN
ajcp-1397	64	49	.778	.778	NUM
ajcp-1397	64	50	*	*	PUNCT
ajcp-1397	64	51	*	*	PUNCT
ajcp-1397	64	52	.618	.618	NUM
ajcp-1397	64	53	*	*	NOUN
ajcp-1397	64	54	*	*	NOUN
ajcp-1397	64	55	number	number	NOUN
ajcp-1397	64	56	of	of	ADP
ajcp-1397	64	57	doses	dose	NOUN
ajcp-1397	64	58	received	receive	VERB
ajcp-1397	64	59	pearson	pearson	NOUN
ajcp-1397	64	60	correlation	correlation	NOUN
ajcp-1397	64	61	-0.75	-0.75	NUM
ajcp-1397	64	62	.828	.828	NUM
ajcp-1397	64	63	*	*	PUNCT
ajcp-1397	64	64	*	*	NOUN
ajcp-1397	64	65	1	1	NUM
ajcp-1397	64	66	.823	.823	NUM
ajcp-1397	64	67	*	*	NOUN
ajcp-1397	64	68	*	*	NOUN
ajcp-1397	64	69	.833	.833	NUM
ajcp-1397	64	70	*	*	PUNCT
ajcp-1397	64	71	*	*	PUNCT
ajcp-1397	64	72	less	less	ADJ
ajcp-1397	64	73	than	than	ADP
ajcp-1397	64	74	6	6	NUM
ajcp-1397	64	75	month	month	NOUN
ajcp-1397	64	76	pearson	pearson	NOUN
ajcp-1397	64	77	correlation	correlation	NOUN
ajcp-1397	64	78	-0.108	-0.108	PUNCT
ajcp-1397	64	79	.778	.778	NUM
ajcp-1397	64	80	*	*	PUNCT
ajcp-1397	64	81	*	*	NOUN
ajcp-1397	64	82	.823	.823	NUM
ajcp-1397	64	83	*	*	PUNCT
ajcp-1397	64	84	*	*	PUNCT
ajcp-1397	64	85	1	1	NUM
ajcp-1397	64	86	.511	.511	NUM
ajcp-1397	64	87	*	*	NOUN
ajcp-1397	65	1	*	*	PUNCT
ajcp-1397	65	2	more	more	ADJ
ajcp-1397	65	3	than	than	ADP
ajcp-1397	65	4	6	6	NUM
ajcp-1397	65	5	months	month	NOUN
ajcp-1397	65	6	pearson	pearson	NOUN
ajcp-1397	65	7	correlation	correlation	NOUN
ajcp-1397	65	8	-0.29	-0.29	NOUN
ajcp-1397	65	9	.618	.618	NUM
ajcp-1397	65	10	*	*	PUNCT
ajcp-1397	65	11	*	*	PUNCT
ajcp-1397	65	12	.833	.833	NUM
ajcp-1397	65	13	*	*	X
ajcp-1397	65	14	*	*	NOUN
ajcp-1397	65	15	.511	.511	NUM
ajcp-1397	65	16	*	*	PUNCT
ajcp-1397	66	1	*	*	PUNCT
ajcp-1397	66	2	1	1	NUM
ajcp-1397	66	3	*	*	PUNCT
ajcp-1397	66	4	*	*	NOUN
ajcp-1397	66	5	.	.	PUNCT
ajcp-1397	67	1	correlation	correlation	NOUN
ajcp-1397	67	2	is	be	AUX
ajcp-1397	67	3	significant	significant	ADJ
ajcp-1397	67	4	at	at	ADP
ajcp-1397	67	5	the	the	DET
ajcp-1397	67	6	0.01	0.01	NUM
ajcp-1397	67	7	level	level	NOUN
ajcp-1397	67	8	(	(	PUNCT
ajcp-1397	67	9	2	2	NUM
ajcp-1397	67	10	-	-	PUNCT
ajcp-1397	67	11	tailed	tailed	ADJ
ajcp-1397	67	12	)	)	PUNCT
ajcp-1397	67	13	.	.	PUNCT
ajcp-1397	68	1	table	table	NOUN
ajcp-1397	68	2	3	3	NUM
ajcp-1397	68	3	.	.	PUNCT
ajcp-1397	68	4	shows	show	VERB
ajcp-1397	68	5	the	the	DET
ajcp-1397	68	6	correlation	correlation	NOUN
ajcp-1397	68	7	between	between	ADP
ajcp-1397	68	8	the	the	DET
ajcp-1397	68	9	severity	severity	NOUN
ajcp-1397	68	10	of	of	ADP
ajcp-1397	68	11	the	the	DET
ajcp-1397	68	12	vaccine	vaccine	NOUN
ajcp-1397	68	13	and	and	CCONJ
ajcp-1397	68	14	the	the	DET
ajcp-1397	68	15	number	number	NOUN
ajcp-1397	68	16	of	of	ADP
ajcp-1397	68	17	doses	dose	NOUN
ajcp-1397	68	18	received	receive	VERB
ajcp-1397	68	19	,	,	PUNCT
ajcp-1397	68	20	dosage	dosage	NOUN
ajcp-1397	68	21	received	receive	VERB
ajcp-1397	68	22	in	in	ADP
ajcp-1397	68	23	less	less	ADJ
ajcp-1397	68	24	than	than	ADP
ajcp-1397	68	25	6	6	NUM
ajcp-1397	68	26	months	month	NOUN
ajcp-1397	68	27	,	,	PUNCT
ajcp-1397	68	28	and	and	CCONJ
ajcp-1397	68	29	more	more	ADJ
ajcp-1397	68	30	than	than	ADP
ajcp-1397	68	31	6	6	NUM
ajcp-1397	68	32	months	month	NOUN
ajcp-1397	68	33	.	.	PUNCT
ajcp-1397	69	1	it	it	PRON
ajcp-1397	69	2	can	can	AUX
ajcp-1397	69	3	be	be	AUX
ajcp-1397	69	4	seen	see	VERB
ajcp-1397	69	5	that	that	SCONJ
ajcp-1397	69	6	a	a	DET
ajcp-1397	69	7	negatively	negatively	ADV
ajcp-1397	69	8	moderate	moderate	ADJ
ajcp-1397	69	9	correlation	correlation	NOUN
ajcp-1397	69	10	was	be	AUX
ajcp-1397	69	11	found	find	VERB
ajcp-1397	69	12	between	between	ADP
ajcp-1397	69	13	the	the	DET
ajcp-1397	69	14	severity	severity	NOUN
ajcp-1397	69	15	of	of	ADP
ajcp-1397	69	16	illness	illness	NOUN
ajcp-1397	69	17	and	and	CCONJ
ajcp-1397	69	18	the	the	DET
ajcp-1397	69	19	type	type	NOUN
ajcp-1397	69	20	of	of	ADP
ajcp-1397	69	21	vaccine	vaccine	NOUN
ajcp-1397	69	22	,	,	PUNCT
ajcp-1397	69	23	and	and	CCONJ
ajcp-1397	69	24	a	a	DET
ajcp-1397	69	25	negatively	negatively	ADV
ajcp-1397	69	26	strong	strong	ADJ
ajcp-1397	69	27	correlation	correlation	NOUN
ajcp-1397	69	28	was	be	AUX
ajcp-1397	69	29	found	find	VERB
ajcp-1397	69	30	between	between	ADP
ajcp-1397	69	31	the	the	DET
ajcp-1397	69	32	dosage	dosage	NOUN
ajcp-1397	69	33	and	and	CCONJ
ajcp-1397	69	34	severity	severity	NOUN
ajcp-1397	69	35	of	of	ADP
ajcp-1397	69	36	illness	illness	NOUN
ajcp-1397	69	37	.	.	PUNCT
ajcp-1397	70	1	in	in	ADP
ajcp-1397	70	2	contrast	contrast	NOUN
ajcp-1397	70	3	,	,	PUNCT
ajcp-1397	70	4	a	a	DET
ajcp-1397	70	5	negatively	negatively	ADV
ajcp-1397	70	6	weak	weak	ADJ
ajcp-1397	70	7	correlation	correlation	NOUN
ajcp-1397	70	8	was	be	AUX
ajcp-1397	70	9	seen	see	VERB
ajcp-1397	70	10	in	in	ADP
ajcp-1397	70	11	the	the	DET
ajcp-1397	70	12	severity	severity	NOUN
ajcp-1397	70	13	of	of	ADP
ajcp-1397	70	14	illness	illness	NOUN
ajcp-1397	70	15	and	and	CCONJ
ajcp-1397	70	16	individuals	individual	NOUN
ajcp-1397	70	17	with	with	ADP
ajcp-1397	70	18	dosage	dosage	NOUN
ajcp-1397	70	19	received	receive	VERB
ajcp-1397	70	20	in	in	ADP
ajcp-1397	70	21	less	less	ADJ
ajcp-1397	70	22	than	than	ADP
ajcp-1397	70	23	6	6	NUM
ajcp-1397	70	24	months	month	NOUN
ajcp-1397	70	25	and	and	CCONJ
ajcp-1397	70	26	in	in	ADP
ajcp-1397	70	27	individuals	individual	NOUN
ajcp-1397	70	28	with	with	ADP
ajcp-1397	70	29	dosage	dosage	NOUN
ajcp-1397	70	30	received	receive	VERB
ajcp-1397	70	31	in	in	ADP
ajcp-1397	70	32	more	more	ADJ
ajcp-1397	70	33	than	than	ADP
ajcp-1397	70	34	6	6	NUM
ajcp-1397	70	35	months	month	NOUN
ajcp-1397	70	36	.	.	PUNCT
ajcp-1397	71	1	the	the	DET
ajcp-1397	71	2	fitted	fit	VERB
ajcp-1397	71	3	model	model	NOUN
ajcp-1397	71	4	data	data	PROPN
ajcp-1397	71	5	’s	’s	PART
ajcp-1397	71	6	chi	chi	NOUN
ajcp-1397	71	7	-	-	PUNCT
ajcp-1397	71	8	squared	square	VERB
ajcp-1397	71	9	ratio	ratio	NOUN
ajcp-1397	71	10	test	test	NOUN
ajcp-1397	71	11	yielded	yield	VERB
ajcp-1397	71	12	a	a	DET
ajcp-1397	71	13	table	table	NOUN
ajcp-1397	71	14	4	4	NUM
ajcp-1397	71	15	:	:	PUNCT
ajcp-1397	71	16	likelihood	likelihood	NOUN
ajcp-1397	71	17	ratio	ratio	NOUN
ajcp-1397	71	18	test	test	NOUN
ajcp-1397	71	19	.	.	PUNCT
ajcp-1397	72	1	effect	effect	NOUN
ajcp-1397	72	2	model	model	NOUN
ajcp-1397	72	3	fitting	fitting	ADJ
ajcp-1397	72	4	criteria	criterion	NOUN
ajcp-1397	72	5	likelihood	likelihood	NOUN
ajcp-1397	72	6	ratio	ratio	NOUN
ajcp-1397	72	7	tests	test	NOUN
ajcp-1397	72	8	-2	-2	INTJ
ajcp-1397	72	9	log	log	PROPN
ajcp-1397	72	10	likelihood	likelihood	NOUN
ajcp-1397	72	11	of	of	ADP
ajcp-1397	72	12	reduced	reduced	ADJ
ajcp-1397	72	13	model	model	NOUN
ajcp-1397	72	14	chi	chi	PROPN
ajcp-1397	72	15	-	-	PUNCT
ajcp-1397	72	16	square	square	ADJ
ajcp-1397	72	17	df	df	PROPN
ajcp-1397	72	18	sig	sig	PROPN
ajcp-1397	72	19	.	.	PUNCT
ajcp-1397	73	1	intercept	intercept	NOUN
ajcp-1397	73	2	(	(	PUNCT
ajcp-1397	73	3	soi	soi	ADJ
ajcp-1397	73	4	)	)	PUNCT
ajcp-1397	73	5	28.185a	28.185a	NOUN
ajcp-1397	73	6	0	0	NUM
ajcp-1397	73	7	0	0	NUM
ajcp-1397	73	8	.	.	PUNCT
ajcp-1397	74	1	diabetes	diabetes	NOUN
ajcp-1397	74	2	miletus	miletus	VERB
ajcp-1397	74	3	28.422	28.422	NUM
ajcp-1397	74	4	0.238	0.238	NUM
ajcp-1397	74	5	1	1	NUM
ajcp-1397	74	6	0	0	NUM
ajcp-1397	74	7	hypertension	hypertension	NOUN
ajcp-1397	74	8	28.29	28.29	NUM
ajcp-1397	74	9	0.105	0.105	NUM
ajcp-1397	74	10	1	1	NUM
ajcp-1397	74	11	0	0	NUM
ajcp-1397	74	12	hyperthyroidism	hyperthyroidism	NOUN
ajcp-1397	74	13	34.893	34.893	NUM
ajcp-1397	74	14	6.708	6.708	NUM
ajcp-1397	74	15	1	1	NUM
ajcp-1397	74	16	0.01	0.01	NUM
ajcp-1397	74	17	iron	iron	NOUN
ajcp-1397	74	18	deficiency	deficiency	NOUN
ajcp-1397	74	19	anemia	anemia	NOUN
ajcp-1397	74	20	30.285	30.285	NUM
ajcp-1397	74	21	2.1	2.1	NUM
ajcp-1397	74	22	1	1	NUM
ajcp-1397	74	23	0	0	NUM
ajcp-1397	74	24	hematology	hematology	NOUN
ajcp-1397	74	25	disease	disease	NOUN
ajcp-1397	74	26	29.714	29.714	NUM
ajcp-1397	74	27	1.529	1.529	NUM
ajcp-1397	74	28	1	1	NUM
ajcp-1397	74	29	0.016	0.016	NUM
ajcp-1397	74	30	sle	sle	NOUN
ajcp-1397	74	31	28.185	28.185	NUM
ajcp-1397	74	32	0.06	0.06	NUM
ajcp-1397	74	33	1	1	NUM
ajcp-1397	74	34	0	0	NUM
ajcp-1397	74	35	others	other	NOUN
ajcp-1397	74	36	28.438	28.438	NUM
ajcp-1397	74	37	0.253	0.253	NUM
ajcp-1397	74	38	1	1	NUM
ajcp-1397	74	39	0	0	NUM
ajcp-1397	74	40	the	the	DET
ajcp-1397	74	41	chi	chi	ADJ
ajcp-1397	74	42	-	-	PUNCT
ajcp-1397	74	43	square	square	ADJ
ajcp-1397	74	44	statistic	statistic	NOUN
ajcp-1397	74	45	is	be	AUX
ajcp-1397	74	46	the	the	DET
ajcp-1397	74	47	difference	difference	NOUN
ajcp-1397	74	48	in	in	ADP
ajcp-1397	74	49	-2	-2	INTJ
ajcp-1397	74	50	log	log	NOUN
ajcp-1397	74	51	-	-	PUNCT
ajcp-1397	74	52	likelihoods	likelihood	NOUN
ajcp-1397	74	53	between	between	ADP
ajcp-1397	74	54	the	the	DET
ajcp-1397	74	55	final	final	ADJ
ajcp-1397	74	56	and	and	CCONJ
ajcp-1397	74	57	reduced	reduced	ADJ
ajcp-1397	74	58	models	model	NOUN
ajcp-1397	74	59	.	.	PUNCT
ajcp-1397	75	1	the	the	DET
ajcp-1397	75	2	reduced	reduced	ADJ
ajcp-1397	75	3	model	model	NOUN
ajcp-1397	75	4	is	be	AUX
ajcp-1397	75	5	formed	form	VERB
ajcp-1397	75	6	by	by	ADP
ajcp-1397	75	7	omitting	omit	VERB
ajcp-1397	75	8	an	an	DET
ajcp-1397	75	9	effect	effect	NOUN
ajcp-1397	75	10	from	from	ADP
ajcp-1397	75	11	the	the	DET
ajcp-1397	75	12	final	final	ADJ
ajcp-1397	75	13	model	model	NOUN
ajcp-1397	75	14	.	.	PUNCT
ajcp-1397	76	1	the	the	DET
ajcp-1397	76	2	null	null	ADJ
ajcp-1397	76	3	hypothesis	hypothesis	NOUN
ajcp-1397	76	4	is	be	AUX
ajcp-1397	76	5	that	that	SCONJ
ajcp-1397	76	6	all	all	DET
ajcp-1397	76	7	parameters	parameter	NOUN
ajcp-1397	76	8	of	of	ADP
ajcp-1397	76	9	that	that	DET
ajcp-1397	76	10	effect	effect	NOUN
ajcp-1397	76	11	are	be	AUX
ajcp-1397	76	12	0	0	NUM
ajcp-1397	76	13	.	.	PUNCT
ajcp-1397	77	1	a.	a.	NOUN
ajcp-1397	78	1	this	this	DET
ajcp-1397	78	2	reduced	reduced	ADJ
ajcp-1397	78	3	model	model	NOUN
ajcp-1397	78	4	is	be	AUX
ajcp-1397	78	5	equivalent	equivalent	ADJ
ajcp-1397	78	6	to	to	ADP
ajcp-1397	78	7	the	the	DET
ajcp-1397	78	8	final	final	ADJ
ajcp-1397	78	9	model	model	NOUN
ajcp-1397	78	10	because	because	SCONJ
ajcp-1397	78	11	omitting	omit	VERB
ajcp-1397	78	12	the	the	DET
ajcp-1397	78	13	effect	effect	NOUN
ajcp-1397	78	14	does	do	AUX
ajcp-1397	78	15	not	not	PART
ajcp-1397	78	16	increase	increase	VERB
ajcp-1397	78	17	the	the	DET
ajcp-1397	78	18	degrees	degree	NOUN
ajcp-1397	78	19	of	of	ADP
ajcp-1397	78	20	freedom	freedom	NOUN
ajcp-1397	78	21	.	.	PUNCT
ajcp-1397	79	1	https://journals.e-palli.com/home/index.php/ajcp	https://journals.e-palli.com/home/index.php/ajcp	PROPN
ajcp-1397	79	2	pa	pa	PROPN
ajcp-1397	79	3	ge	ge	PROPN
ajcp-1397	79	4	36	36	NUM
ajcp-1397	79	5	https://journals.e-palli.com/home/index.php/ajcp	https://journals.e-palli.com/home/index.php/ajcp	PROPN
ajcp-1397	79	6	am	be	AUX
ajcp-1397	79	7	.	.	PUNCT
ajcp-1397	80	1	j.	j.	PROPN
ajcp-1397	80	2	chem	chem	PROPN
ajcp-1397	80	3	.	.	PUNCT
ajcp-1397	81	1	pharm	pharm	NOUN
ajcp-1397	81	2	.	.	PUNCT
ajcp-1397	82	1	2(1	2(1	NUM
ajcp-1397	82	2	)	)	PUNCT
ajcp-1397	82	3	32	32	NUM
ajcp-1397	82	4	-	-	SYM
ajcp-1397	82	5	37	37	NUM
ajcp-1397	82	6	,	,	PUNCT
ajcp-1397	82	7	2023	2023	NUM
ajcp-1397	82	8	score	score	NOUN
ajcp-1397	82	9	of	of	ADP
ajcp-1397	82	10	11.557	11.557	NUM
ajcp-1397	82	11	(	(	PUNCT
ajcp-1397	82	12	p	p	X
ajcp-1397	82	13	=	=	NOUN
ajcp-1397	82	14	0.000	0.000	NUM
ajcp-1397	82	15	)	)	PUNCT
ajcp-1397	82	16	,	,	PUNCT
ajcp-1397	82	17	indicating	indicate	VERB
ajcp-1397	82	18	a	a	DET
ajcp-1397	82	19	good	good	ADJ
ajcp-1397	82	20	model	model	NOUN
ajcp-1397	82	21	fit	fit	PROPN
ajcp-1397	82	22	.	.	PUNCT
ajcp-1397	83	1	furthermore	furthermore	ADV
ajcp-1397	83	2	,	,	PUNCT
ajcp-1397	83	3	suitable	suitable	ADJ
ajcp-1397	83	4	outcomes	outcome	NOUN
ajcp-1397	83	5	for	for	ADP
ajcp-1397	83	6	the	the	DET
ajcp-1397	83	7	pseudo	pseudo	NOUN
ajcp-1397	83	8	r	r	NOUN
ajcp-1397	83	9	-	-	PUNCT
ajcp-1397	83	10	squared	square	VERB
ajcp-1397	83	11	(	(	PUNCT
ajcp-1397	83	12	cox	cox	PROPN
ajcp-1397	83	13	and	and	CCONJ
ajcp-1397	83	14	snell	snell	PROPN
ajcp-1397	83	15	:	:	PUNCT
ajcp-1397	83	16	0.907	0.907	NUM
ajcp-1397	83	17	,	,	PUNCT
ajcp-1397	83	18	nagelkerke	nagelkerke	NOUN
ajcp-1397	83	19	:	:	PUNCT
ajcp-1397	83	20	0.726	0.726	NUM
ajcp-1397	83	21	)	)	PUNCT
ajcp-1397	83	22	.	.	PUNCT
ajcp-1397	84	1	our	our	PRON
ajcp-1397	84	2	logistic	logistic	ADJ
ajcp-1397	84	3	multinomial	multinomial	ADJ
ajcp-1397	84	4	model	model	NOUN
ajcp-1397	84	5	’s	’s	PART
ajcp-1397	84	6	power	power	NOUN
ajcp-1397	84	7	was	be	AUX
ajcp-1397	84	8	appropriate	appropriate	ADJ
ajcp-1397	84	9	since	since	SCONJ
ajcp-1397	84	10	it	it	PRON
ajcp-1397	84	11	correctly	correctly	ADV
ajcp-1397	84	12	recognized	recognize	VERB
ajcp-1397	84	13	93.2	93.2	NUM
ajcp-1397	84	14	%	%	NOUN
ajcp-1397	84	15	of	of	ADP
ajcp-1397	84	16	the	the	DET
ajcp-1397	84	17	observed	observe	VERB
ajcp-1397	84	18	data	datum	NOUN
ajcp-1397	84	19	and	and	CCONJ
ajcp-1397	84	20	can	can	AUX
ajcp-1397	84	21	be	be	AUX
ajcp-1397	84	22	relied	rely	VERB
ajcp-1397	84	23	upon	upon	SCONJ
ajcp-1397	84	24	to	to	PART
ajcp-1397	84	25	predict	predict	VERB
ajcp-1397	84	26	future	future	ADJ
ajcp-1397	84	27	guesses	guess	NOUN
ajcp-1397	84	28	.	.	PUNCT
ajcp-1397	85	1	the	the	DET
ajcp-1397	85	2	likelihood	likelihood	NOUN
ajcp-1397	85	3	ratio	ratio	NOUN
ajcp-1397	85	4	tests	test	NOUN
ajcp-1397	85	5	for	for	ADP
ajcp-1397	85	6	the	the	DET
ajcp-1397	85	7	model	model	NOUN
ajcp-1397	85	8	’s	’s	PART
ajcp-1397	85	9	effects	effect	NOUN
ajcp-1397	85	10	and	and	CCONJ
ajcp-1397	85	11	partials	partial	NOUN
ajcp-1397	85	12	are	be	AUX
ajcp-1397	85	13	shown	show	VERB
ajcp-1397	85	14	in	in	ADP
ajcp-1397	85	15	table	table	NOUN
ajcp-1397	85	16	4	4	NUM
ajcp-1397	85	17	,	,	PUNCT
ajcp-1397	85	18	and	and	CCONJ
ajcp-1397	85	19	their	their	PRON
ajcp-1397	85	20	low	low	ADJ
ajcp-1397	85	21	p	p	NOUN
ajcp-1397	85	22	-	-	PUNCT
ajcp-1397	85	23	values	value	NOUN
ajcp-1397	85	24	show	show	VERB
ajcp-1397	85	25	how	how	SCONJ
ajcp-1397	85	26	highly	highly	ADV
ajcp-1397	85	27	relevant	relevant	ADJ
ajcp-1397	85	28	the	the	DET
ajcp-1397	85	29	model	model	NOUN
ajcp-1397	85	30	’s	’s	PART
ajcp-1397	85	31	variables	variable	NOUN
ajcp-1397	85	32	are	be	AUX
ajcp-1397	85	33	.	.	PUNCT
ajcp-1397	86	1	discussion	discussion	NOUN
ajcp-1397	86	2	this	this	DET
ajcp-1397	86	3	study	study	NOUN
ajcp-1397	86	4	aimed	aim	VERB
ajcp-1397	86	5	to	to	PART
ajcp-1397	86	6	contribute	contribute	VERB
ajcp-1397	86	7	to	to	ADP
ajcp-1397	86	8	the	the	DET
ajcp-1397	86	9	association	association	NOUN
ajcp-1397	86	10	between	between	ADP
ajcp-1397	86	11	covid-19	covid-19	PROPN
ajcp-1397	86	12	severity	severity	NOUN
ajcp-1397	86	13	in	in	ADP
ajcp-1397	86	14	pregnancies	pregnancy	NOUN
ajcp-1397	86	15	and	and	CCONJ
ajcp-1397	86	16	their	their	PRON
ajcp-1397	86	17	outcomes	outcome	NOUN
ajcp-1397	86	18	.	.	PUNCT
ajcp-1397	87	1	literature	literature	NOUN
ajcp-1397	87	2	showed	show	VERB
ajcp-1397	87	3	that	that	SCONJ
ajcp-1397	87	4	of	of	ADP
ajcp-1397	87	5	the	the	DET
ajcp-1397	87	6	184	184	NUM
ajcp-1397	87	7	critically	critically	ADV
ajcp-1397	87	8	ill	ill	ADJ
ajcp-1397	87	9	patients	patient	NOUN
ajcp-1397	87	10	(	(	PUNCT
ajcp-1397	87	11	24	24	NUM
ajcp-1397	87	12	%	%	NOUN
ajcp-1397	87	13	of	of	ADP
ajcp-1397	87	14	whom	whom	PRON
ajcp-1397	87	15	were	be	AUX
ajcp-1397	87	16	female	female	NOUN
ajcp-1397	87	17	)	)	PUNCT
ajcp-1397	87	18	found	find	VERB
ajcp-1397	87	19	that	that	SCONJ
ajcp-1397	87	20	31	31	NUM
ajcp-1397	87	21	%	%	NOUN
ajcp-1397	87	22	of	of	ADP
ajcp-1397	87	23	them	they	PRON
ajcp-1397	87	24	experienced	experience	VERB
ajcp-1397	87	25	thrombotic	thrombotic	ADJ
ajcp-1397	87	26	events	event	NOUN
ajcp-1397	87	27	,	,	PUNCT
ajcp-1397	87	28	demonstrating	demonstrate	VERB
ajcp-1397	87	29	that	that	SCONJ
ajcp-1397	87	30	covid-19	covid-19	PROPN
ajcp-1397	87	31	is	be	AUX
ajcp-1397	87	32	linked	link	VERB
ajcp-1397	87	33	to	to	ADP
ajcp-1397	87	34	the	the	DET
ajcp-1397	87	35	high	high	ADJ
ajcp-1397	87	36	incidence	incidence	NOUN
ajcp-1397	87	37	of	of	ADP
ajcp-1397	87	38	thromboembolic	thromboembolic	ADJ
ajcp-1397	87	39	consequences	consequence	NOUN
ajcp-1397	87	40	in	in	ADP
ajcp-1397	87	41	the	the	DET
ajcp-1397	87	42	general	general	ADJ
ajcp-1397	87	43	population	population	NOUN
ajcp-1397	87	44	(	(	PUNCT
ajcp-1397	87	45	64	64	NUM
ajcp-1397	87	46	)	)	PUNCT
ajcp-1397	87	47	.	.	PUNCT
ajcp-1397	88	1	the	the	DET
ajcp-1397	88	2	cause	cause	NOUN
ajcp-1397	88	3	of	of	ADP
ajcp-1397	88	4	this	this	PRON
ajcp-1397	88	5	is	be	AUX
ajcp-1397	88	6	the	the	DET
ajcp-1397	88	7	stimulation	stimulation	NOUN
ajcp-1397	88	8	of	of	ADP
ajcp-1397	88	9	coagulation	coagulation	NOUN
ajcp-1397	88	10	pathways	pathway	NOUN
ajcp-1397	88	11	,	,	PUNCT
ajcp-1397	88	12	which	which	PRON
ajcp-1397	88	13	may	may	AUX
ajcp-1397	88	14	lead	lead	VERB
ajcp-1397	88	15	to	to	PART
ajcp-1397	88	16	diffuse	diffuse	VERB
ajcp-1397	88	17	vascular	vascular	ADJ
ajcp-1397	88	18	coagulopathy	coagulopathy	ADJ
ajcp-1397	88	19	(	(	PUNCT
ajcp-1397	88	20	dic	dic	ADJ
ajcp-1397	88	21	)	)	PUNCT
ajcp-1397	88	22	,	,	PUNCT
ajcp-1397	88	23	fibrinolysis	fibrinolysis	NOUN
ajcp-1397	88	24	,	,	PUNCT
ajcp-1397	88	25	and	and	CCONJ
ajcp-1397	88	26	dynamic	dynamic	ADJ
ajcp-1397	88	27	hypercoagulation	hypercoagulation	NOUN
ajcp-1397	88	28	associated	associate	VERB
ajcp-1397	88	29	with	with	ADP
ajcp-1397	88	30	thrombocytopenia	thrombocytopenia	PROPN
ajcp-1397	88	31	.	.	PUNCT
ajcp-1397	89	1	the	the	DET
ajcp-1397	89	2	results	result	NOUN
ajcp-1397	89	3	showed	show	VERB
ajcp-1397	89	4	insignificance	insignificance	NOUN
ajcp-1397	89	5	concerning	concern	VERB
ajcp-1397	89	6	covid	covid	PROPN
ajcp-1397	89	7	and	and	CCONJ
ajcp-1397	89	8	gestation	gestation	NOUN
ajcp-1397	89	9	age(week	age(week	PROPN
ajcp-1397	89	10	)	)	PUNCT
ajcp-1397	89	11	,	,	PUNCT
ajcp-1397	89	12	while	while	SCONJ
ajcp-1397	89	13	the	the	DET
ajcp-1397	89	14	severity	severity	NOUN
ajcp-1397	89	15	of	of	ADP
ajcp-1397	89	16	the	the	DET
ajcp-1397	89	17	condition	condition	NOUN
ajcp-1397	89	18	was	be	AUX
ajcp-1397	89	19	significantly	significantly	ADV
ajcp-1397	89	20	correlated	correlate	VERB
ajcp-1397	89	21	with	with	ADP
ajcp-1397	89	22	gestational	gestational	ADJ
ajcp-1397	89	23	age	age	NOUN
ajcp-1397	89	24	upon	upon	SCONJ
ajcp-1397	89	25	presentation	presentation	NOUN
ajcp-1397	89	26	.	.	PUNCT
ajcp-1397	90	1	for	for	ADP
ajcp-1397	90	2	asymptomatic	asymptomatic	ADJ
ajcp-1397	90	3	patients	patient	NOUN
ajcp-1397	90	4	,	,	PUNCT
ajcp-1397	90	5	the	the	DET
ajcp-1397	90	6	median	median	ADJ
ajcp-1397	90	7	gestational	gestational	ADJ
ajcp-1397	90	8	age	age	NOUN
ajcp-1397	90	9	at	at	ADP
ajcp-1397	90	10	symptom	symptom	NOUN
ajcp-1397	90	11	start	start	NOUN
ajcp-1397	90	12	or	or	CCONJ
ajcp-1397	90	13	diagnosis	diagnosis	NOUN
ajcp-1397	90	14	was	be	AUX
ajcp-1397	90	15	37	37	NUM
ajcp-1397	90	16	weeks	week	NOUN
ajcp-1397	90	17	;	;	PUNCT
ajcp-1397	90	18	for	for	ADP
ajcp-1397	90	19	symptomatic	symptomatic	ADJ
ajcp-1397	90	20	patients	patient	NOUN
ajcp-1397	90	21	,	,	PUNCT
ajcp-1397	90	22	it	it	PRON
ajcp-1397	90	23	was	be	AUX
ajcp-1397	90	24	33	33	NUM
ajcp-1397	90	25	weeks	week	NOUN
ajcp-1397	90	26	;	;	PUNCT
ajcp-1397	90	27	and	and	CCONJ
ajcp-1397	90	28	for	for	ADP
ajcp-1397	90	29	patients	patient	NOUN
ajcp-1397	90	30	who	who	PRON
ajcp-1397	90	31	needed	need	VERB
ajcp-1397	90	32	oxygen	oxygen	NOUN
ajcp-1397	90	33	assistance	assistance	NOUN
ajcp-1397	90	34	,	,	PUNCT
ajcp-1397	90	35	it	it	PRON
ajcp-1397	90	36	was	be	AUX
ajcp-1397	90	37	36	36	NUM
ajcp-1397	90	38	weeks	week	NOUN
ajcp-1397	90	39	.	.	PUNCT
ajcp-1397	91	1	this	this	PRON
ajcp-1397	91	2	indicated	indicate	VERB
ajcp-1397	91	3	a	a	DET
ajcp-1397	91	4	risk	risk	NOUN
ajcp-1397	91	5	of	of	ADP
ajcp-1397	91	6	severe	severe	ADJ
ajcp-1397	91	7	covid-19	covid-19	PROPN
ajcp-1397	91	8	infection	infection	NOUN
ajcp-1397	91	9	in	in	ADP
ajcp-1397	91	10	late	late	ADJ
ajcp-1397	91	11	pregnancy	pregnancy	NOUN
ajcp-1397	91	12	.	.	PUNCT
ajcp-1397	92	1	a	a	DET
ajcp-1397	92	2	modified	modify	VERB
ajcp-1397	92	3	immune	immune	ADJ
ajcp-1397	92	4	system	system	NOUN
ajcp-1397	92	5	may	may	AUX
ajcp-1397	92	6	control	control	VERB
ajcp-1397	92	7	the	the	DET
ajcp-1397	92	8	extreme	extreme	NOUN
ajcp-1397	92	9	changing	change	VERB
ajcp-1397	92	10	in	in	ADP
ajcp-1397	92	11	secondary	secondary	ADJ
ajcp-1397	92	12	physiological	physiological	ADJ
ajcp-1397	92	13	aspects	aspect	NOUN
ajcp-1397	92	14	adapted	adapt	VERB
ajcp-1397	92	15	due	due	ADJ
ajcp-1397	92	16	to	to	ADP
ajcp-1397	92	17	pregnancy	pregnancy	NOUN
ajcp-1397	92	18	.	.	PUNCT
ajcp-1397	93	1	however	however	ADV
ajcp-1397	93	2	,	,	PUNCT
ajcp-1397	93	3	the	the	DET
ajcp-1397	93	4	hormonal	hormonal	ADJ
ajcp-1397	93	5	role	role	NOUN
ajcp-1397	93	6	in	in	ADP
ajcp-1397	93	7	modifying	modify	VERB
ajcp-1397	93	8	the	the	DET
ajcp-1397	93	9	immune	immune	ADJ
ajcp-1397	93	10	system	system	NOUN
ajcp-1397	93	11	in	in	ADP
ajcp-1397	93	12	pregnancy	pregnancy	NOUN
ajcp-1397	93	13	was	be	AUX
ajcp-1397	93	14	significant	significant	ADJ
ajcp-1397	93	15	.	.	PUNCT
ajcp-1397	94	1	according	accord	VERB
ajcp-1397	94	2	to	to	ADP
ajcp-1397	94	3	the	the	DET
ajcp-1397	94	4	evidence	evidence	NOUN
ajcp-1397	94	5	,	,	PUNCT
ajcp-1397	94	6	severe	severe	ADJ
ajcp-1397	94	7	covid-19	covid-19	PROPN
ajcp-1397	94	8	during	during	ADP
ajcp-1397	94	9	pregnancy	pregnancy	NOUN
ajcp-1397	94	10	is	be	AUX
ajcp-1397	94	11	linked	link	VERB
ajcp-1397	94	12	to	to	ADP
ajcp-1397	94	13	iatrogenic	iatrogenic	ADJ
ajcp-1397	94	14	premature	premature	ADJ
ajcp-1397	94	15	births	birth	NOUN
ajcp-1397	94	16	(	(	PUNCT
ajcp-1397	94	17	75	75	NUM
ajcp-1397	94	18	%	%	NOUN
ajcp-1397	94	19	)	)	PUNCT
ajcp-1397	94	20	,	,	PUNCT
ajcp-1397	94	21	mostly	mostly	ADV
ajcp-1397	94	22	due	due	ADP
ajcp-1397	94	23	to	to	ADP
ajcp-1397	94	24	maternal	maternal	ADJ
ajcp-1397	94	25	indication	indication	NOUN
ajcp-1397	94	26	and	and	CCONJ
ajcp-1397	94	27	during	during	ADP
ajcp-1397	94	28	the	the	DET
ajcp-1397	94	29	third	third	ADJ
ajcp-1397	94	30	trimester	trimester	NOUN
ajcp-1397	94	31	(	(	PUNCT
ajcp-1397	94	32	pierce	pierce	PROPN
ajcp-1397	94	33	-	-	PUNCT
ajcp-1397	94	34	williams	williams	PROPN
ajcp-1397	94	35	et	et	PROPN
ajcp-1397	94	36	al	al	PROPN
ajcp-1397	94	37	.	.	PROPN
ajcp-1397	94	38	,	,	PUNCT
ajcp-1397	94	39	2020	2020	NUM
ajcp-1397	94	40	)	)	PUNCT
ajcp-1397	94	41	.	.	PUNCT
ajcp-1397	95	1	the	the	DET
ajcp-1397	95	2	results	result	NOUN
ajcp-1397	95	3	also	also	ADV
ajcp-1397	95	4	showed	show	VERB
ajcp-1397	95	5	low	low	ADJ
ajcp-1397	95	6	wbcs	wbc	NOUN
ajcp-1397	95	7	compared	compare	VERB
ajcp-1397	95	8	with	with	ADP
ajcp-1397	95	9	uninfected	uninfected	ADJ
ajcp-1397	95	10	pregnant	pregnant	ADJ
ajcp-1397	95	11	women	woman	NOUN
ajcp-1397	95	12	,	,	PUNCT
ajcp-1397	95	13	similar	similar	ADJ
ajcp-1397	95	14	results	result	NOUN
ajcp-1397	95	15	in	in	ADP
ajcp-1397	95	16	the	the	DET
ajcp-1397	95	17	observation	observation	NOUN
ajcp-1397	95	18	of	of	ADP
ajcp-1397	95	19	mohr	mohr	PROPN
ajcp-1397	95	20	-	-	PUNCT
ajcp-1397	95	21	sasson	sasson	PROPN
ajcp-1397	95	22	2020	2020	NUM
ajcp-1397	95	23	(	(	PUNCT
ajcp-1397	95	24	mohr	mohr	PROPN
ajcp-1397	95	25	-	-	PUNCT
ajcp-1397	95	26	sasson	sasson	PROPN
ajcp-1397	95	27	et	et	PROPN
ajcp-1397	95	28	al	al	PROPN
ajcp-1397	95	29	.	.	PROPN
ajcp-1397	95	30	,	,	PUNCT
ajcp-1397	95	31	2020	2020	NUM
ajcp-1397	95	32	)	)	PUNCT
ajcp-1397	95	33	.	.	PUNCT
ajcp-1397	96	1	c	c	X
ajcp-1397	96	2	-	-	PUNCT
ajcp-1397	96	3	reactive	reactive	ADJ
ajcp-1397	96	4	protein	protein	NOUN
ajcp-1397	96	5	was	be	AUX
ajcp-1397	96	6	also	also	ADV
ajcp-1397	96	7	insignificant	insignificant	ADJ
ajcp-1397	96	8	(	(	PUNCT
ajcp-1397	96	9	fig	fig	NOUN
ajcp-1397	96	10	2	2	NUM
ajcp-1397	96	11	)	)	PUNCT
ajcp-1397	96	12	and	and	CCONJ
ajcp-1397	96	13	similar	similar	ADJ
ajcp-1397	96	14	to	to	ADP
ajcp-1397	96	15	the	the	DET
ajcp-1397	96	16	results	result	NOUN
ajcp-1397	96	17	observed	observe	VERB
ajcp-1397	96	18	by	by	ADP
ajcp-1397	96	19	rizo	rizo	PROPN
ajcp-1397	96	20	-	-	PUNCT
ajcp-1397	96	21	téllez	téllez	PROPN
ajcp-1397	96	22	in	in	ADP
ajcp-1397	96	23	2020	2020	NUM
ajcp-1397	96	24	(	(	PUNCT
ajcp-1397	96	25	rizo	rizo	PROPN
ajcp-1397	96	26	-	-	PUNCT
ajcp-1397	96	27	téllez	téllez	PROPN
ajcp-1397	96	28	et	et	PROPN
ajcp-1397	96	29	al	al	PROPN
ajcp-1397	96	30	.	.	PROPN
ajcp-1397	96	31	,	,	PUNCT
ajcp-1397	96	32	2020	2020	NUM
ajcp-1397	96	33	)	)	PUNCT
ajcp-1397	96	34	.	.	PUNCT
ajcp-1397	97	1	the	the	DET
ajcp-1397	97	2	study	study	NOUN
ajcp-1397	97	3	showed	show	VERB
ajcp-1397	97	4	that	that	SCONJ
ajcp-1397	97	5	pregnant	pregnant	ADJ
ajcp-1397	97	6	women	woman	NOUN
ajcp-1397	97	7	affected	affect	VERB
ajcp-1397	97	8	by	by	ADP
ajcp-1397	97	9	covid	covid	PROPN
ajcp-1397	97	10	do	do	AUX
ajcp-1397	97	11	not	not	PART
ajcp-1397	97	12	have	have	VERB
ajcp-1397	97	13	a	a	DET
ajcp-1397	97	14	significant	significant	ADJ
ajcp-1397	97	15	chance	chance	NOUN
ajcp-1397	97	16	to	to	PART
ajcp-1397	97	17	transfer	transfer	VERB
ajcp-1397	97	18	it	it	PRON
ajcp-1397	97	19	.	.	PUNCT
ajcp-1397	98	1	it	it	PRON
ajcp-1397	98	2	may	may	AUX
ajcp-1397	98	3	affect	affect	VERB
ajcp-1397	98	4	the	the	DET
ajcp-1397	98	5	baby	baby	NOUN
ajcp-1397	98	6	during	during	ADP
ajcp-1397	98	7	and	and	CCONJ
ajcp-1397	98	8	after	after	ADP
ajcp-1397	98	9	birth	birth	NOUN
ajcp-1397	98	10	.	.	PUNCT
ajcp-1397	99	1	furthermore	furthermore	ADV
ajcp-1397	99	2	,	,	PUNCT
ajcp-1397	99	3	the	the	DET
ajcp-1397	99	4	modified	modify	VERB
ajcp-1397	99	5	immune	immune	ADJ
ajcp-1397	99	6	system	system	NOUN
ajcp-1397	99	7	in	in	ADP
ajcp-1397	99	8	pregnancy	pregnancy	NOUN
ajcp-1397	99	9	prevents	prevent	VERB
ajcp-1397	99	10	most	most	ADJ
ajcp-1397	99	11	diseases	disease	NOUN
ajcp-1397	99	12	but	but	CCONJ
ajcp-1397	99	13	not	not	PART
ajcp-1397	99	14	viral	viral	ADJ
ajcp-1397	99	15	ones	one	NOUN
ajcp-1397	99	16	.	.	PUNCT
ajcp-1397	100	1	it	it	PRON
ajcp-1397	100	2	is	be	AUX
ajcp-1397	100	3	challenging	challenge	VERB
ajcp-1397	100	4	to	to	PART
ajcp-1397	100	5	determine	determine	VERB
ajcp-1397	100	6	with	with	ADP
ajcp-1397	100	7	certainty	certainty	NOUN
ajcp-1397	100	8	whether	whether	SCONJ
ajcp-1397	100	9	pregnant	pregnant	ADJ
ajcp-1397	100	10	women	woman	NOUN
ajcp-1397	100	11	are	be	AUX
ajcp-1397	100	12	at	at	ADP
ajcp-1397	100	13	a	a	DET
ajcp-1397	100	14	higher	high	ADJ
ajcp-1397	100	15	risk	risk	NOUN
ajcp-1397	100	16	of	of	ADP
ajcp-1397	100	17	covid-19	covid-19	PROPN
ajcp-1397	100	18	’s	’s	PART
ajcp-1397	100	19	severe	severe	ADJ
ajcp-1397	100	20	repercussions	repercussion	NOUN
ajcp-1397	100	21	based	base	VERB
ajcp-1397	100	22	on	on	ADP
ajcp-1397	100	23	the	the	DET
ajcp-1397	100	24	available	available	ADJ
ajcp-1397	100	25	research	research	NOUN
ajcp-1397	100	26	.	.	PUNCT
ajcp-1397	101	1	pregnant	pregnant	ADJ
ajcp-1397	101	2	women	woman	NOUN
ajcp-1397	101	3	are	be	AUX
ajcp-1397	101	4	nearly	nearly	ADV
ajcp-1397	101	5	always	always	ADV
ajcp-1397	101	6	excluded	exclude	VERB
ajcp-1397	101	7	from	from	ADP
ajcp-1397	101	8	more	more	ADJ
ajcp-1397	101	9	than	than	ADP
ajcp-1397	101	10	300	300	NUM
ajcp-1397	101	11	clinical	clinical	ADJ
ajcp-1397	101	12	trials	trial	NOUN
ajcp-1397	101	13	looking	look	VERB
ajcp-1397	101	14	into	into	ADP
ajcp-1397	101	15	potential	potential	ADJ
ajcp-1397	101	16	therapy	therapy	NOUN
ajcp-1397	101	17	alternatives	alternative	NOUN
ajcp-1397	101	18	,	,	PUNCT
ajcp-1397	101	19	despite	despite	SCONJ
ajcp-1397	101	20	worries	worry	NOUN
ajcp-1397	101	21	about	about	ADP
ajcp-1397	101	22	their	their	PRON
ajcp-1397	101	23	heightened	heighten	VERB
ajcp-1397	101	24	sensitivity	sensitivity	NOUN
ajcp-1397	101	25	to	to	ADP
ajcp-1397	101	26	covid-19	covid-19	PROPN
ajcp-1397	101	27	(	(	PUNCT
ajcp-1397	101	28	whitehead	whitehead	PROPN
ajcp-1397	101	29	&	&	CCONJ
ajcp-1397	101	30	walker	walker	PROPN
ajcp-1397	101	31	,	,	PUNCT
ajcp-1397	101	32	2020	2020	NUM
ajcp-1397	101	33	)	)	PUNCT
ajcp-1397	101	34	.	.	PUNCT
ajcp-1397	102	1	pregnant	pregnant	ADJ
ajcp-1397	102	2	participants	participant	NOUN
ajcp-1397	102	3	are	be	AUX
ajcp-1397	102	4	seldom	seldom	ADV
ajcp-1397	102	5	included	include	VERB
ajcp-1397	102	6	in	in	ADP
ajcp-1397	102	7	clinical	clinical	ADJ
ajcp-1397	102	8	studies	study	NOUN
ajcp-1397	102	9	,	,	PUNCT
ajcp-1397	102	10	not	not	PART
ajcp-1397	102	11	even	even	ADV
ajcp-1397	102	12	those	those	PRON
ajcp-1397	102	13	examining	examine	VERB
ajcp-1397	102	14	treatments	treatment	NOUN
ajcp-1397	102	15	with	with	ADP
ajcp-1397	102	16	a	a	DET
ajcp-1397	102	17	wellestablished	wellestablished	ADJ
ajcp-1397	102	18	safety	safety	NOUN
ajcp-1397	102	19	profile	profile	NOUN
ajcp-1397	102	20	during	during	ADP
ajcp-1397	102	21	pregnancy	pregnancy	NOUN
ajcp-1397	102	22	.	.	PUNCT
ajcp-1397	103	1	in	in	ADP
ajcp-1397	103	2	order	order	NOUN
ajcp-1397	103	3	to	to	PART
ajcp-1397	103	4	build	build	VERB
ajcp-1397	103	5	a	a	DET
ajcp-1397	103	6	fair	fair	ADJ
ajcp-1397	103	7	and	and	CCONJ
ajcp-1397	103	8	knowledgeable	knowledgeable	ADJ
ajcp-1397	103	9	evidence	evidence	NOUN
ajcp-1397	103	10	base	base	NOUN
ajcp-1397	103	11	with	with	ADP
ajcp-1397	103	12	data	datum	NOUN
ajcp-1397	103	13	from	from	ADP
ajcp-1397	103	14	a	a	DET
ajcp-1397	103	15	representative	representative	ADJ
ajcp-1397	103	16	population	population	NOUN
ajcp-1397	103	17	,	,	PUNCT
ajcp-1397	103	18	researchers	researcher	NOUN
ajcp-1397	103	19	should	should	AUX
ajcp-1397	103	20	be	be	AUX
ajcp-1397	103	21	pushed	push	VERB
ajcp-1397	103	22	to	to	PART
ajcp-1397	103	23	consider	consider	VERB
ajcp-1397	103	24	pregnant	pregnant	ADJ
ajcp-1397	103	25	women	woman	NOUN
ajcp-1397	103	26	and	and	CCONJ
ajcp-1397	103	27	other	other	ADJ
ajcp-1397	103	28	groups	group	NOUN
ajcp-1397	103	29	.	.	PUNCT
ajcp-1397	104	1	in	in	ADP
ajcp-1397	104	2	several	several	ADJ
ajcp-1397	104	3	research	research	NOUN
ajcp-1397	104	4	,	,	PUNCT
ajcp-1397	104	5	vaccination	vaccination	NOUN
ajcp-1397	104	6	was	be	AUX
ajcp-1397	104	7	seen	see	VERB
ajcp-1397	104	8	as	as	ADP
ajcp-1397	104	9	a	a	DET
ajcp-1397	104	10	prophylactic	prophylactic	ADJ
ajcp-1397	104	11	method	method	NOUN
ajcp-1397	104	12	to	to	PART
ajcp-1397	104	13	improve	improve	VERB
ajcp-1397	104	14	their	their	PRON
ajcp-1397	104	15	health	health	NOUN
ajcp-1397	104	16	(	(	PUNCT
ajcp-1397	104	17	taryam	taryam	NOUN
ajcp-1397	104	18	et	et	PROPN
ajcp-1397	104	19	al	al	PROPN
ajcp-1397	104	20	.	.	PROPN
ajcp-1397	104	21	,	,	PUNCT
ajcp-1397	104	22	2021	2021	NUM
ajcp-1397	104	23	)	)	PUNCT
ajcp-1397	104	24	.	.	PUNCT
ajcp-1397	105	1	similar	similar	ADJ
ajcp-1397	105	2	beliefs	belief	NOUN
ajcp-1397	105	3	about	about	ADP
ajcp-1397	105	4	immunization	immunization	NOUN
ajcp-1397	105	5	being	be	AUX
ajcp-1397	105	6	wise	wise	ADJ
ajcp-1397	105	7	,	,	PUNCT
ajcp-1397	105	8	necessary	necessary	ADJ
ajcp-1397	105	9	,	,	PUNCT
ajcp-1397	105	10	or	or	CCONJ
ajcp-1397	105	11	beneficial	beneficial	ADJ
ajcp-1397	105	12	undoubtedly	undoubtedly	ADV
ajcp-1397	105	13	influenced	influence	VERB
ajcp-1397	105	14	or	or	CCONJ
ajcp-1397	105	15	anticipated	anticipate	VERB
ajcp-1397	105	16	vaccine	vaccine	NOUN
ajcp-1397	105	17	acceptance	acceptance	NOUN
ajcp-1397	105	18	.	.	PUNCT
ajcp-1397	106	1	other	other	ADJ
ajcp-1397	106	2	factors	factor	NOUN
ajcp-1397	106	3	mentioned	mention	VERB
ajcp-1397	106	4	by	by	ADP
ajcp-1397	106	5	tuite	tuite	PROPN
ajcp-1397	106	6	et	et	PROPN
ajcp-1397	106	7	al	al	PROPN
ajcp-1397	106	8	.	.	PUNCT
ajcp-1397	107	1	(	(	PUNCT
ajcp-1397	107	2	tuite	tuite	PROPN
ajcp-1397	107	3	et	et	PROPN
ajcp-1397	107	4	al	al	PROPN
ajcp-1397	107	5	.	.	PROPN
ajcp-1397	107	6	,	,	PUNCT
ajcp-1397	107	7	2010	2010	NUM
ajcp-1397	107	8	)	)	PUNCT
ajcp-1397	107	9	were	be	AUX
ajcp-1397	107	10	protecting	protect	VERB
ajcp-1397	107	11	others	other	NOUN
ajcp-1397	107	12	and	and	CCONJ
ajcp-1397	107	13	residing	reside	VERB
ajcp-1397	107	14	with	with	ADP
ajcp-1397	107	15	people	people	NOUN
ajcp-1397	107	16	who	who	PRON
ajcp-1397	107	17	could	could	AUX
ajcp-1397	107	18	be	be	AUX
ajcp-1397	107	19	exposed	expose	VERB
ajcp-1397	107	20	.	.	PUNCT
ajcp-1397	108	1	immunization	immunization	NOUN
ajcp-1397	108	2	.	.	PUNCT
ajcp-1397	109	1	the	the	DET
ajcp-1397	109	2	belief	belief	NOUN
ajcp-1397	109	3	that	that	SCONJ
ajcp-1397	109	4	immunization	immunization	NOUN
ajcp-1397	109	5	weakens	weaken	VERB
ajcp-1397	109	6	one	one	NUM
ajcp-1397	109	7	’s	’s	PART
ajcp-1397	109	8	natural	natural	ADJ
ajcp-1397	109	9	defences	defence	NOUN
ajcp-1397	109	10	,	,	PUNCT
ajcp-1397	109	11	is	be	AUX
ajcp-1397	109	12	unpleasant	unpleasant	ADJ
ajcp-1397	109	13	,	,	PUNCT
ajcp-1397	109	14	brings	bring	VERB
ajcp-1397	109	15	on	on	ADP
ajcp-1397	109	16	illness	illness	NOUN
ajcp-1397	109	17	,	,	PUNCT
ajcp-1397	109	18	or	or	CCONJ
ajcp-1397	109	19	has	have	AUX
ajcp-1397	109	20	no	no	DET
ajcp-1397	109	21	bearing	bearing	NOUN
ajcp-1397	109	22	on	on	ADP
ajcp-1397	109	23	one	one	NUM
ajcp-1397	109	24	’s	’s	PART
ajcp-1397	109	25	health	health	NOUN
ajcp-1397	109	26	was	be	AUX
ajcp-1397	109	27	adversely	adversely	ADV
ajcp-1397	109	28	connected	connect	VERB
ajcp-1397	109	29	with	with	ADP
ajcp-1397	109	30	vaccination	vaccination	NOUN
ajcp-1397	109	31	uptake	uptake	ADJ
ajcp-1397	109	32	(	(	PUNCT
ajcp-1397	109	33	taryam	taryam	NOUN
ajcp-1397	109	34	et	et	PROPN
ajcp-1397	109	35	al	al	PROPN
ajcp-1397	109	36	.	.	PROPN
ajcp-1397	109	37	,	,	PUNCT
ajcp-1397	109	38	2021	2021	NUM
ajcp-1397	109	39	)	)	PUNCT
ajcp-1397	109	40	.	.	PUNCT
ajcp-1397	110	1	the	the	DET
ajcp-1397	110	2	provision	provision	NOUN
ajcp-1397	110	3	of	of	ADP
ajcp-1397	110	4	acute	acute	ADJ
ajcp-1397	110	5	medical	medical	ADJ
ajcp-1397	110	6	treatment	treatment	NOUN
ajcp-1397	110	7	has	have	AUX
ajcp-1397	110	8	taken	take	VERB
ajcp-1397	110	9	priority	priority	NOUN
ajcp-1397	110	10	over	over	ADP
ajcp-1397	110	11	the	the	DET
ajcp-1397	110	12	provision	provision	NOUN
ajcp-1397	110	13	of	of	ADP
ajcp-1397	110	14	prenatal	prenatal	ADJ
ajcp-1397	110	15	care	care	NOUN
ajcp-1397	110	16	,	,	PUNCT
ajcp-1397	110	17	resulting	result	VERB
ajcp-1397	110	18	in	in	ADP
ajcp-1397	110	19	a	a	DET
ajcp-1397	110	20	restricted	restricted	ADJ
ajcp-1397	110	21	capacity	capacity	NOUN
ajcp-1397	110	22	of	of	ADP
ajcp-1397	110	23	clinics	clinic	NOUN
ajcp-1397	110	24	and	and	CCONJ
ajcp-1397	110	25	a	a	DET
ajcp-1397	110	26	reduced	reduce	VERB
ajcp-1397	110	27	capability	capability	NOUN
ajcp-1397	110	28	to	to	PART
ajcp-1397	110	29	screen	screen	VERB
ajcp-1397	110	30	for	for	ADP
ajcp-1397	110	31	disorders	disorder	NOUN
ajcp-1397	110	32	like	like	ADP
ajcp-1397	110	33	gestational	gestational	ADJ
ajcp-1397	110	34	diabetes	diabetes	NOUN
ajcp-1397	110	35	.	.	PUNCT
ajcp-1397	111	1	healthcare	healthcare	NOUN
ajcp-1397	111	2	services	service	NOUN
ajcp-1397	111	3	have	have	AUX
ajcp-1397	111	4	had	have	VERB
ajcp-1397	111	5	to	to	PART
ajcp-1397	111	6	be	be	AUX
ajcp-1397	111	7	reorganized	reorganize	VERB
ajcp-1397	111	8	in	in	ADP
ajcp-1397	111	9	many	many	ADJ
ajcp-1397	111	10	contexts	context	NOUN
ajcp-1397	111	11	due	due	ADP
ajcp-1397	111	12	to	to	ADP
ajcp-1397	111	13	social	social	ADJ
ajcp-1397	111	14	distancing	distancing	NOUN
ajcp-1397	111	15	regulations	regulation	NOUN
ajcp-1397	111	16	that	that	PRON
ajcp-1397	111	17	limit	limit	VERB
ajcp-1397	111	18	direct	direct	ADJ
ajcp-1397	111	19	interaction	interaction	NOUN
ajcp-1397	111	20	between	between	ADP
ajcp-1397	111	21	specialists	specialist	NOUN
ajcp-1397	111	22	and	and	CCONJ
ajcp-1397	111	23	patients	patient	NOUN
ajcp-1397	111	24	to	to	PART
ajcp-1397	111	25	suggest	suggest	VERB
ajcp-1397	111	26	identifying	identify	VERB
ajcp-1397	111	27	and	and	CCONJ
ajcp-1397	111	28	treating	treat	VERB
ajcp-1397	111	29	mental	mental	ADJ
ajcp-1397	111	30	health	health	NOUN
ajcp-1397	111	31	issues	issue	NOUN
ajcp-1397	111	32	more	more	ADV
ajcp-1397	111	33	effectively	effectively	ADV
ajcp-1397	111	34	(	(	PUNCT
ajcp-1397	111	35	brooks	brooks	PROPN
ajcp-1397	111	36	et	et	PROPN
ajcp-1397	111	37	al	al	PROPN
ajcp-1397	111	38	.	.	PROPN
ajcp-1397	111	39	,	,	PUNCT
ajcp-1397	111	40	2020	2020	NUM
ajcp-1397	111	41	)	)	PUNCT
ajcp-1397	111	42	.	.	PUNCT
ajcp-1397	112	1	in	in	ADP
ajcp-1397	112	2	this	this	DET
ajcp-1397	112	3	situation	situation	NOUN
ajcp-1397	112	4	,	,	PUNCT
ajcp-1397	112	5	most	most	ADJ
ajcp-1397	112	6	women	woman	NOUN
ajcp-1397	112	7	are	be	AUX
ajcp-1397	112	8	extra	extra	ADV
ajcp-1397	112	9	susceptible	susceptible	ADJ
ajcp-1397	112	10	to	to	ADP
ajcp-1397	112	11	intimate	intimate	ADJ
ajcp-1397	112	12	partner	partner	NOUN
ajcp-1397	112	13	abuse	abuse	NOUN
ajcp-1397	112	14	(	(	PUNCT
ajcp-1397	112	15	bradbury‐jones	bradbury‐jone	NOUN
ajcp-1397	112	16	&	&	CCONJ
ajcp-1397	112	17	isham	isham	PROPN
ajcp-1397	112	18	,	,	PUNCT
ajcp-1397	112	19	2020	2020	NUM
ajcp-1397	112	20	;	;	PUNCT
ajcp-1397	112	21	pal	pal	NOUN
ajcp-1397	112	22	&	&	CCONJ
ajcp-1397	112	23	rao	rao	PROPN
ajcp-1397	112	24	,	,	PUNCT
ajcp-1397	112	25	2020	2020	NUM
ajcp-1397	112	26	)	)	PUNCT
ajcp-1397	112	27	and	and	CCONJ
ajcp-1397	112	28	the	the	DET
ajcp-1397	112	29	harmful	harmful	ADJ
ajcp-1397	112	30	pregnancy	pregnancy	NOUN
ajcp-1397	112	31	related	relate	VERB
ajcp-1397	112	32	to	to	ADP
ajcp-1397	112	33	it	it	PRON
ajcp-1397	112	34	,	,	PUNCT
ajcp-1397	112	35	and	and	CCONJ
ajcp-1397	112	36	they	they	PRON
ajcp-1397	112	37	are	be	AUX
ajcp-1397	112	38	also	also	ADV
ajcp-1397	112	39	less	less	ADV
ajcp-1397	112	40	able	able	ADJ
ajcp-1397	112	41	to	to	PART
ajcp-1397	112	42	seek	seek	VERB
ajcp-1397	112	43	help	help	NOUN
ajcp-1397	112	44	.	.	PUNCT
ajcp-1397	113	1	(	(	PUNCT
ajcp-1397	113	2	wenham	wenham	PROPN
ajcp-1397	113	3	et	et	PROPN
ajcp-1397	113	4	al	al	PROPN
ajcp-1397	113	5	.	.	PROPN
ajcp-1397	113	6	,	,	PUNCT
ajcp-1397	113	7	2020	2020	NUM
ajcp-1397	113	8	)	)	PUNCT
ajcp-1397	113	9	the	the	DET
ajcp-1397	113	10	study	study	NOUN
ajcp-1397	113	11	results	result	NOUN
ajcp-1397	113	12	observed	observe	VERB
ajcp-1397	113	13	an	an	DET
ajcp-1397	113	14	insignificance	insignificance	NOUN
ajcp-1397	113	15	relation	relation	NOUN
ajcp-1397	113	16	between	between	ADP
ajcp-1397	113	17	comorbid	comorbid	NOUN
ajcp-1397	113	18	diseases	disease	NOUN
ajcp-1397	113	19	with	with	ADP
ajcp-1397	113	20	covid	covid	ADJ
ajcp-1397	113	21	-	-	PUNCT
ajcp-1397	113	22	infected	infected	ADJ
ajcp-1397	113	23	women	woman	NOUN
ajcp-1397	113	24	,	,	PUNCT
ajcp-1397	113	25	similar	similar	ADJ
ajcp-1397	113	26	to	to	ADP
ajcp-1397	113	27	wang	wang	PROPN
ajcp-1397	113	28	’s	’s	PART
ajcp-1397	113	29	research	research	NOUN
ajcp-1397	113	30	in	in	ADP
ajcp-1397	113	31	2020	2020	NUM
ajcp-1397	113	32	.	.	PUNCT
ajcp-1397	114	1	(	(	PUNCT
ajcp-1397	114	2	wang	wang	PROPN
ajcp-1397	114	3	et	et	PROPN
ajcp-1397	114	4	al	al	PROPN
ajcp-1397	114	5	.	.	PROPN
ajcp-1397	114	6	,	,	PUNCT
ajcp-1397	114	7	2020	2020	NUM
ajcp-1397	114	8	)	)	PUNCT
ajcp-1397	114	9	the	the	DET
ajcp-1397	114	10	vaccination	vaccination	NOUN
ajcp-1397	114	11	and	and	CCONJ
ajcp-1397	114	12	the	the	DET
ajcp-1397	114	13	booster	booster	NOUN
ajcp-1397	114	14	dose	dose	NOUN
ajcp-1397	114	15	were	be	AUX
ajcp-1397	114	16	very	very	ADV
ajcp-1397	114	17	helpful	helpful	ADJ
ajcp-1397	114	18	in	in	ADP
ajcp-1397	114	19	reducing	reduce	VERB
ajcp-1397	114	20	the	the	DET
ajcp-1397	114	21	intense	intense	ADJ
ajcp-1397	114	22	onset	onset	NOUN
ajcp-1397	114	23	of	of	ADP
ajcp-1397	114	24	the	the	DET
ajcp-1397	114	25	disease	disease	NOUN
ajcp-1397	114	26	that	that	PRON
ajcp-1397	114	27	leads	lead	VERB
ajcp-1397	114	28	to	to	ADP
ajcp-1397	114	29	death	death	NOUN
ajcp-1397	114	30	.	.	PUNCT
ajcp-1397	115	1	besides	besides	SCONJ
ajcp-1397	115	2	all	all	PRON
ajcp-1397	115	3	,	,	PUNCT
ajcp-1397	115	4	vaccination	vaccination	NOUN
ajcp-1397	115	5	is	be	AUX
ajcp-1397	115	6	more	more	ADV
ajcp-1397	115	7	important	important	ADJ
ajcp-1397	115	8	not	not	PART
ajcp-1397	115	9	only	only	ADV
ajcp-1397	115	10	to	to	PART
ajcp-1397	115	11	stop	stop	VERB
ajcp-1397	115	12	the	the	DET
ajcp-1397	115	13	onset	onset	NOUN
ajcp-1397	115	14	of	of	ADP
ajcp-1397	115	15	disease	disease	NOUN
ajcp-1397	115	16	but	but	CCONJ
ajcp-1397	115	17	also	also	ADV
ajcp-1397	115	18	to	to	PART
ajcp-1397	115	19	restrict	restrict	VERB
ajcp-1397	115	20	the	the	DET
ajcp-1397	115	21	severity	severity	NOUN
ajcp-1397	115	22	of	of	ADP
ajcp-1397	115	23	the	the	DET
ajcp-1397	115	24	disease	disease	NOUN
ajcp-1397	115	25	.	.	PUNCT
ajcp-1397	116	1	(	(	PUNCT
ajcp-1397	116	2	menni	menni	NOUN
ajcp-1397	116	3	et	et	PROPN
ajcp-1397	116	4	al	al	PROPN
ajcp-1397	116	5	.	.	PROPN
ajcp-1397	116	6	,	,	PUNCT
ajcp-1397	116	7	2021	2021	NUM
ajcp-1397	116	8	)	)	PUNCT
ajcp-1397	116	9	social	social	ADJ
ajcp-1397	116	10	distancing	distancing	NOUN
ajcp-1397	116	11	and	and	CCONJ
ajcp-1397	116	12	precautionary	precautionary	ADJ
ajcp-1397	116	13	measures	measure	NOUN
ajcp-1397	116	14	such	such	ADJ
ajcp-1397	116	15	as	as	ADP
ajcp-1397	116	16	masks	mask	NOUN
ajcp-1397	116	17	,	,	PUNCT
ajcp-1397	116	18	gloves	glove	NOUN
ajcp-1397	116	19	and	and	CCONJ
ajcp-1397	116	20	hand	hand	NOUN
ajcp-1397	116	21	sanitization	sanitization	NOUN
ajcp-1397	116	22	restrict	restrict	VERB
ajcp-1397	116	23	the	the	DET
ajcp-1397	116	24	spread	spread	NOUN
ajcp-1397	116	25	.	.	PUNCT
ajcp-1397	117	1	in	in	ADP
ajcp-1397	117	2	conclusion	conclusion	NOUN
ajcp-1397	117	3	,	,	PUNCT
ajcp-1397	117	4	the	the	DET
ajcp-1397	117	5	overall	overall	ADJ
ajcp-1397	117	6	features	feature	NOUN
ajcp-1397	117	7	of	of	ADP
ajcp-1397	117	8	individuals	individual	NOUN
ajcp-1397	117	9	with	with	ADP
ajcp-1397	117	10	covid-19	covid-19	PROPN
ajcp-1397	117	11	infection	infection	NOUN
ajcp-1397	117	12	who	who	PRON
ajcp-1397	117	13	appear	appear	VERB
ajcp-1397	117	14	from	from	ADP
ajcp-1397	117	15	mid	mid	ADJ
ajcp-1397	117	16	-	-	NOUN
ajcp-1397	117	17	trimester	trimester	ADJ
ajcp-1397	117	18	forward	forward	ADV
ajcp-1397	117	19	are	be	AUX
ajcp-1397	117	20	comparable	comparable	ADJ
ajcp-1397	117	21	to	to	ADP
ajcp-1397	117	22	those	those	PRON
ajcp-1397	117	23	of	of	ADP
ajcp-1397	117	24	non	non	ADJ
ajcp-1397	117	25	-	-	ADJ
ajcp-1397	117	26	pregnant	pregnant	ADJ
ajcp-1397	117	27	people	people	NOUN
ajcp-1397	117	28	based	base	VERB
ajcp-1397	117	29	on	on	ADP
ajcp-1397	117	30	the	the	DET
ajcp-1397	117	31	clinical	clinical	ADJ
ajcp-1397	117	32	and	and	CCONJ
ajcp-1397	117	33	scientific	scientific	ADJ
ajcp-1397	117	34	evidence	evidence	NOUN
ajcp-1397	117	35	that	that	PRON
ajcp-1397	117	36	is	be	AUX
ajcp-1397	117	37	currently	currently	ADV
ajcp-1397	117	38	available	available	ADJ
ajcp-1397	117	39	.	.	PUNCT
ajcp-1397	118	1	there	there	PRON
ajcp-1397	118	2	is	be	VERB
ajcp-1397	118	3	currently	currently	ADV
ajcp-1397	118	4	no	no	DET
ajcp-1397	118	5	proof	proof	NOUN
ajcp-1397	118	6	that	that	SCONJ
ajcp-1397	118	7	covid-19	covid-19	PROPN
ajcp-1397	118	8	infection	infection	NOUN
ajcp-1397	118	9	is	be	AUX
ajcp-1397	118	10	more	more	ADV
ajcp-1397	118	11	likely	likely	ADJ
ajcp-1397	118	12	to	to	PART
ajcp-1397	118	13	affect	affect	VERB
ajcp-1397	118	14	pregnant	pregnant	ADJ
ajcp-1397	118	15	women	woman	NOUN
ajcp-1397	118	16	or	or	CCONJ
ajcp-1397	118	17	that	that	SCONJ
ajcp-1397	118	18	covid-19	covid-19	PROPN
ajcp-1397	118	19	infection	infection	NOUN
ajcp-1397	118	20	increases	increase	VERB
ajcp-1397	118	21	the	the	DET
ajcp-1397	118	22	risk	risk	NOUN
ajcp-1397	118	23	of	of	ADP
ajcp-1397	118	24	developing	develop	VERB
ajcp-1397	118	25	severe	severe	ADJ
ajcp-1397	118	26	pneumonia	pneumonia	NOUN
ajcp-1397	118	27	.	.	PUNCT
ajcp-1397	119	1	conclusion	conclusion	NOUN
ajcp-1397	119	2	the	the	DET
ajcp-1397	119	3	results	result	NOUN
ajcp-1397	119	4	showed	show	VERB
ajcp-1397	119	5	insignificance	insignificance	NOUN
ajcp-1397	119	6	with	with	ADP
ajcp-1397	119	7	comorbid	comorbid	NOUN
ajcp-1397	119	8	diseases	disease	NOUN
ajcp-1397	119	9	when	when	SCONJ
ajcp-1397	119	10	compared	compare	VERB
ajcp-1397	119	11	with	with	ADP
ajcp-1397	119	12	covidinfected	covidinfecte	VERB
ajcp-1397	119	13	pregnant	pregnant	ADJ
ajcp-1397	119	14	women	woman	NOUN
ajcp-1397	119	15	and	and	CCONJ
ajcp-1397	119	16	uninfected	uninfected	ADJ
ajcp-1397	119	17	pregnant	pregnant	ADJ
ajcp-1397	119	18	women	woman	NOUN
ajcp-1397	119	19	,	,	PUNCT
ajcp-1397	119	20	while	while	SCONJ
ajcp-1397	119	21	a	a	DET
ajcp-1397	119	22	decrease	decrease	NOUN
ajcp-1397	119	23	in	in	ADP
ajcp-1397	119	24	wbc	wbc	PROPN
ajcp-1397	119	25	and	and	CCONJ
ajcp-1397	119	26	crp	crp	PROPN
ajcp-1397	119	27	was	be	AUX
ajcp-1397	119	28	observed	observe	VERB
ajcp-1397	119	29	in	in	ADP
ajcp-1397	119	30	covidinfected	covidinfecte	VERB
ajcp-1397	119	31	pregnant	pregnant	ADJ
ajcp-1397	119	32	women	woman	NOUN
ajcp-1397	119	33	.	.	PUNCT
ajcp-1397	120	1	acknowledgments	acknowledgment	NOUN
ajcp-1397	120	2	the	the	DET
ajcp-1397	120	3	author	author	NOUN
ajcp-1397	120	4	thanks	thanks	PROPN
ajcp-1397	120	5	dha	dha	PROPN
ajcp-1397	120	6	latifa	latifa	PROPN
ajcp-1397	120	7	hospital	hospital	PROPN
ajcp-1397	120	8	,	,	PUNCT
ajcp-1397	120	9	dubai	dubai	NOUN
ajcp-1397	120	10	,	,	PUNCT
ajcp-1397	120	11	for	for	ADP
ajcp-1397	120	12	continuous	continuous	ADJ
ajcp-1397	120	13	support	support	NOUN
ajcp-1397	120	14	throughout	throughout	ADP
ajcp-1397	120	15	the	the	DET
ajcp-1397	120	16	study	study	NOUN
ajcp-1397	120	17	.	.	PUNCT
ajcp-1397	121	1	references	reference	NOUN
ajcp-1397	121	2	bradbury	bradbury	PROPN
ajcp-1397	121	3	-	-	PUNCT
ajcp-1397	121	4	jones	jones	PROPN
ajcp-1397	121	5	,	,	PUNCT
ajcp-1397	121	6	c.	c.	PROPN
ajcp-1397	121	7	,	,	PUNCT
ajcp-1397	121	8	&	&	CCONJ
ajcp-1397	121	9	isham	isham	PROPN
ajcp-1397	121	10	,	,	PUNCT
ajcp-1397	121	11	l.	l.	PROPN
ajcp-1397	121	12	(	(	PUNCT
ajcp-1397	121	13	2020	2020	NUM
ajcp-1397	121	14	)	)	PUNCT
ajcp-1397	121	15	.	.	PUNCT
ajcp-1397	122	1	the	the	DET
ajcp-1397	122	2	pandemic	pandemic	ADJ
ajcp-1397	122	3	paradox	paradox	NOUN
ajcp-1397	122	4	:	:	PUNCT
ajcp-1397	122	5	the	the	DET
ajcp-1397	122	6	consequences	consequence	NOUN
ajcp-1397	122	7	of	of	ADP
ajcp-1397	122	8	covid-19	covid-19	PROPN
ajcp-1397	122	9	on	on	ADP
ajcp-1397	122	10	https://journals.e-palli.com/home/index.php/ajcp	https://journals.e-palli.com/home/index.php/ajcp	PROPN
ajcp-1397	122	11	pa	pa	PROPN
ajcp-1397	122	12	ge	ge	PROPN
ajcp-1397	122	13	37	37	NUM
ajcp-1397	122	14	https://journals.e-palli.com/home/index.php/ajcp	https://journals.e-palli.com/home/index.php/ajcp	PROPN
ajcp-1397	122	15	am	be	AUX
ajcp-1397	122	16	.	.	PUNCT
ajcp-1397	123	1	j.	j.	PROPN
ajcp-1397	123	2	chem	chem	PROPN
ajcp-1397	123	3	.	.	PUNCT
ajcp-1397	124	1	pharm	pharm	NOUN
ajcp-1397	124	2	.	.	PUNCT
ajcp-1397	125	1	2(1	2(1	NUM
ajcp-1397	125	2	)	)	PUNCT
ajcp-1397	125	3	32	32	NUM
ajcp-1397	125	4	-	-	SYM
ajcp-1397	125	5	37	37	NUM
ajcp-1397	125	6	,	,	PUNCT
ajcp-1397	125	7	2023	2023	NUM
ajcp-1397	125	8	domestic	domestic	ADJ
ajcp-1397	125	9	violence	violence	NOUN
ajcp-1397	125	10	.	.	PUNCT
ajcp-1397	126	1	journal	journal	NOUN
ajcp-1397	126	2	of	of	ADP
ajcp-1397	126	3	clinical	clinical	ADJ
ajcp-1397	126	4	nursing	nursing	NOUN
ajcp-1397	126	5	,	,	PUNCT
ajcp-1397	126	6	29(13	29(13	NUM
ajcp-1397	126	7	-	-	SYM
ajcp-1397	126	8	14	14	NUM
ajcp-1397	126	9	)	)	PUNCT
ajcp-1397	126	10	,	,	PUNCT
ajcp-1397	126	11	2047	2047	NUM
ajcp-1397	126	12	.	.	PUNCT
ajcp-1397	127	1	brooks	brooks	PROPN
ajcp-1397	127	2	,	,	PUNCT
ajcp-1397	127	3	s.	s.	PROPN
ajcp-1397	127	4	k.	k.	PROPN
ajcp-1397	127	5	,	,	PUNCT
ajcp-1397	127	6	webster	webster	PROPN
ajcp-1397	127	7	,	,	PUNCT
ajcp-1397	127	8	r.	r.	PROPN
ajcp-1397	127	9	k.	k.	PROPN
ajcp-1397	127	10	,	,	PUNCT
ajcp-1397	127	11	smith	smith	PROPN
ajcp-1397	127	12	,	,	PUNCT
ajcp-1397	127	13	l.	l.	PROPN
ajcp-1397	127	14	e.	e.	PROPN
ajcp-1397	127	15	,	,	PUNCT
ajcp-1397	127	16	woodland	woodland	PROPN
ajcp-1397	127	17	,	,	PUNCT
ajcp-1397	127	18	l.	l.	PROPN
ajcp-1397	127	19	,	,	PUNCT
ajcp-1397	127	20	wessely	wessely	ADV
ajcp-1397	127	21	,	,	PUNCT
ajcp-1397	127	22	s.	s.	PROPN
ajcp-1397	127	23	,	,	PUNCT
ajcp-1397	127	24	greenberg	greenberg	PROPN
ajcp-1397	127	25	,	,	PUNCT
ajcp-1397	127	26	n.	n.	PROPN
ajcp-1397	127	27	,	,	PUNCT
ajcp-1397	127	28	&	&	CCONJ
ajcp-1397	127	29	rubin	rubin	PROPN
ajcp-1397	127	30	,	,	PUNCT
ajcp-1397	127	31	g.	g.	PROPN
ajcp-1397	127	32	j.	j.	PROPN
ajcp-1397	127	33	(	(	PUNCT
ajcp-1397	127	34	2020	2020	NUM
ajcp-1397	127	35	)	)	PUNCT
ajcp-1397	127	36	.	.	PUNCT
ajcp-1397	128	1	the	the	DET
ajcp-1397	128	2	psychological	psychological	ADJ
ajcp-1397	128	3	impact	impact	NOUN
ajcp-1397	128	4	of	of	ADP
ajcp-1397	128	5	quarantine	quarantine	NOUN
ajcp-1397	128	6	and	and	CCONJ
ajcp-1397	128	7	how	how	SCONJ
ajcp-1397	128	8	to	to	PART
ajcp-1397	128	9	reduce	reduce	VERB
ajcp-1397	128	10	it	it	PRON
ajcp-1397	128	11	:	:	PUNCT
ajcp-1397	128	12	a	a	DET
ajcp-1397	128	13	rapid	rapid	ADJ
ajcp-1397	128	14	review	review	NOUN
ajcp-1397	128	15	of	of	ADP
ajcp-1397	128	16	the	the	DET
ajcp-1397	128	17	evidence	evidence	NOUN
ajcp-1397	128	18	.	.	PUNCT
ajcp-1397	129	1	the	the	DET
ajcp-1397	129	2	lancet	lancet	PROPN
ajcp-1397	129	3	,	,	PUNCT
ajcp-1397	129	4	395(10227	395(10227	NUM
ajcp-1397	129	5	)	)	PUNCT
ajcp-1397	129	6	,	,	PUNCT
ajcp-1397	129	7	912	912	NUM
ajcp-1397	129	8	-	-	SYM
ajcp-1397	129	9	920	920	NUM
ajcp-1397	129	10	.	.	PUNCT
ajcp-1397	130	1	chen	chen	PROPN
ajcp-1397	130	2	,	,	PUNCT
ajcp-1397	130	3	h.	h.	PROPN
ajcp-1397	130	4	,	,	PUNCT
ajcp-1397	130	5	guo	guo	PROPN
ajcp-1397	130	6	,	,	PUNCT
ajcp-1397	130	7	j.	j.	PROPN
ajcp-1397	130	8	,	,	PUNCT
ajcp-1397	130	9	wang	wang	PROPN
ajcp-1397	130	10	,	,	PUNCT
ajcp-1397	130	11	c.	c.	PROPN
ajcp-1397	130	12	,	,	PUNCT
ajcp-1397	130	13	luo	luo	PROPN
ajcp-1397	130	14	,	,	PUNCT
ajcp-1397	130	15	f.	f.	PROPN
ajcp-1397	130	16	,	,	PUNCT
ajcp-1397	130	17	yu	yu	PROPN
ajcp-1397	130	18	,	,	PUNCT
ajcp-1397	130	19	x.	x.	PROPN
ajcp-1397	130	20	,	,	PUNCT
ajcp-1397	130	21	zhang	zhang	PROPN
ajcp-1397	130	22	,	,	PUNCT
ajcp-1397	130	23	w.	w.	PROPN
ajcp-1397	130	24	,	,	PUNCT
ajcp-1397	130	25	li	li	PROPN
ajcp-1397	130	26	,	,	PUNCT
ajcp-1397	130	27	j.	j.	PROPN
ajcp-1397	130	28	,	,	PUNCT
ajcp-1397	130	29	zhao	zhao	PROPN
ajcp-1397	130	30	,	,	PUNCT
ajcp-1397	130	31	d.	d.	PROPN
ajcp-1397	130	32	,	,	PUNCT
ajcp-1397	130	33	xu	xu	PROPN
ajcp-1397	130	34	,	,	PUNCT
ajcp-1397	130	35	d.	d.	PROPN
ajcp-1397	130	36	,	,	PUNCT
ajcp-1397	130	37	&	&	CCONJ
ajcp-1397	130	38	gong	gong	PROPN
ajcp-1397	130	39	,	,	PUNCT
ajcp-1397	130	40	q.	q.	PROPN
ajcp-1397	130	41	(	(	PUNCT
ajcp-1397	130	42	2020	2020	NUM
ajcp-1397	130	43	)	)	PUNCT
ajcp-1397	130	44	.	.	PUNCT
ajcp-1397	131	1	clinical	clinical	ADJ
ajcp-1397	131	2	characteristics	characteristic	NOUN
ajcp-1397	131	3	and	and	CCONJ
ajcp-1397	131	4	intrauterine	intrauterine	ADJ
ajcp-1397	131	5	vertical	vertical	ADJ
ajcp-1397	131	6	transmission	transmission	NOUN
ajcp-1397	131	7	potential	potential	NOUN
ajcp-1397	131	8	of	of	ADP
ajcp-1397	131	9	covid-19	covid-19	PROPN
ajcp-1397	131	10	infection	infection	NOUN
ajcp-1397	131	11	in	in	ADP
ajcp-1397	131	12	nine	nine	NUM
ajcp-1397	131	13	pregnant	pregnant	ADJ
ajcp-1397	131	14	women	woman	NOUN
ajcp-1397	131	15	:	:	PUNCT
ajcp-1397	131	16	a	a	DET
ajcp-1397	131	17	retrospective	retrospective	ADJ
ajcp-1397	131	18	review	review	NOUN
ajcp-1397	131	19	of	of	ADP
ajcp-1397	131	20	medical	medical	ADJ
ajcp-1397	131	21	records	record	NOUN
ajcp-1397	131	22	.	.	PUNCT
ajcp-1397	132	1	the	the	DET
ajcp-1397	132	2	lancet	lancet	PROPN
ajcp-1397	132	3	,	,	PUNCT
ajcp-1397	132	4	395(10226	395(10226	NUM
ajcp-1397	132	5	)	)	PUNCT
ajcp-1397	132	6	,	,	PUNCT
ajcp-1397	132	7	809	809	NUM
ajcp-1397	132	8	-	-	SYM
ajcp-1397	132	9	815	815	NUM
ajcp-1397	132	10	.	.	PUNCT
ajcp-1397	132	11	dorélien	dorélien	PROPN
ajcp-1397	132	12	,	,	PUNCT
ajcp-1397	132	13	a.	a.	NOUN
ajcp-1397	132	14	(	(	PUNCT
ajcp-1397	132	15	2019	2019	NUM
ajcp-1397	132	16	)	)	PUNCT
ajcp-1397	132	17	.	.	PUNCT
ajcp-1397	133	1	the	the	DET
ajcp-1397	133	2	effects	effect	NOUN
ajcp-1397	133	3	of	of	ADP
ajcp-1397	133	4	in	in	ADP
ajcp-1397	133	5	utero	utero	ADJ
ajcp-1397	133	6	exposure	exposure	NOUN
ajcp-1397	133	7	to	to	ADP
ajcp-1397	133	8	influenza	influenza	NOUN
ajcp-1397	133	9	on	on	ADP
ajcp-1397	133	10	birth	birth	NOUN
ajcp-1397	133	11	and	and	CCONJ
ajcp-1397	133	12	infant	infant	VERB
ajcp-1397	133	13	outcomes	outcome	NOUN
ajcp-1397	133	14	in	in	ADP
ajcp-1397	133	15	the	the	DET
ajcp-1397	133	16	us	us	PROPN
ajcp-1397	133	17	.	.	PUNCT
ajcp-1397	134	1	population	population	NOUN
ajcp-1397	134	2	and	and	CCONJ
ajcp-1397	134	3	development	development	PROPN
ajcp-1397	134	4	review	review	PROPN
ajcp-1397	134	5	,	,	PUNCT
ajcp-1397	134	6	45(3	45(3	NUM
ajcp-1397	134	7	)	)	PUNCT
ajcp-1397	134	8	,	,	PUNCT
ajcp-1397	134	9	489	489	NUM
ajcp-1397	134	10	.	.	PUNCT
ajcp-1397	135	1	kamel	kamel	PROPN
ajcp-1397	135	2	boulos	boulos	PROPN
ajcp-1397	135	3	,	,	PUNCT
ajcp-1397	135	4	m.	m.	NOUN
ajcp-1397	135	5	n.	n.	PROPN
ajcp-1397	135	6	,	,	PUNCT
ajcp-1397	135	7	&	&	CCONJ
ajcp-1397	135	8	geraghty	geraghty	PROPN
ajcp-1397	135	9	,	,	PUNCT
ajcp-1397	135	10	e.	e.	PROPN
ajcp-1397	135	11	m.	m.	PROPN
ajcp-1397	135	12	(	(	PUNCT
ajcp-1397	135	13	2020	2020	NUM
ajcp-1397	135	14	)	)	PUNCT
ajcp-1397	135	15	.	.	PUNCT
ajcp-1397	136	1	geographical	geographical	ADJ
ajcp-1397	136	2	tracking	tracking	NOUN
ajcp-1397	136	3	and	and	CCONJ
ajcp-1397	136	4	mapping	mapping	NOUN
ajcp-1397	136	5	of	of	ADP
ajcp-1397	136	6	coronavirus	coronavirus	NOUN
ajcp-1397	136	7	disease	disease	NOUN
ajcp-1397	136	8	covid-19	covid-19	PROPN
ajcp-1397	136	9	/	/	SYM
ajcp-1397	136	10	severe	severe	ADJ
ajcp-1397	136	11	acute	acute	ADJ
ajcp-1397	136	12	respiratory	respiratory	ADJ
ajcp-1397	136	13	syndrome	syndrome	NOUN
ajcp-1397	136	14	coronavirus	coronavirus	NOUN
ajcp-1397	136	15	2	2	NUM
ajcp-1397	136	16	(	(	PUNCT
ajcp-1397	136	17	sars	sar	NOUN
ajcp-1397	136	18	-	-	PUNCT
ajcp-1397	136	19	cov-2	cov-2	NOUN
ajcp-1397	136	20	)	)	PUNCT
ajcp-1397	136	21	epidemic	epidemic	NOUN
ajcp-1397	136	22	and	and	CCONJ
ajcp-1397	136	23	associated	associated	ADJ
ajcp-1397	136	24	events	event	NOUN
ajcp-1397	136	25	around	around	ADP
ajcp-1397	136	26	the	the	DET
ajcp-1397	136	27	world	world	NOUN
ajcp-1397	136	28	:	:	PUNCT
ajcp-1397	136	29	how	how	SCONJ
ajcp-1397	136	30	21st	21st	ADJ
ajcp-1397	136	31	century	century	NOUN
ajcp-1397	136	32	gis	gis	NOUN
ajcp-1397	136	33	technologies	technology	NOUN
ajcp-1397	136	34	are	be	AUX
ajcp-1397	136	35	supporting	support	VERB
ajcp-1397	136	36	the	the	DET
ajcp-1397	136	37	global	global	ADJ
ajcp-1397	136	38	fight	fight	NOUN
ajcp-1397	136	39	against	against	ADP
ajcp-1397	136	40	outbreaks	outbreak	NOUN
ajcp-1397	136	41	and	and	CCONJ
ajcp-1397	136	42	epidemics	epidemic	NOUN
ajcp-1397	136	43	.	.	PUNCT
ajcp-1397	137	1	international	international	ADJ
ajcp-1397	137	2	journal	journal	PROPN
ajcp-1397	137	3	of	of	ADP
ajcp-1397	137	4	health	health	NOUN
ajcp-1397	137	5	geographics	geographic	NOUN
ajcp-1397	137	6	,	,	PUNCT
ajcp-1397	137	7	19(1	19(1	NUM
ajcp-1397	137	8	)	)	PUNCT
ajcp-1397	137	9	,	,	PUNCT
ajcp-1397	137	10	1	1	NUM
ajcp-1397	137	11	-	-	SYM
ajcp-1397	137	12	12	12	NUM
ajcp-1397	137	13	.	.	PUNCT
ajcp-1397	138	1	https://doi.org/10.1186/	https://doi.org/10.1186/	PROPN
ajcp-1397	138	2	s12942	s12942	PROPN
ajcp-1397	138	3	-	-	PUNCT
ajcp-1397	138	4	020	020	NUM
ajcp-1397	138	5	-	-	PUNCT
ajcp-1397	138	6	00202	00202	NUM
ajcp-1397	138	7	-	-	SYM
ajcp-1397	138	8	8	8	NUM
ajcp-1397	138	9	menni	menni	PROPN
ajcp-1397	138	10	,	,	PUNCT
ajcp-1397	138	11	c.	c.	PROPN
ajcp-1397	138	12	,	,	PUNCT
ajcp-1397	138	13	klaser	klaser	PROPN
ajcp-1397	138	14	,	,	PUNCT
ajcp-1397	138	15	k.	k.	PROPN
ajcp-1397	138	16	,	,	PUNCT
ajcp-1397	138	17	may	may	AUX
ajcp-1397	138	18	,	,	PUNCT
ajcp-1397	138	19	a.	a.	NOUN
ajcp-1397	138	20	,	,	PUNCT
ajcp-1397	138	21	polidori	polidori	PROPN
ajcp-1397	138	22	,	,	PUNCT
ajcp-1397	138	23	l.	l.	PROPN
ajcp-1397	138	24	,	,	PUNCT
ajcp-1397	138	25	capdevila	capdevila	PROPN
ajcp-1397	138	26	,	,	PUNCT
ajcp-1397	138	27	j.	j.	PROPN
ajcp-1397	138	28	,	,	PUNCT
ajcp-1397	138	29	louca	louca	PROPN
ajcp-1397	138	30	,	,	PUNCT
ajcp-1397	138	31	p.	p.	PROPN
ajcp-1397	138	32	,	,	PUNCT
ajcp-1397	138	33	sudre	sudre	PROPN
ajcp-1397	138	34	,	,	PUNCT
ajcp-1397	138	35	c.	c.	PROPN
ajcp-1397	138	36	h.	h.	PROPN
ajcp-1397	138	37	,	,	PUNCT
ajcp-1397	138	38	nguyen	nguyen	PROPN
ajcp-1397	138	39	,	,	PUNCT
ajcp-1397	138	40	l.	l.	PROPN
ajcp-1397	138	41	h.	h.	PROPN
ajcp-1397	138	42	,	,	PUNCT
ajcp-1397	138	43	drew	draw	VERB
ajcp-1397	138	44	,	,	PUNCT
ajcp-1397	138	45	d.	d.	PROPN
ajcp-1397	138	46	a.	a.	PROPN
ajcp-1397	138	47	,	,	PUNCT
ajcp-1397	138	48	&	&	CCONJ
ajcp-1397	138	49	merino	merino	PROPN
ajcp-1397	138	50	,	,	PUNCT
ajcp-1397	138	51	j.	j.	PROPN
ajcp-1397	138	52	(	(	PUNCT
ajcp-1397	138	53	2021	2021	NUM
ajcp-1397	138	54	)	)	PUNCT
ajcp-1397	138	55	.	.	PUNCT
ajcp-1397	139	1	vaccine	vaccine	NOUN
ajcp-1397	139	2	side	side	NOUN
ajcp-1397	139	3	-	-	PUNCT
ajcp-1397	139	4	effects	effect	NOUN
ajcp-1397	139	5	and	and	CCONJ
ajcp-1397	139	6	sars	sar	NOUN
ajcp-1397	139	7	-	-	PUNCT
ajcp-1397	139	8	cov-2	cov-2	NOUN
ajcp-1397	139	9	infection	infection	NOUN
ajcp-1397	139	10	after	after	ADP
ajcp-1397	139	11	vaccination	vaccination	NOUN
ajcp-1397	139	12	in	in	ADP
ajcp-1397	139	13	users	user	NOUN
ajcp-1397	139	14	of	of	ADP
ajcp-1397	139	15	the	the	DET
ajcp-1397	139	16	covid	covid	PROPN
ajcp-1397	139	17	symptom	symptom	PROPN
ajcp-1397	139	18	study	study	PROPN
ajcp-1397	139	19	app	app	PROPN
ajcp-1397	139	20	in	in	ADP
ajcp-1397	139	21	the	the	DET
ajcp-1397	139	22	uk	uk	PROPN
ajcp-1397	139	23	:	:	PUNCT
ajcp-1397	139	24	a	a	DET
ajcp-1397	139	25	prospective	prospective	ADJ
ajcp-1397	139	26	observational	observational	ADJ
ajcp-1397	139	27	study	study	NOUN
ajcp-1397	139	28	.	.	PUNCT
ajcp-1397	140	1	the	the	DET
ajcp-1397	140	2	lancet	lancet	ADJ
ajcp-1397	140	3	infectious	infectious	ADJ
ajcp-1397	140	4	diseases	disease	NOUN
ajcp-1397	140	5	,	,	PUNCT
ajcp-1397	140	6	21(7	21(7	NOUN
ajcp-1397	140	7	)	)	PUNCT
ajcp-1397	140	8	,	,	PUNCT
ajcp-1397	140	9	939	939	NUM
ajcp-1397	140	10	-	-	SYM
ajcp-1397	140	11	949	949	NUM
ajcp-1397	140	12	.	.	PUNCT
ajcp-1397	141	1	https://doi.org/10.1016/	https://doi.org/10.1016/	PROPN
ajcp-1397	141	2	s1473	s1473	PROPN
ajcp-1397	141	3	-	-	PUNCT
ajcp-1397	141	4	3099(21)00224	3099(21)00224	NUM
ajcp-1397	141	5	-	-	PUNCT
ajcp-1397	141	6	3	3	NUM
ajcp-1397	141	7	mohr	mohr	PROPN
ajcp-1397	141	8	-	-	PUNCT
ajcp-1397	141	9	sasson	sasson	PROPN
ajcp-1397	141	10	,	,	PUNCT
ajcp-1397	141	11	a.	a.	NOUN
ajcp-1397	141	12	,	,	PUNCT
ajcp-1397	141	13	chayo	chayo	VERB
ajcp-1397	141	14	,	,	PUNCT
ajcp-1397	141	15	j.	j.	PROPN
ajcp-1397	141	16	,	,	PUNCT
ajcp-1397	141	17	bart	bart	PROPN
ajcp-1397	141	18	,	,	PUNCT
ajcp-1397	141	19	y.	y.	PROPN
ajcp-1397	141	20	,	,	PUNCT
ajcp-1397	141	21	meyer	meyer	PROPN
ajcp-1397	141	22	,	,	PUNCT
ajcp-1397	141	23	r.	r.	PROPN
ajcp-1397	141	24	,	,	PUNCT
ajcp-1397	141	25	sivan	sivan	PROPN
ajcp-1397	141	26	,	,	PUNCT
ajcp-1397	141	27	e.	e.	PROPN
ajcp-1397	141	28	,	,	PUNCT
ajcp-1397	141	29	mazaki	mazaki	ADJ
ajcp-1397	141	30	-	-	PUNCT
ajcp-1397	141	31	tovi	tovi	PROPN
ajcp-1397	141	32	,	,	PUNCT
ajcp-1397	141	33	s.	s.	PROPN
ajcp-1397	141	34	,	,	PUNCT
ajcp-1397	141	35	&	&	CCONJ
ajcp-1397	141	36	yinon	yinon	PROPN
ajcp-1397	141	37	,	,	PUNCT
ajcp-1397	141	38	y.	y.	PROPN
ajcp-1397	141	39	(	(	PUNCT
ajcp-1397	141	40	2020	2020	NUM
ajcp-1397	141	41	)	)	PUNCT
ajcp-1397	141	42	.	.	PUNCT
ajcp-1397	142	1	laboratory	laboratory	NOUN
ajcp-1397	142	2	characteristics	characteristic	NOUN
ajcp-1397	142	3	of	of	ADP
ajcp-1397	142	4	pregnant	pregnant	ADJ
ajcp-1397	142	5	compared	compare	VERB
ajcp-1397	142	6	to	to	ADP
ajcp-1397	142	7	nonpregnant	nonpregnant	ADJ
ajcp-1397	142	8	women	woman	NOUN
ajcp-1397	142	9	infected	infect	VERB
ajcp-1397	142	10	with	with	ADP
ajcp-1397	142	11	sars	sar	NOUN
ajcp-1397	142	12	-	-	PUNCT
ajcp-1397	142	13	cov-2	cov-2	NOUN
ajcp-1397	142	14	.	.	PUNCT
ajcp-1397	143	1	archives	archive	NOUN
ajcp-1397	143	2	of	of	ADP
ajcp-1397	143	3	gynecology	gynecology	NOUN
ajcp-1397	143	4	and	and	CCONJ
ajcp-1397	143	5	obstetrics	obstetric	NOUN
ajcp-1397	143	6	,	,	PUNCT
ajcp-1397	143	7	302(3	302(3	NUM
ajcp-1397	143	8	)	)	PUNCT
ajcp-1397	143	9	,	,	PUNCT
ajcp-1397	143	10	629	629	NUM
ajcp-1397	143	11	-	-	SYM
ajcp-1397	143	12	634	634	NUM
ajcp-1397	143	13	.	.	PUNCT
ajcp-1397	144	1	https://doi	https://doi	X
ajcp-1397	144	2	.	.	PUNCT
ajcp-1397	144	3	org/10.1007	org/10.1007	PROPN
ajcp-1397	144	4	/	/	SYM
ajcp-1397	144	5	s00404	s00404	NOUN
ajcp-1397	144	6	-	-	PUNCT
ajcp-1397	144	7	020	020	NUM
ajcp-1397	144	8	-	-	PUNCT
ajcp-1397	144	9	05655	05655	NUM
ajcp-1397	144	10	-	-	SYM
ajcp-1397	144	11	7	7	NUM
ajcp-1397	144	12	mosby	mosby	NOUN
ajcp-1397	144	13	,	,	PUNCT
ajcp-1397	144	14	l.	l.	PROPN
ajcp-1397	144	15	g.	g.	PROPN
ajcp-1397	144	16	,	,	PUNCT
ajcp-1397	144	17	rasmussen	rasmussen	PROPN
ajcp-1397	144	18	,	,	PUNCT
ajcp-1397	144	19	s.	s.	PROPN
ajcp-1397	144	20	a.	a.	PROPN
ajcp-1397	144	21	,	,	PUNCT
ajcp-1397	144	22	&	&	CCONJ
ajcp-1397	144	23	jamieson	jamieson	PROPN
ajcp-1397	144	24	,	,	PUNCT
ajcp-1397	144	25	d.	d.	PROPN
ajcp-1397	144	26	j.	j.	PROPN
ajcp-1397	144	27	(	(	PUNCT
ajcp-1397	144	28	2011	2011	NUM
ajcp-1397	144	29	)	)	PUNCT
ajcp-1397	144	30	.	.	PUNCT
ajcp-1397	144	31	2009	2009	NUM
ajcp-1397	144	32	pandemic	pandemic	ADJ
ajcp-1397	144	33	influenza	influenza	NOUN
ajcp-1397	144	34	a	a	DET
ajcp-1397	144	35	(	(	PUNCT
ajcp-1397	144	36	h1n1	h1n1	NOUN
ajcp-1397	144	37	)	)	PUNCT
ajcp-1397	144	38	in	in	ADP
ajcp-1397	144	39	pregnancy	pregnancy	NOUN
ajcp-1397	144	40	:	:	PUNCT
ajcp-1397	144	41	a	a	DET
ajcp-1397	144	42	systematic	systematic	ADJ
ajcp-1397	144	43	review	review	NOUN
ajcp-1397	144	44	of	of	ADP
ajcp-1397	144	45	the	the	DET
ajcp-1397	144	46	literature	literature	NOUN
ajcp-1397	144	47	.	.	PUNCT
ajcp-1397	145	1	american	american	PROPN
ajcp-1397	145	2	journal	journal	PROPN
ajcp-1397	145	3	of	of	ADP
ajcp-1397	145	4	obstetrics	obstetric	NOUN
ajcp-1397	145	5	and	and	CCONJ
ajcp-1397	145	6	gynecology	gynecology	NOUN
ajcp-1397	145	7	,	,	PUNCT
ajcp-1397	145	8	205(1	205(1	NUM
ajcp-1397	145	9	)	)	PUNCT
ajcp-1397	145	10	,	,	PUNCT
ajcp-1397	145	11	10	10	NUM
ajcp-1397	145	12	-	-	SYM
ajcp-1397	145	13	18	18	NUM
ajcp-1397	145	14	.	.	PUNCT
ajcp-1397	146	1	https://doi	https://doi	X
ajcp-1397	146	2	.	.	PUNCT
ajcp-1397	147	1	org/10.1016	org/10.1016	PROPN
ajcp-1397	147	2	/	/	SYM
ajcp-1397	147	3	j.ajog.2010.12.033	j.ajog.2010.12.033	X
ajcp-1397	147	4	pal	pal	NOUN
ajcp-1397	147	5	,	,	PUNCT
ajcp-1397	147	6	a.	a.	PROPN
ajcp-1397	147	7	,	,	PUNCT
ajcp-1397	147	8	&	&	CCONJ
ajcp-1397	147	9	rao	rao	PROPN
ajcp-1397	147	10	,	,	PUNCT
ajcp-1397	147	11	r.	r.	PROPN
ajcp-1397	147	12	(	(	PUNCT
ajcp-1397	147	13	2020	2020	NUM
ajcp-1397	147	14	)	)	PUNCT
ajcp-1397	147	15	.	.	PUNCT
ajcp-1397	148	1	intimate	intimate	ADJ
ajcp-1397	148	2	partner	partner	NOUN
ajcp-1397	148	3	violence	violence	NOUN
ajcp-1397	148	4	during	during	ADP
ajcp-1397	148	5	pregnancy	pregnancy	NOUN
ajcp-1397	148	6	.	.	PUNCT
ajcp-1397	149	1	labour	labour	ADJ
ajcp-1397	149	2	room	room	NOUN
ajcp-1397	149	3	emergencies	emergency	NOUN
ajcp-1397	149	4	,	,	PUNCT
ajcp-1397	149	5	515	515	NUM
ajcp-1397	149	6	-	-	SYM
ajcp-1397	149	7	520	520	NUM
ajcp-1397	149	8	.	.	PUNCT
ajcp-1397	150	1	https://	https://	PROPN
ajcp-1397	150	2	doi.org/10.1007/978-981-10-4953-8_52	doi.org/10.1007/978-981-10-4953-8_52	PROPN
ajcp-1397	150	3	pierce	pierce	PROPN
ajcp-1397	150	4	-	-	PUNCT
ajcp-1397	150	5	williams	williams	PROPN
ajcp-1397	150	6	,	,	PUNCT
ajcp-1397	150	7	r.	r.	PROPN
ajcp-1397	150	8	a.	a.	PROPN
ajcp-1397	150	9	,	,	PUNCT
ajcp-1397	150	10	burd	burd	PROPN
ajcp-1397	150	11	,	,	PUNCT
ajcp-1397	150	12	j.	j.	PROPN
ajcp-1397	150	13	,	,	PUNCT
ajcp-1397	150	14	felder	felder	PROPN
ajcp-1397	150	15	,	,	PUNCT
ajcp-1397	150	16	l.	l.	PROPN
ajcp-1397	150	17	,	,	PUNCT
ajcp-1397	150	18	khoury	khoury	PROPN
ajcp-1397	150	19	,	,	PUNCT
ajcp-1397	150	20	r.	r.	PROPN
ajcp-1397	150	21	,	,	PUNCT
ajcp-1397	150	22	bernstein	bernstein	PROPN
ajcp-1397	150	23	,	,	PUNCT
ajcp-1397	150	24	p.	p.	PROPN
ajcp-1397	150	25	s.	s.	PROPN
ajcp-1397	150	26	,	,	PUNCT
ajcp-1397	150	27	avila	avila	PROPN
ajcp-1397	150	28	,	,	PUNCT
ajcp-1397	150	29	k.	k.	PROPN
ajcp-1397	150	30	,	,	PUNCT
ajcp-1397	150	31	penfield	penfield	PROPN
ajcp-1397	150	32	,	,	PUNCT
ajcp-1397	150	33	c.	c.	PROPN
ajcp-1397	150	34	a.	a.	PROPN
ajcp-1397	150	35	,	,	PUNCT
ajcp-1397	150	36	roman	roman	NOUN
ajcp-1397	150	37	,	,	PUNCT
ajcp-1397	150	38	a.	a.	PROPN
ajcp-1397	150	39	s.	s.	PROPN
ajcp-1397	150	40	,	,	PUNCT
ajcp-1397	150	41	debolt	debolt	NOUN
ajcp-1397	150	42	,	,	PUNCT
ajcp-1397	150	43	c.	c.	PROPN
ajcp-1397	150	44	a.	a.	PROPN
ajcp-1397	150	45	,	,	PUNCT
ajcp-1397	150	46	&	&	CCONJ
ajcp-1397	150	47	stone	stone	PROPN
ajcp-1397	150	48	,	,	PUNCT
ajcp-1397	150	49	j.	j.	PROPN
ajcp-1397	150	50	l.	l.	PROPN
ajcp-1397	150	51	(	(	PUNCT
ajcp-1397	150	52	2020	2020	NUM
ajcp-1397	150	53	)	)	PUNCT
ajcp-1397	150	54	.	.	PUNCT
ajcp-1397	151	1	clinical	clinical	ADJ
ajcp-1397	151	2	course	course	NOUN
ajcp-1397	151	3	of	of	ADP
ajcp-1397	151	4	severe	severe	ADJ
ajcp-1397	151	5	and	and	CCONJ
ajcp-1397	151	6	critical	critical	ADJ
ajcp-1397	151	7	coronavirus	coronavirus	NOUN
ajcp-1397	151	8	disease	disease	NOUN
ajcp-1397	151	9	2019	2019	NUM
ajcp-1397	151	10	in	in	ADP
ajcp-1397	151	11	hospitalized	hospitalize	VERB
ajcp-1397	151	12	pregnancies	pregnancy	NOUN
ajcp-1397	151	13	:	:	PUNCT
ajcp-1397	151	14	a	a	DET
ajcp-1397	151	15	united	united	PROPN
ajcp-1397	151	16	states	states	PROPN
ajcp-1397	151	17	cohort	cohort	NOUN
ajcp-1397	151	18	study	study	NOUN
ajcp-1397	151	19	.	.	PUNCT
ajcp-1397	152	1	american	american	ADJ
ajcp-1397	152	2	journal	journal	PROPN
ajcp-1397	152	3	of	of	ADP
ajcp-1397	152	4	obstetrics	obstetric	NOUN
ajcp-1397	152	5	&	&	CCONJ
ajcp-1397	152	6	gynecology	gynecology	PROPN
ajcp-1397	152	7	mfm	mfm	PROPN
ajcp-1397	152	8	,	,	PUNCT
ajcp-1397	152	9	2(3	2(3	NUM
ajcp-1397	152	10	)	)	PUNCT
ajcp-1397	152	11	,	,	PUNCT
ajcp-1397	152	12	100134	100134	NUM
ajcp-1397	152	13	.	.	PUNCT
ajcp-1397	153	1	rizo	rizo	PROPN
ajcp-1397	153	2	-	-	PUNCT
ajcp-1397	153	3	téllez	téllez	PROPN
ajcp-1397	153	4	,	,	PUNCT
ajcp-1397	153	5	s.	s.	PROPN
ajcp-1397	153	6	a.	a.	PROPN
ajcp-1397	153	7	,	,	PUNCT
ajcp-1397	153	8	méndez	méndez	NOUN
ajcp-1397	153	9	-	-	PUNCT
ajcp-1397	153	10	garcía	garcía	NOUN
ajcp-1397	153	11	,	,	PUNCT
ajcp-1397	153	12	l.	l.	PROPN
ajcp-1397	153	13	a.	a.	PROPN
ajcp-1397	153	14	,	,	PUNCT
ajcp-1397	153	15	flores	flores	PROPN
ajcp-1397	153	16	-	-	PUNCT
ajcp-1397	153	17	rebollo	rebollo	PROPN
ajcp-1397	153	18	,	,	PUNCT
ajcp-1397	153	19	c.	c.	PROPN
ajcp-1397	153	20	,	,	PUNCT
ajcp-1397	153	21	alba	alba	NOUN
ajcp-1397	153	22	-	-	PUNCT
ajcp-1397	153	23	flores	flores	PROPN
ajcp-1397	153	24	,	,	PUNCT
ajcp-1397	153	25	f.	f.	PROPN
ajcp-1397	153	26	,	,	PUNCT
ajcp-1397	153	27	alcántara	alcántara	ADJ
ajcp-1397	153	28	-	-	PUNCT
ajcp-1397	153	29	suárez	suárez	NOUN
ajcp-1397	153	30	,	,	PUNCT
ajcp-1397	153	31	r.	r.	PROPN
ajcp-1397	153	32	,	,	PUNCT
ajcp-1397	153	33	manjarrezreyna	manjarrezreyna	NOUN
ajcp-1397	153	34	,	,	PUNCT
ajcp-1397	153	35	a.	a.	NOUN
ajcp-1397	153	36	n.	n.	PROPN
ajcp-1397	153	37	,	,	PUNCT
ajcp-1397	153	38	baltazar	baltazar	NOUN
ajcp-1397	153	39	-	-	PUNCT
ajcp-1397	153	40	lópez	lópez	NOUN
ajcp-1397	153	41	,	,	PUNCT
ajcp-1397	153	42	n.	n.	NOUN
ajcp-1397	153	43	,	,	PUNCT
ajcp-1397	153	44	hernándezguzmán	hernándezguzmán	ADJ
ajcp-1397	153	45	,	,	PUNCT
ajcp-1397	153	46	v.	v.	ADP
ajcp-1397	153	47	a.	a.	NOUN
ajcp-1397	153	48	,	,	PUNCT
ajcp-1397	153	49	león	león	PROPN
ajcp-1397	153	50	-	-	PUNCT
ajcp-1397	153	51	pedroza	pedroza	PROPN
ajcp-1397	153	52	,	,	PUNCT
ajcp-1397	153	53	j.	j.	PROPN
ajcp-1397	153	54	i.	i.	PROPN
ajcp-1397	153	55	,	,	PUNCT
ajcp-1397	153	56	&	&	CCONJ
ajcp-1397	153	57	zapata	zapata	PROPN
ajcp-1397	153	58	-	-	PUNCT
ajcp-1397	153	59	arenas	arenas	PROPN
ajcp-1397	153	60	,	,	PUNCT
ajcp-1397	153	61	r.	r.	PROPN
ajcp-1397	153	62	(	(	PUNCT
ajcp-1397	153	63	2020	2020	NUM
ajcp-1397	153	64	)	)	PUNCT
ajcp-1397	153	65	.	.	PUNCT
ajcp-1397	154	1	the	the	DET
ajcp-1397	154	2	neutrophil	neutrophil	NOUN
ajcp-1397	154	3	-	-	PUNCT
ajcp-1397	154	4	to	to	ADP
ajcp-1397	154	5	-	-	PUNCT
ajcp-1397	154	6	monocyte	monocyte	NOUN
ajcp-1397	154	7	ratio	ratio	NOUN
ajcp-1397	154	8	and	and	CCONJ
ajcp-1397	154	9	lymphocyte	lymphocyte	NOUN
ajcp-1397	154	10	-	-	PUNCT
ajcp-1397	154	11	to	to	ADP
ajcp-1397	154	12	-	-	PUNCT
ajcp-1397	154	13	neutrophil	neutrophil	ADJ
ajcp-1397	154	14	ratio	ratio	NOUN
ajcp-1397	154	15	at	at	ADP
ajcp-1397	154	16	admission	admission	NOUN
ajcp-1397	154	17	predict	predict	VERB
ajcp-1397	154	18	in	in	ADP
ajcp-1397	154	19	-	-	PUNCT
ajcp-1397	154	20	hospital	hospital	NOUN
ajcp-1397	154	21	mortality	mortality	NOUN
ajcp-1397	154	22	in	in	ADP
ajcp-1397	154	23	mexican	mexican	ADJ
ajcp-1397	154	24	patients	patient	NOUN
ajcp-1397	154	25	with	with	ADP
ajcp-1397	154	26	severe	severe	ADJ
ajcp-1397	154	27	sars	sar	NOUN
ajcp-1397	154	28	-	-	PUNCT
ajcp-1397	154	29	cov-2	cov-2	PART
ajcp-1397	154	30	infection	infection	NOUN
ajcp-1397	154	31	(	(	PUNCT
ajcp-1397	154	32	covid-19	covid-19	PROPN
ajcp-1397	154	33	)	)	PUNCT
ajcp-1397	154	34	.	.	PUNCT
ajcp-1397	155	1	microorganisms	microorganism	NOUN
ajcp-1397	155	2	,	,	PUNCT
ajcp-1397	155	3	8(10	8(10	NUM
ajcp-1397	155	4	)	)	PUNCT
ajcp-1397	155	5	,	,	PUNCT
ajcp-1397	155	6	1560	1560	NUM
ajcp-1397	155	7	.	.	PUNCT
ajcp-1397	156	1	sohrabi	sohrabi	NOUN
ajcp-1397	156	2	,	,	PUNCT
ajcp-1397	156	3	c.	c.	PROPN
ajcp-1397	156	4	,	,	PUNCT
ajcp-1397	156	5	alsafi	alsafi	PROPN
ajcp-1397	156	6	,	,	PUNCT
ajcp-1397	156	7	z.	z.	PROPN
ajcp-1397	156	8	,	,	PUNCT
ajcp-1397	156	9	o’neill	o’neill	PROPN
ajcp-1397	156	10	,	,	PUNCT
ajcp-1397	156	11	n.	n.	PROPN
ajcp-1397	156	12	,	,	PUNCT
ajcp-1397	156	13	khan	khan	PROPN
ajcp-1397	156	14	,	,	PUNCT
ajcp-1397	156	15	m.	m.	NOUN
ajcp-1397	156	16	,	,	PUNCT
ajcp-1397	156	17	kerwan	kerwan	PROPN
ajcp-1397	156	18	,	,	PUNCT
ajcp-1397	156	19	a.	a.	PROPN
ajcp-1397	156	20	,	,	PUNCT
ajcp-1397	156	21	al	al	PROPN
ajcp-1397	156	22	-	-	PUNCT
ajcp-1397	156	23	jabir	jabir	PROPN
ajcp-1397	156	24	,	,	PUNCT
ajcp-1397	156	25	a.	a.	NOUN
ajcp-1397	156	26	,	,	PUNCT
ajcp-1397	156	27	iosifidis	iosifidis	PROPN
ajcp-1397	156	28	,	,	PUNCT
ajcp-1397	156	29	c.	c.	PROPN
ajcp-1397	156	30	,	,	PUNCT
ajcp-1397	156	31	&	&	CCONJ
ajcp-1397	156	32	agha	agha	PROPN
ajcp-1397	156	33	,	,	PUNCT
ajcp-1397	156	34	r.	r.	PROPN
ajcp-1397	156	35	(	(	PUNCT
ajcp-1397	156	36	2020	2020	NUM
ajcp-1397	156	37	)	)	PUNCT
ajcp-1397	156	38	.	.	PUNCT
ajcp-1397	157	1	world	world	PROPN
ajcp-1397	157	2	health	health	PROPN
ajcp-1397	157	3	organization	organization	PROPN
ajcp-1397	157	4	declares	declare	VERB
ajcp-1397	157	5	global	global	ADJ
ajcp-1397	157	6	emergency	emergency	NOUN
ajcp-1397	157	7	:	:	PUNCT
ajcp-1397	157	8	a	a	DET
ajcp-1397	157	9	review	review	NOUN
ajcp-1397	157	10	of	of	ADP
ajcp-1397	157	11	the	the	DET
ajcp-1397	157	12	2019	2019	NUM
ajcp-1397	157	13	novel	novel	ADJ
ajcp-1397	157	14	coronavirus	coronavirus	NOUN
ajcp-1397	157	15	(	(	PUNCT
ajcp-1397	157	16	covid-19	covid-19	PROPN
ajcp-1397	157	17	)	)	PUNCT
ajcp-1397	157	18	.	.	PUNCT
ajcp-1397	158	1	international	international	ADJ
ajcp-1397	158	2	journal	journal	NOUN
ajcp-1397	158	3	of	of	ADP
ajcp-1397	158	4	surgery	surgery	NOUN
ajcp-1397	158	5	,	,	PUNCT
ajcp-1397	158	6	76	76	NUM
ajcp-1397	158	7	,	,	PUNCT
ajcp-1397	158	8	71	71	NUM
ajcp-1397	158	9	-	-	SYM
ajcp-1397	158	10	76	76	NUM
ajcp-1397	158	11	.	.	PUNCT
ajcp-1397	159	1	taryam	taryam	ADV
ajcp-1397	159	2	,	,	PUNCT
ajcp-1397	159	3	m.	m.	NOUN
ajcp-1397	159	4	,	,	PUNCT
ajcp-1397	159	5	alawadhi	alawadhi	PROPN
ajcp-1397	159	6	,	,	PUNCT
ajcp-1397	159	7	d.	d.	PROPN
ajcp-1397	159	8	,	,	PUNCT
ajcp-1397	159	9	al	al	PROPN
ajcp-1397	159	10	marzouqi	marzouqi	PROPN
ajcp-1397	159	11	,	,	PUNCT
ajcp-1397	159	12	a.	a.	NOUN
ajcp-1397	159	13	,	,	PUNCT
ajcp-1397	159	14	aburayya	aburayya	PROPN
ajcp-1397	159	15	,	,	PUNCT
ajcp-1397	159	16	a.	a.	PROPN
ajcp-1397	159	17	,	,	PUNCT
ajcp-1397	159	18	albaqa’een	albaqa’een	PROPN
ajcp-1397	159	19	,	,	PUNCT
ajcp-1397	159	20	a.	a.	NOUN
ajcp-1397	159	21	,	,	PUNCT
ajcp-1397	159	22	alfarsi	alfarsi	ADJ
ajcp-1397	159	23	,	,	PUNCT
ajcp-1397	159	24	a.	a.	NOUN
ajcp-1397	159	25	,	,	PUNCT
ajcp-1397	159	26	makki	makki	PROPN
ajcp-1397	159	27	,	,	PUNCT
ajcp-1397	159	28	i.	i.	PROPN
ajcp-1397	159	29	,	,	PUNCT
ajcp-1397	159	30	rahmani	rahmani	PROPN
ajcp-1397	159	31	,	,	PUNCT
ajcp-1397	159	32	n.	n.	NOUN
ajcp-1397	159	33	,	,	PUNCT
ajcp-1397	159	34	aljasmi	aljasmi	PROPN
ajcp-1397	159	35	,	,	PUNCT
ajcp-1397	159	36	m.	m.	NOUN
ajcp-1397	159	37	,	,	PUNCT
ajcp-1397	159	38	&	&	CCONJ
ajcp-1397	159	39	mubarak	mubarak	PROPN
ajcp-1397	159	40	,	,	PUNCT
ajcp-1397	159	41	s.	s.	PROPN
ajcp-1397	159	42	(	(	PUNCT
ajcp-1397	159	43	2021	2021	NUM
ajcp-1397	159	44	)	)	PUNCT
ajcp-1397	159	45	.	.	PUNCT
ajcp-1397	160	1	the	the	DET
ajcp-1397	160	2	impact	impact	NOUN
ajcp-1397	160	3	of	of	ADP
ajcp-1397	160	4	the	the	DET
ajcp-1397	160	5	covid-19	covid-19	PROPN
ajcp-1397	160	6	pandemic	pandemic	NOUN
ajcp-1397	160	7	on	on	ADP
ajcp-1397	160	8	the	the	DET
ajcp-1397	160	9	mental	mental	ADJ
ajcp-1397	160	10	health	health	NOUN
ajcp-1397	160	11	status	status	NOUN
ajcp-1397	160	12	of	of	ADP
ajcp-1397	160	13	healthcare	healthcare	NOUN
ajcp-1397	160	14	providers	provider	NOUN
ajcp-1397	160	15	in	in	ADP
ajcp-1397	160	16	the	the	DET
ajcp-1397	160	17	primary	primary	ADJ
ajcp-1397	160	18	health	health	NOUN
ajcp-1397	160	19	care	care	NOUN
ajcp-1397	160	20	sector	sector	NOUN
ajcp-1397	160	21	in	in	ADP
ajcp-1397	160	22	dubai	dubai	PROPN
ajcp-1397	160	23	.	.	PUNCT
ajcp-1397	161	1	linguistica	linguistica	PROPN
ajcp-1397	161	2	antverpiensia	antverpiensia	PROPN
ajcp-1397	161	3	,	,	PUNCT
ajcp-1397	161	4	21(2	21(2	NUM
ajcp-1397	161	5	)	)	PUNCT
ajcp-1397	161	6	,	,	PUNCT
ajcp-1397	161	7	2995	2995	NUM
ajcp-1397	161	8	-	-	SYM
ajcp-1397	161	9	3015	3015	NUM
ajcp-1397	161	10	.	.	PUNCT
ajcp-1397	162	1	thompson	thompson	PROPN
ajcp-1397	162	2	,	,	PUNCT
ajcp-1397	162	3	j.	j.	PROPN
ajcp-1397	162	4	l.	l.	PROPN
ajcp-1397	162	5	,	,	PUNCT
ajcp-1397	162	6	nguyen	nguyen	PROPN
ajcp-1397	162	7	,	,	PUNCT
ajcp-1397	162	8	l.	l.	PROPN
ajcp-1397	162	9	m.	m.	PROPN
ajcp-1397	162	10	,	,	PUNCT
ajcp-1397	162	11	noble	noble	ADJ
ajcp-1397	162	12	,	,	PUNCT
ajcp-1397	162	13	k.	k.	PROPN
ajcp-1397	162	14	n.	n.	PROPN
ajcp-1397	162	15	,	,	PUNCT
ajcp-1397	162	16	&	&	CCONJ
ajcp-1397	162	17	aronoff	aronoff	PROPN
ajcp-1397	162	18	,	,	PUNCT
ajcp-1397	162	19	d.	d.	PROPN
ajcp-1397	162	20	m.	m.	PROPN
ajcp-1397	162	21	(	(	PUNCT
ajcp-1397	162	22	2020	2020	NUM
ajcp-1397	162	23	)	)	PUNCT
ajcp-1397	162	24	.	.	PUNCT
ajcp-1397	163	1	covid-19	covid-19	PROPN
ajcp-1397	163	2	-	-	PUNCT
ajcp-1397	163	3	related	relate	VERB
ajcp-1397	163	4	disease	disease	NOUN
ajcp-1397	163	5	severity	severity	NOUN
ajcp-1397	163	6	in	in	ADP
ajcp-1397	163	7	pregnancy	pregnancy	NOUN
ajcp-1397	163	8	.	.	PUNCT
ajcp-1397	164	1	american	american	ADJ
ajcp-1397	164	2	journal	journal	PROPN
ajcp-1397	164	3	of	of	ADP
ajcp-1397	164	4	reproductive	reproductive	ADJ
ajcp-1397	164	5	immunology	immunology	NOUN
ajcp-1397	164	6	,	,	PUNCT
ajcp-1397	164	7	84(5	84(5	NOUN
ajcp-1397	164	8	)	)	PUNCT
ajcp-1397	164	9	,	,	PUNCT
ajcp-1397	164	10	e13339	e13339	PROPN
ajcp-1397	164	11	.	.	PUNCT
ajcp-1397	164	12	tuite	tuite	PROPN
ajcp-1397	164	13	,	,	PUNCT
ajcp-1397	164	14	a.	a.	PROPN
ajcp-1397	164	15	r.	r.	PROPN
ajcp-1397	164	16	,	,	PUNCT
ajcp-1397	164	17	fisman	fisman	PROPN
ajcp-1397	164	18	,	,	PUNCT
ajcp-1397	164	19	d.	d.	PROPN
ajcp-1397	164	20	n.	n.	PROPN
ajcp-1397	164	21	,	,	PUNCT
ajcp-1397	164	22	kwong	kwong	PROPN
ajcp-1397	164	23	,	,	PUNCT
ajcp-1397	164	24	j.	j.	PROPN
ajcp-1397	164	25	c.	c.	PROPN
ajcp-1397	164	26	,	,	PUNCT
ajcp-1397	164	27	&	&	CCONJ
ajcp-1397	164	28	greer	greer	PROPN
ajcp-1397	164	29	,	,	PUNCT
ajcp-1397	164	30	a.	a.	NOUN
ajcp-1397	164	31	l.	l.	PROPN
ajcp-1397	164	32	(	(	PUNCT
ajcp-1397	164	33	2010	2010	NUM
ajcp-1397	164	34	)	)	PUNCT
ajcp-1397	164	35	.	.	PUNCT
ajcp-1397	165	1	optimal	optimal	ADJ
ajcp-1397	165	2	pandemic	pandemic	ADJ
ajcp-1397	165	3	influenza	influenza	NOUN
ajcp-1397	165	4	vaccine	vaccine	NOUN
ajcp-1397	165	5	allocation	allocation	NOUN
ajcp-1397	165	6	strategies	strategy	NOUN
ajcp-1397	165	7	for	for	ADP
ajcp-1397	165	8	the	the	DET
ajcp-1397	165	9	canadian	canadian	ADJ
ajcp-1397	165	10	population	population	NOUN
ajcp-1397	165	11	.	.	PUNCT
ajcp-1397	166	1	plos	plos	PROPN
ajcp-1397	166	2	one	one	NUM
ajcp-1397	166	3	,	,	PUNCT
ajcp-1397	166	4	5(5	5(5	NUM
ajcp-1397	166	5	)	)	PUNCT
ajcp-1397	166	6	,	,	PUNCT
ajcp-1397	166	7	e10520	e10520	PROPN
ajcp-1397	166	8	.	.	PROPN
ajcp-1397	166	9	vousden	vousden	PROPN
ajcp-1397	166	10	,	,	PUNCT
ajcp-1397	166	11	n.	n.	NOUN
ajcp-1397	166	12	,	,	PUNCT
ajcp-1397	166	13	bunch	bunch	NOUN
ajcp-1397	166	14	,	,	PUNCT
ajcp-1397	166	15	k.	k.	PROPN
ajcp-1397	166	16	,	,	PUNCT
ajcp-1397	166	17	morris	morris	PROPN
ajcp-1397	166	18	,	,	PUNCT
ajcp-1397	166	19	e.	e.	PROPN
ajcp-1397	166	20	,	,	PUNCT
ajcp-1397	166	21	simpson	simpson	PROPN
ajcp-1397	166	22	,	,	PUNCT
ajcp-1397	166	23	n.	n.	NOUN
ajcp-1397	166	24	,	,	PUNCT
ajcp-1397	166	25	gale	gale	PROPN
ajcp-1397	166	26	,	,	PUNCT
ajcp-1397	166	27	c.	c.	NOUN
ajcp-1397	166	28	,	,	PUNCT
ajcp-1397	166	29	o’brien	o’brien	PROPN
ajcp-1397	166	30	,	,	PUNCT
ajcp-1397	166	31	p.	p.	NOUN
ajcp-1397	166	32	,	,	PUNCT
ajcp-1397	166	33	quigley	quigley	PROPN
ajcp-1397	166	34	,	,	PUNCT
ajcp-1397	166	35	m.	m.	NOUN
ajcp-1397	166	36	,	,	PUNCT
ajcp-1397	166	37	brocklehurst	brocklehurst	ADJ
ajcp-1397	166	38	,	,	PUNCT
ajcp-1397	166	39	p.	p.	NOUN
ajcp-1397	166	40	,	,	PUNCT
ajcp-1397	166	41	kurinczuk	kurinczuk	PROPN
ajcp-1397	166	42	,	,	PUNCT
ajcp-1397	166	43	j.	j.	PROPN
ajcp-1397	166	44	j.	j.	PROPN
ajcp-1397	166	45	,	,	PUNCT
ajcp-1397	166	46	&	&	CCONJ
ajcp-1397	166	47	knight	knight	NOUN
ajcp-1397	166	48	,	,	PUNCT
ajcp-1397	166	49	m.	m.	NOUN
ajcp-1397	166	50	(	(	PUNCT
ajcp-1397	166	51	2021	2021	NUM
ajcp-1397	166	52	)	)	PUNCT
ajcp-1397	166	53	.	.	PUNCT
ajcp-1397	167	1	the	the	DET
ajcp-1397	167	2	incidence	incidence	NOUN
ajcp-1397	167	3	,	,	PUNCT
ajcp-1397	167	4	characteristics	characteristic	NOUN
ajcp-1397	167	5	and	and	CCONJ
ajcp-1397	167	6	outcomes	outcome	NOUN
ajcp-1397	167	7	of	of	ADP
ajcp-1397	167	8	pregnant	pregnant	ADJ
ajcp-1397	167	9	women	woman	NOUN
ajcp-1397	167	10	hospitalized	hospitalize	VERB
ajcp-1397	167	11	with	with	ADP
ajcp-1397	167	12	symptomatic	symptomatic	ADJ
ajcp-1397	167	13	and	and	CCONJ
ajcp-1397	167	14	asymptomatic	asymptomatic	ADJ
ajcp-1397	167	15	sars	sar	NOUN
ajcp-1397	167	16	-	-	PUNCT
ajcp-1397	167	17	cov-2	cov-2	NOUN
ajcp-1397	167	18	infection	infection	NOUN
ajcp-1397	167	19	in	in	ADP
ajcp-1397	167	20	the	the	DET
ajcp-1397	167	21	uk	uk	PROPN
ajcp-1397	167	22	from	from	ADP
ajcp-1397	167	23	march	march	PROPN
ajcp-1397	167	24	to	to	ADP
ajcp-1397	167	25	september	september	PROPN
ajcp-1397	167	26	2020	2020	NUM
ajcp-1397	167	27	:	:	PUNCT
ajcp-1397	167	28	a	a	DET
ajcp-1397	167	29	national	national	ADJ
ajcp-1397	167	30	cohort	cohort	NOUN
ajcp-1397	167	31	study	study	NOUN
ajcp-1397	167	32	using	use	VERB
ajcp-1397	167	33	the	the	DET
ajcp-1397	167	34	uk	uk	PROPN
ajcp-1397	167	35	obstetric	obstetric	ADJ
ajcp-1397	167	36	surveillance	surveillance	NOUN
ajcp-1397	167	37	system	system	NOUN
ajcp-1397	167	38	(	(	PUNCT
ajcp-1397	167	39	ukoss	ukoss	NOUN
ajcp-1397	167	40	)	)	PUNCT
ajcp-1397	167	41	.	.	PUNCT
ajcp-1397	168	1	plos	plos	PROPN
ajcp-1397	168	2	one	one	NUM
ajcp-1397	168	3	,	,	PUNCT
ajcp-1397	168	4	16(5	16(5	NUM
ajcp-1397	168	5	)	)	PUNCT
ajcp-1397	168	6	,	,	PUNCT
ajcp-1397	168	7	e0251123	e0251123	NOUN
ajcp-1397	168	8	.	.	PUNCT
ajcp-1397	169	1	https://doi.org/10.1371/journal	https://doi.org/10.1371/journal	ADJ
ajcp-1397	169	2	.	.	PUNCT
ajcp-1397	170	1	pone.0251123	pone.0251123	PROPN
ajcp-1397	170	2	wang	wang	PROPN
ajcp-1397	170	3	,	,	PUNCT
ajcp-1397	170	4	d.	d.	PROPN
ajcp-1397	170	5	,	,	PUNCT
ajcp-1397	170	6	hu	hu	PROPN
ajcp-1397	170	7	,	,	PUNCT
ajcp-1397	170	8	b.	b.	PROPN
ajcp-1397	170	9	,	,	PUNCT
ajcp-1397	170	10	hu	hu	PROPN
ajcp-1397	170	11	,	,	PUNCT
ajcp-1397	170	12	c.	c.	PROPN
ajcp-1397	170	13	,	,	PUNCT
ajcp-1397	170	14	zhu	zhu	PROPN
ajcp-1397	170	15	,	,	PUNCT
ajcp-1397	170	16	f.	f.	PROPN
ajcp-1397	170	17	,	,	PUNCT
ajcp-1397	170	18	liu	liu	PROPN
ajcp-1397	170	19	,	,	PUNCT
ajcp-1397	170	20	x.	x.	PROPN
ajcp-1397	170	21	,	,	PUNCT
ajcp-1397	170	22	zhang	zhang	PROPN
ajcp-1397	170	23	,	,	PUNCT
ajcp-1397	170	24	j.	j.	PROPN
ajcp-1397	170	25	,	,	PUNCT
ajcp-1397	170	26	wang	wang	PROPN
ajcp-1397	170	27	,	,	PUNCT
ajcp-1397	170	28	b.	b.	PROPN
ajcp-1397	170	29	,	,	PUNCT
ajcp-1397	170	30	xiang	xiang	PROPN
ajcp-1397	170	31	,	,	PUNCT
ajcp-1397	170	32	h.	h.	PROPN
ajcp-1397	170	33	,	,	PUNCT
ajcp-1397	170	34	cheng	cheng	PROPN
ajcp-1397	170	35	,	,	PUNCT
ajcp-1397	170	36	z.	z.	PROPN
ajcp-1397	170	37	,	,	PUNCT
ajcp-1397	170	38	&	&	CCONJ
ajcp-1397	170	39	xiong	xiong	PROPN
ajcp-1397	170	40	,	,	PUNCT
ajcp-1397	170	41	y.	y.	PROPN
ajcp-1397	170	42	(	(	PUNCT
ajcp-1397	170	43	2020	2020	NUM
ajcp-1397	170	44	)	)	PUNCT
ajcp-1397	170	45	.	.	PUNCT
ajcp-1397	171	1	clinical	clinical	ADJ
ajcp-1397	171	2	characteristics	characteristic	NOUN
ajcp-1397	171	3	of	of	ADP
ajcp-1397	171	4	138	138	NUM
ajcp-1397	171	5	hospitalized	hospitalize	VERB
ajcp-1397	171	6	patients	patient	NOUN
ajcp-1397	171	7	with	with	ADP
ajcp-1397	171	8	2019	2019	NUM
ajcp-1397	171	9	novel	novel	ADJ
ajcp-1397	171	10	coronavirus	coronavirus	NOUN
ajcp-1397	171	11	–	–	PUNCT
ajcp-1397	171	12	infected	infected	ADJ
ajcp-1397	171	13	pneumonia	pneumonia	NOUN
ajcp-1397	171	14	in	in	ADP
ajcp-1397	171	15	wuhan	wuhan	PROPN
ajcp-1397	171	16	,	,	PUNCT
ajcp-1397	171	17	china	china	PROPN
ajcp-1397	171	18	.	.	PUNCT
ajcp-1397	172	1	jama	jama	PROPN
ajcp-1397	172	2	,	,	PUNCT
ajcp-1397	172	3	323(11	323(11	NUM
ajcp-1397	172	4	)	)	PUNCT
ajcp-1397	172	5	,	,	PUNCT
ajcp-1397	172	6	1061	1061	NUM
ajcp-1397	172	7	-	-	SYM
ajcp-1397	172	8	1069	1069	NUM
ajcp-1397	172	9	.	.	PUNCT
ajcp-1397	173	1	https://doi	https://doi	PROPN
ajcp-1397	173	2	.	.	PUNCT
ajcp-1397	173	3	org/10.1001	org/10.1001	PROPN
ajcp-1397	173	4	/	/	SYM
ajcp-1397	173	5	jama.2020.1585	jama.2020.1585	PROPN
ajcp-1397	173	6	wastnedge	wastnedge	NOUN
ajcp-1397	173	7	,	,	PUNCT
ajcp-1397	173	8	e.	e.	PROPN
ajcp-1397	173	9	a.	a.	PROPN
ajcp-1397	173	10	,	,	PUNCT
ajcp-1397	173	11	reynolds	reynolds	PROPN
ajcp-1397	173	12	,	,	PUNCT
ajcp-1397	173	13	r.	r.	PROPN
ajcp-1397	173	14	m.	m.	PROPN
ajcp-1397	173	15	,	,	PUNCT
ajcp-1397	173	16	van	van	PROPN
ajcp-1397	173	17	boeckel	boeckel	NOUN
ajcp-1397	173	18	,	,	PUNCT
ajcp-1397	173	19	s.	s.	PROPN
ajcp-1397	173	20	r.	r.	PROPN
ajcp-1397	173	21	,	,	PUNCT
ajcp-1397	173	22	stock	stock	NOUN
ajcp-1397	173	23	,	,	PUNCT
ajcp-1397	173	24	s.	s.	PROPN
ajcp-1397	173	25	j.	j.	PROPN
ajcp-1397	173	26	,	,	PUNCT
ajcp-1397	173	27	denison	denison	PROPN
ajcp-1397	173	28	,	,	PUNCT
ajcp-1397	173	29	f.	f.	PROPN
ajcp-1397	173	30	c.	c.	PROPN
ajcp-1397	173	31	,	,	PUNCT
ajcp-1397	173	32	maybin	maybin	PROPN
ajcp-1397	173	33	,	,	PUNCT
ajcp-1397	173	34	j.	j.	PROPN
ajcp-1397	173	35	a.	a.	PROPN
ajcp-1397	173	36	,	,	PUNCT
ajcp-1397	173	37	&	&	CCONJ
ajcp-1397	173	38	critchley	critchley	PROPN
ajcp-1397	173	39	,	,	PUNCT
ajcp-1397	173	40	h.	h.	PROPN
ajcp-1397	173	41	o.	o.	PROPN
ajcp-1397	173	42	(	(	PUNCT
ajcp-1397	173	43	2021	2021	NUM
ajcp-1397	173	44	)	)	PUNCT
ajcp-1397	173	45	.	.	PUNCT
ajcp-1397	174	1	pregnancy	pregnancy	NOUN
ajcp-1397	174	2	and	and	CCONJ
ajcp-1397	174	3	covid-19	covid-19	PROPN
ajcp-1397	174	4	.	.	PUNCT
ajcp-1397	174	5	physiological	physiological	ADJ
ajcp-1397	174	6	reviews	review	NOUN
ajcp-1397	174	7	,	,	PUNCT
ajcp-1397	174	8	101(1	101(1	NUM
ajcp-1397	174	9	)	)	PUNCT
ajcp-1397	174	10	,	,	PUNCT
ajcp-1397	174	11	303	303	NUM
ajcp-1397	174	12	-	-	SYM
ajcp-1397	174	13	318	318	NUM
ajcp-1397	174	14	.	.	PUNCT
ajcp-1397	175	1	wenham	wenham	PROPN
ajcp-1397	175	2	,	,	PUNCT
ajcp-1397	175	3	c.	c.	PROPN
ajcp-1397	175	4	,	,	PUNCT
ajcp-1397	175	5	smith	smith	PROPN
ajcp-1397	175	6	,	,	PUNCT
ajcp-1397	175	7	j.	j.	PROPN
ajcp-1397	175	8	,	,	PUNCT
ajcp-1397	175	9	&	&	CCONJ
ajcp-1397	175	10	morgan	morgan	PROPN
ajcp-1397	175	11	,	,	PUNCT
ajcp-1397	175	12	r.	r.	PROPN
ajcp-1397	175	13	(	(	PUNCT
ajcp-1397	175	14	2020	2020	NUM
ajcp-1397	175	15	)	)	PUNCT
ajcp-1397	175	16	.	.	PUNCT
ajcp-1397	176	1	covid-19	covid-19	PROPN
ajcp-1397	176	2	:	:	PUNCT
ajcp-1397	176	3	the	the	DET
ajcp-1397	176	4	gendered	gendere	VERB
ajcp-1397	176	5	impacts	impact	NOUN
ajcp-1397	176	6	of	of	ADP
ajcp-1397	176	7	the	the	DET
ajcp-1397	176	8	outbreak	outbreak	NOUN
ajcp-1397	176	9	.	.	PUNCT
ajcp-1397	177	1	the	the	DET
ajcp-1397	177	2	lancet	lancet	PROPN
ajcp-1397	177	3	,	,	PUNCT
ajcp-1397	177	4	395(10227	395(10227	NUM
ajcp-1397	177	5	)	)	PUNCT
ajcp-1397	177	6	,	,	PUNCT
ajcp-1397	177	7	846	846	NUM
ajcp-1397	177	8	-	-	SYM
ajcp-1397	177	9	848	848	NUM
ajcp-1397	177	10	.	.	PUNCT
ajcp-1397	178	1	https://doi.org/10.1016/	https://doi.org/10.1016/	PROPN
ajcp-1397	178	2	s0140	s0140	PROPN
ajcp-1397	178	3	-	-	PUNCT
ajcp-1397	178	4	6736(20)30526	6736(20)30526	NUM
ajcp-1397	178	5	-	-	PUNCT
ajcp-1397	178	6	2	2	NUM
ajcp-1397	178	7	whitehead	whitehead	NOUN
ajcp-1397	178	8	,	,	PUNCT
ajcp-1397	178	9	c.	c.	PROPN
ajcp-1397	178	10	l.	l.	PROPN
ajcp-1397	178	11	,	,	PUNCT
ajcp-1397	178	12	&	&	CCONJ
ajcp-1397	178	13	walker	walker	PROPN
ajcp-1397	178	14	,	,	PUNCT
ajcp-1397	178	15	s.	s.	PROPN
ajcp-1397	178	16	p.	p.	PROPN
ajcp-1397	178	17	(	(	PUNCT
ajcp-1397	178	18	2020	2020	NUM
ajcp-1397	178	19	)	)	PUNCT
ajcp-1397	178	20	.	.	PUNCT
ajcp-1397	179	1	consider	consider	VERB
ajcp-1397	179	2	pregnancy	pregnancy	NOUN
ajcp-1397	179	3	in	in	ADP
ajcp-1397	179	4	covid-19	covid-19	PROPN
ajcp-1397	179	5	therapeutic	therapeutic	ADJ
ajcp-1397	179	6	drug	drug	NOUN
ajcp-1397	179	7	and	and	CCONJ
ajcp-1397	179	8	vaccine	vaccine	NOUN
ajcp-1397	179	9	trials	trial	NOUN
ajcp-1397	179	10	.	.	PUNCT
ajcp-1397	180	1	the	the	DET
ajcp-1397	180	2	lancet	lancet	NOUN
ajcp-1397	180	3	,	,	PUNCT
ajcp-1397	180	4	395(10237	395(10237	NUM
ajcp-1397	180	5	)	)	PUNCT
ajcp-1397	180	6	,	,	PUNCT
ajcp-1397	180	7	e92	e92	NOUN
ajcp-1397	180	8	.	.	PUNCT
ajcp-1397	181	1	https://doi	https://doi	PROPN
ajcp-1397	181	2	.	.	PUNCT
ajcp-1397	182	1	org/10.1016	org/10.1016	PROPN
ajcp-1397	182	2	/	/	SYM
ajcp-1397	182	3	s0140	s0140	PROPN
ajcp-1397	182	4	-	-	PUNCT
ajcp-1397	182	5	6736(20)31029	6736(20)31029	NUM
ajcp-1397	182	6	-	-	PUNCT
ajcp-1397	182	7	1	1	NUM
ajcp-1397	182	8	yan	yan	PROPN
ajcp-1397	182	9	,	,	PUNCT
ajcp-1397	182	10	j.	j.	PROPN
ajcp-1397	182	11	,	,	PUNCT
ajcp-1397	182	12	guo	guo	PROPN
ajcp-1397	182	13	,	,	PUNCT
ajcp-1397	182	14	j.	j.	PROPN
ajcp-1397	182	15	,	,	PUNCT
ajcp-1397	182	16	fan	fan	PROPN
ajcp-1397	182	17	,	,	PUNCT
ajcp-1397	182	18	c.	c.	PROPN
ajcp-1397	182	19	,	,	PUNCT
ajcp-1397	182	20	juan	juan	PROPN
ajcp-1397	182	21	,	,	PUNCT
ajcp-1397	182	22	j.	j.	PROPN
ajcp-1397	182	23	,	,	PUNCT
ajcp-1397	182	24	yu	yu	PROPN
ajcp-1397	182	25	,	,	PUNCT
ajcp-1397	182	26	x.	x.	PROPN
ajcp-1397	182	27	,	,	PUNCT
ajcp-1397	182	28	li	li	PROPN
ajcp-1397	182	29	,	,	PUNCT
ajcp-1397	182	30	j.	j.	PROPN
ajcp-1397	182	31	,	,	PUNCT
ajcp-1397	182	32	feng	feng	PROPN
ajcp-1397	182	33	,	,	PUNCT
ajcp-1397	182	34	l.	l.	PROPN
ajcp-1397	182	35	,	,	PUNCT
ajcp-1397	182	36	li	li	PROPN
ajcp-1397	182	37	,	,	PUNCT
ajcp-1397	182	38	c.	c.	PROPN
ajcp-1397	182	39	,	,	PUNCT
ajcp-1397	182	40	chen	chen	PROPN
ajcp-1397	182	41	,	,	PUNCT
ajcp-1397	182	42	h.	h.	PROPN
ajcp-1397	182	43	,	,	PUNCT
ajcp-1397	182	44	&	&	CCONJ
ajcp-1397	182	45	qiao	qiao	PROPN
ajcp-1397	182	46	,	,	PUNCT
ajcp-1397	182	47	y.	y.	PROPN
ajcp-1397	182	48	(	(	PUNCT
ajcp-1397	182	49	2020	2020	NUM
ajcp-1397	182	50	)	)	PUNCT
ajcp-1397	182	51	.	.	PUNCT
ajcp-1397	183	1	coronavirus	coronavirus	NOUN
ajcp-1397	183	2	disease	disease	NOUN
ajcp-1397	183	3	2019	2019	NUM
ajcp-1397	183	4	in	in	ADP
ajcp-1397	183	5	pregnant	pregnant	ADJ
ajcp-1397	183	6	women	woman	NOUN
ajcp-1397	183	7	:	:	PUNCT
ajcp-1397	183	8	a	a	DET
ajcp-1397	183	9	report	report	NOUN
ajcp-1397	183	10	based	base	VERB
ajcp-1397	183	11	on	on	ADP
ajcp-1397	183	12	116	116	NUM
ajcp-1397	183	13	cases	case	NOUN
ajcp-1397	183	14	.	.	PUNCT
ajcp-1397	184	1	american	american	ADJ
ajcp-1397	184	2	journal	journal	PROPN
ajcp-1397	184	3	of	of	ADP
ajcp-1397	184	4	obstetrics	obstetric	NOUN
ajcp-1397	184	5	and	and	CCONJ
ajcp-1397	184	6	gynecology	gynecology	NOUN
ajcp-1397	184	7	,	,	PUNCT
ajcp-1397	184	8	223(1	223(1	NUM
ajcp-1397	184	9	)	)	PUNCT
ajcp-1397	184	10	,	,	PUNCT
ajcp-1397	184	11	111	111	NUM
ajcp-1397	184	12	e1	e1	NOUN
ajcp-1397	184	13	.	.	PUNCT
ajcp-1397	185	1	https://doi.org/10.1016/j.ajog.2020.04.014	https://doi.org/10.1016/j.ajog.2020.04.014	VERB
ajcp-1397	185	2	https://journals.e-palli.com/home/index.php/ajcp	https://journals.e-palli.com/home/index.php/ajcp	PROPN